Stockabbreviation:BGIGenomics
Stockcode:3067
and Governance Report
CONTENTS
Solid Foundation and Shared Ecological Benefit
AppendixI:KeyPerformanceIndicator17
Steady Progress
AppendixII:ReportIndex 12
CorporateGovernance 21 EnvironmentalComplianceManagement
83 AppendixIII:ReaderFeedbackForm 123
RiskandComplianceManagement 27
PollutantandWasteManagement 87
BusinessEthics 31
AddressingClimateChange 90
EnergyManagementandCircular
Economy 92
EcosystemandBiodiversityConservation
94
Intelligence for Life 04 People-Oriented:
Inclusiveness for the
Common Good
ProductSafetyandQuality 39 EmployeeEmployment 97
CustomerService 49 ProtectionofEmployeeRights 9
Innovation-DrivenDevelopment
AboutThisReport 01
DataSecurityandCustomerPrivacy
AboutBGIGenomics 05 SupplyChainManagement 73 HealthcareAccessibilityandInclusive
Healthcare 10
SectorCollaboration 78
ESGManagement 09
SpecialTopic
Intelligently Shaping the Future
of Genomics,Empowering a New
Ecosystem of Precision Medicine
with Digital Intelligence 15
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
About This Report
Introduction
This Report is the Environmental, Social and Governance Report issued by BGI Genomics Co. , Ltd. ( hereinafter
referred to as 4BGI Genomics4 or the 4Company4) to its stakeholders. The Company has systematically reviewed
and presented its key ESG management initiatives, progress, and performance in 2 0 5 , framed within the three
dimensions of environment, society, and corporate governance. This Report illustrates the Company5s approaches
and achievements in implementing sustainability concepts in its daily operations and management activities.
Through clearer and more traceable disclosure of responsibility information, the Company hopes to help all
stakeholdersfullyunderstanditsESGpracticesandrespondpromptlytotheirconcernsandexpectations.
Reporting Period GlobalReportingInitiative(GRI)Standards
This Report covers the period from January 1, 205 to December 31, 205. To enhance comparability, some content Self-Regulatory Guidelines No. 2 for Listed Companies on Shenzhen Stock Exchange !? Standardized Operation of
hasbeenappropriatelyextendedtopreviousandsubsequentyears. CompaniesListedontheChiNextMarket
Reporting Boundary Self-RegulatoryGuidelinesNo.17forListedCompaniesonShenzhenStockExchange!?SustainabilityReport(forTrial
Implementation)
This Report is based on BGI Genomics Co., Ltd. as the main entity. Unless otherwise specified, the scope of this
Report is consistent with the scope of the Company5s consolidated Gnancial statements for its 205 annual report, Self- Regulator y Guidance No. 3 for Companies Listed on the ChiNext Market of Shenzhen Stock Exchange ! ?
coveringthegroup5sheadquartersanditssubordinatebranchesandsubsidiaries. PreparationofSustainabilityReports
Data Sources Definitions
The qualitative and quantitative information used in this Report is derived from BGI Genomics5 official internal For ease of expression and reading, BGI Genomics Co., Ltd. is also referred to as 4BGI Genomics4, the 4Company4, or
documents and annual reports. The data disclosed in this Report is sourced from the Company5s actual operational 4we4inthisReport.
How to Obtain the Report
raw data, publicly available government data, annual Gnancial data, internal statistical reports, third-party surveys,
and third- party evaluation interviews. The financial data in this Report is denominated in RMB. In case of any
ThisReportisavailableinelectronicformat.YoucanviewitontheCompany5swebsite(https:/www.bgi.com/)oron
discrepancieswiththeCompany5sannualGnancialreport,theannualGnancialreportshallprevail.
CNINFO (http:/www.cninfo.com.cn). If you have any questions or suggestions regarding this Report, please send an
Preparation Basis emailtoinfo@genomics.cnorcall+86-75302
UnitedNationsSustainableDevelopmentGoals(SDGs)
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
— Safeguarding Public Health Through Genomics
qualitydevelopment.
With stable growth as our foundation, we are committed to improving quality and efficiency and serving pu
well-being.
We will continue to focus on the steady growth and proGtability of our core business, strengthen lea
operations and cost control, and build a solid foundation for development through sound management. We wil
steadfastly uphold our mission of 4Omics for All4, making dedicated progress in critical public-need areas such
reproductive health, cancer prevention and control, infectious diseases, and chronic disease management. We wil
usecutting-edgetechnologytobuildastronglineofdefenseforpublichealthandsafeguardthewell-beingofe
familywiththewarmthoftechnology.
With intelligent large models at our core, we will transition to a life and health intelligence
We will plat
To all our partners, friends from all walks of life comprehensivelypromotethedeepintegrationofAIandlifesciences.Usingthelarge-scaleapplicationoftheGene
who care for and support BGI Genomics, and clinical large model as a key entry point, we will significantly improve the efficiency of pathogenic sit
everyinvestor: reducethecostofgeneinterpretation,andstrivetoclosetheloopbetweendatagovernanceandclinicaltransl
Chairman
Wang Jian
This will drive the Company5s transformation from a gene testing service provider to a life and health intelli
platform. By training vertical-domain life science large models with multi-omics data, we aim to bring gene testi
into the hundred-yuan era. Meanwhile, our SIRO high-throughput gene testing localized medical solution integrates
the four core advantages of standardization, automation, informatization, and intelligence, truly realizing the l
scaleandin-depthapplicationofartiGcialintelligencetechnologyintheGeldofgenesequencing.
Theyear205wasayearoftransformation,buildingmomentum,andsteadyqualityimprovementforBGIGenomics.
We remained true to our original aspiration in scientific research, deepened our industrial application, and Withglobalizationasourwings,wewillexpandintothe4BeltandRoad4andBRICScountries.
Wewillmakeoverseas
continuously solidiGed our foundation in technological innovation and global expansion, leveraging our proprietary expansion a core engine for growth, adhering to a country- specific and deeply localized approach. Thro
technologyplatformsandcorebigdataadvantagestogathermomentumforanewroundofstrategicupgrades.This a 4 technology export + local cooperation4 model, we will deepen overseas technology transfer and indus
conGdence in our steady progress is inseparable from the valuable experience accumulated through the dedicated implementation,integratelocalsupplychains,andcollaboratewithotherChineseenterprisesgoingabroadtobr
eFortsofourpastmanagementteams,andevenmoresofromtheunitedandconcertedeFortsofallBGIemployees China5sgenetechnology,standards,andservicestotheworld.
andpartnersfromallsectors.
In 206, challenges and opportunities coexist, and our original aspiration and mission go hand in hand. Standing at
The year 20 6 is a crucial year for forging ahead and achieving breakthroughs.
As the inaugural year of the 415th theforefrontofanerawherebiotechnologyandthedigitaleconomyaredeeplyintegrated,allofusatBGIwillalwa
Five-Year Plan4 , we are closely following the national strategic direction driven by technological innovation and embodytherigorofresearchers,thepassionofentrepreneurs,andtheresponsibilityofstrivers.Wewillempowerlife
meeting the era5s demand for technological self-reliance, seizing the momentum to plan for the long term. The Year sciences with AI, connect the world through globalization, and work together to create a magniGcent vision of gene
of the Horse symbolizes momentum and breakthroughs. Standing at the forefront of an era where bio-intelligence technologysafeguardinglifeandbeneGtingallofhumanity!
and globalization are deeply integrated, BGI Genomics will be driven by the twin engines of AI and globalization. We
will anchor our eForts in three major directions: 4stable growth in core business, leapfrog development of our life
platform,andincrementalexpansionofourglobalfootprint4,asweforgeaheadtoembarkonanewjourneyofhigh-
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
About BGI Genomics
In the field of reproductive health, the Company provides a complete 4 Five- pre4 maternal and child hea
management product system, covering the pre- marital, pre- conception, prenatal, neonatal, and child gr
Company profile
stages. In cancer prevention and control, it has formed a closed-loop management system for the entire life cycle
tumors, focusing on 4prevention, screening, diagnosis, and monitoring,4 oFering comprehensive testing services at
each stage. For chronic disease management, the Company is committed to improving the eIciency of screening
As a leader in the global genomics sector, BGI Genomics upholds the mission of 4Omics for All.4 Through over 20 and treatment for cardiovascular and cerebrovascular diseases and cognitive disorders, promoting a diagnosi
years of talent acquisition, scientific research, and industrial development, we have established a marketing and treatmentmodelcenteredonpreventionandproactivehealth.Intheareaofinfectionpreventionandcontrol,it
service network covering more than 10 countries and all provinces, municipalities, and autonomous regions in developedprecisetestingproductsolutionsforeverythingfromcommoncommunityinfectionstocomplexhospi
China.Wehavebecomeoneofthefewtechnologycompaniesthatcovertheentireindustrychainandallapplication acquiredinfections,meetingtheneedsofall-scenariotesting.
fields in our sector. Leveraging our technologically advanced, fully equipped, and large-scale multi-omics output
platform, we have become one of the world5s few providers of scientiGc and technological services and operators of Business regions
Main business
precisionmedicineservices.
Headquartered in Shenzhen, China, the Company has branches and medical laboratories in major domestic cities
The Company5 s main business is to provide research services, comprehensive solutions for precision medicine such as Beijing, Tianjin, Wuhan, Shanghai, and Guangzhou. It also has overseas centers and core laboratories in
testing, and health management services for scientific research institutions, enterprises and public institutions, regions including Hong Kong, Europe, Asia-Pacific, and the Middle East. It has established a network that covers
medical institutions, and social health organizations through multi-omics and big data technologies such as gene the entire country and reaches globally, with business operations in over 10 countries and regions. This includes
testing,massspectrometrytesting,bioinformaticsanalysis,andmedicalintelligentlargemodels. more than 2 , 0 research institutions and 2 , 4 0 medical institutions in China, over 3 , 0 overseas medical and
research institutions in Europe, the Americas, and the Asia-PaciGc region, and cooperative relationships with health
authoritiesinmorethan30countriesandregions.
Corporate culture
Premaritalandpre-pregnancy Prenatal Newborn ChildrenAdolescents
&
Infertility
Mission Vision
Miscarriagecause
investigation
Chromosomal 4OmicsforAll4 HealthandBeauty,LeadingtheLife
Marriageandpregnancy
Pregnancy abnormality
testing(CNV-seq)
ScienceEra
Childbirth
Secondaryprevention Tertiaryprevention Auxiliarydiagnosis
Non-invasiveprenataltestingNewbornhearingloss Geneticdiseasetesting
Primaryprevention (NIFTY) genescreening (CNV-seq,WGS)
Infertility IVF Non-invasiveprenataltesting
Newbornscreeningfor
Expandedcarrier formultiplemonogenic inheritedmetabolic
screeningfor diseases diseases Precisionmedication
thalassemiagenes Selectionof PrenataldiagnosisofgeneticNewborngenetic Genetictesting
healthyembryos diseases(CNV-seq,WGS) diseasescreening forpersonalized
Preimplantation Prenatalnutritiontesting medicationguidance
genetictesting(PGT) forchildren
Middle-agedandelderly
Infection Cancer Chronicdiseases
Precisiondiagnostics CancerpreventionEarlycancerscreening Riskassessment Nutritional
High-throughputgenetic Genetictestingfor DNAmethylationtesting Genetictestingfor metabolism
testingforpathogenic hereditarytumors forcolorectalcancer hereditarycardiovascularPrecision
microorganisms HPVgenotypingtest DNAmethylationtesting diseases nutritiontesting
Targetedgenetictestingfor Helicobacterpyloriforlivercancer GenetictestingfortheriskPrecision CoreValues
pathogenicmicroorganisms testing DNAmethylationtesting ofprematurecoronary metabolism
Multiplexnucleicacid forcervicalcancer heartdisease testing
testingforpathogenic Companion Recurrencemonitoring Homocysteinemetabolism Unlocking the Mysteries of Life, Composing a New
microorganisms diagnostics pathwaytesting
CustomizedMRDtesting
InHuenzaA/Bvirusantigen
self-test Genetictesting fortumors
TrimethylamineN-oxide
(TMAO)metabolism
IndustrialChapter,andExperiencingaWonderfulLife
forpersonalized pathwaytesting
Medicationguidance diagnosisand Multipleneurocarboxylic
treatmentofsingle acidtesting
Multiplextestingforbacterial cancertypes
drugresistancegenes Genetictestingforcognitive
Genetictesting disorders
Mycobacteriumtuberculosis forpersonalized
anddrugresistancegene diagnosisand
testing treatmentofpan- Precisionmedication
solidtumors
Genetictestingforpersonalizedmedication
guidanceforadults
Therapeuticdrugmonitoring
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Core honors of 2025
ESG Performance
Competitiveness
Selected as a demonstrative case in Biomedicine for ChinaFund 2025 China isted Companies inghua on two rst pri es of the 202 Guangdong Provincial
Global
new quality productive forces practice by the Award A-share ESG Demonstration Case Science and Technology Progress Award
Times
Selected for the Top 00 isted Healthcare CompaniesSelected as one of 6Kr s 2025 Innovative Enterprises Recogni ed as Outstanding Sci-tech Innovation arge-scale Application of AI-driven Precision Medicine
by Innovation Capability for Globali ation Enterprise of the ear Big Data won the People s Artisan Technology Award
Selected by the National Data Administration as
Selected into the 2025 China Technology Fast 50
a pioneering unit for High-quality Sector Dataset
Construction
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
ESG management
Communications with stakeholders
BGI Genomics identiGes government and regulatory agencies, shareholders and investors, customers, employees,
suppliers and partners, and the community and public as its core stakeholders. Through regular communication
mechanisms such as earnings calls, investor sur veys, customer forums, employee inter views, and supplier
conferences, the Company continuously collects stakeholder requests and suggestions to align its ESG work with
theirneedsandconcerns.
BGIGenomics5keystakeholdersandcommunicationmethods
Stakeholders Topicsofconcern Communicationandresponsechannels Stakeholders Topicsofconcern Communicationandresponsechannels
Corporategovernance Corporategovernance
Riskandcompliancemanagement ConveningoftheTwoMeetings Riskandcompliancemanagement Regularcommunicationandreporting
Anti-commercialbriberyandanti- Periodicinformationdisclosure Anti-commercialbriberyandanti- On-sitereview
corruption Internalaudit corruption Institutionalresearch
Shareholdersandsenior Anti-unfaircompetition Roadshowsandcommunicationwiththe Governmentand Ethicsofscienceandtechnology Policyimplementation
management Duediligence Company regulatoryagencies Environmentalcompliancemanagement Informationdisclosure
Communicationswithstakeholders Pollutantandwastemanagement
Supplychainsecurity
Productsafetyandquality On-sitecommunication Publicbiddingmeetings
Industrycollaboration
Customerservice Marketresearch Supplieraudit
Productsafetyandquality
Innovation-drivendevelopment Customercomplainthandling Strategiccooperation
Customerservice
Datasecurityandcustomerprivacy Customersatisfactionsurveys Participationinindustryexhibitions
Customers Partners Equaltreatmenttosmallandmedium-
protection Informationsecurityprotection Exchangevisits
sizedenterprises
Employeeactivities
Employeeemployment Employeetraining Pollutantandwastemanagement Environmentalmanagement
Protectionofemployeerights Employeecare Contributionstothesocietyandrural Communityvolunteeractivities
Employeetraininganddevelopment Employeeforums revitalization Medicalcommunityactivities
Community,public,and
Employees Occupationalhealthandsafety Employeehandbook Medicalaccessibility Socialwelfaresupportprojects
media
Employeehealthcheck-ups
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Double materiality analysis Environmentaldimension Socialdimension Governancedimension
In 2 0 2 5 , guided by national policies, research on domestic and international social responsibility standards, 1.Environmentalcompliancemanagement 2.Corporategovernance
ruralrevitalization rights
and industry benchmarking, BGI Genomics conducted a systematic materiality analysis based on its business
developmentstrategy,operationalmanagementpractices,andkeystakeholderconcerns.Throughaprocessoftopic 16.Employeetrainingand 23.Riskandcompliance
development management
identiGcation, assessment, and conGrmation, the Company ultimately identiGed a total of 27 material ESG topics to
address stakeholder demands more eFectively. The Company prioritized these topics based on the two dimensions 17.Occupationalhealthand 4.Anti-
Water
safety anti-corruption
of financial materiality and impact materiality, providing a basis for defining annual sustainability management
priorities,optimizingimplementationsequences,andsettinglong-termandspeciGcESGgoals. 18.Equaltreatmentto
enterprises
BGIGenomics5materialityanalysissteps 19.Ethicsofscienceand
technology
Step1 Topicbenchmarkingandscreening protection stakeholders
BasedontheCompany5sbusinessdevelopmentandcurrentESGmanagementstatus,andwithreference
to the latest national sustainability policies and mainstream domestic and international sustainability
standards, the Company comprehensively identiGes ESG topics related to its business operations and
sustainabilitymanagement.Thisprocessalsoinvolvesbenchmarkingagainsttheinformationdisclosure 10
practices of leading peers and the key focus areas of mainstream ESG rating agencies in the capital
market. 9 19
Step2 Communicationswithstakeholders
Impactmateriality
The Company continuously monitors social needs and policy trends, including regulatory requirements,
sustainability status and trends, and capital market dynamics. Through diverse communication
channels, it maintains communication and exchanges with stakeholders, establishing and preserving
essential positive relationships to fully understand their key concerns and feedback on sustainability 18
matters. 3
Step3 Topicmaterialityassessment
Building on prior identification and communication, the Company further conducted a materiality Financialmateriality
analysis to screen and confirm key topics closely related to sustainability. Integrating stakeholder
concerns, the Company systematically assessed the relevance of each topic to its development and its
WithGnancialmaterialitybutnotimpact
WithbothGnancialandimpactmateriality
impactonstakeholders,andprioritizedthemaccordingly,ultimatelyidentifyingthreedoublemateriality
materiality
topics.
With impact materiality but not Gnancial
WithoutGnancialorimpactmateriality
materiality
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Sustainability governance
InaccordancewiththeWorkingRulesoftheBoardofDirectors5Environmental,SocialandGovernanceESG)
( Committee
,
BGI Genomics has established and continuously improved its sustainability governance structure. The Company has
embeddedESGrequirementsintotheentireprocess,includingBoardofDirectors5supervision,specializedcommittee
deliberation,managementexecution,andfunctionaldepartmentimplementation.Thishasgraduallyformedaclosed-
loopESGsystemwithclearresponsibilities,acompletechain,andtop-downintegration,providinginstitutionalsupport
fortheCompany5shigh-qualityandsustainabledevelopment.
BGIGenomics5ESGstructure
SupervisematerialESG-relatedmattersoftheCompany
ReviewrelevantproposalssubmittedbytheESGCommittee
BoardofDirectors
Reviewstrategicplans,systems,andworkingrulesrelatedtosustainabilityandESG
MonitorandstudyESG-relatedlaws,regulations,andpolicies
Environmental,Social
andGovernance(ESG) ReviewESG-relateddisclosuredocuments,includingtheannualESGreport
Committee MonitormaterialESGrisksandopportunitiesandproviderecommendations BGIGenomicswashonoredwiththeChinaFund4205ChinaListedCompaniesYinghuaAward?A-shareESG
DemonstrationCase4
Linking ESG performance with senior executive remuneration
Remuneration Management System for Directors and
BGI Genomics has formulated and improved the
Senior Management, linking the remuneration of directors and senior management with the Company5s
OrganizeandimplementmattersapprovedbytheBoardofDirectors
long-term interests and sustainability. The performance-based remuneration of senior management is
PromotetheintegrationofESGrequirementsintobusinessoperationsand tied to annual operating performance and individual performance evaluations. Furthermore, a clawback
Management management mechanism for remuneration strengthens constraints on governance risk behaviors such as majo
violationsoflawsandregulationsandGnancialfraud.
ProvideESG-relatedinformation
Functionaldepartments, ImplementspeciGcmeasuresbasedonactualbusinessneeds
businessunits,and
subsidiaries
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Special
Intelligently Shaping the Future of
Topic Genomics, Geneticdigitalintelligencestrategy
Empowering a New Ecosystem of BGIGenomicsregardsartiGcialintelligenceanddigitalintelligenceasimportantenginesforitsstrategictransfo
Precision Medicine with Digital Intelligence
and upgrading. Centered on the overall concept of 4generative biological intelligence,4 the Company continuo
explores new paths to enhance the eIciency of life data insight and application through intelligent means. In term
ofitsstrategicpath,theCompanyhasestablishedanimplementationpathwayoftechnological
InaccordancewiththeWorkingRulesoftheBoardofDirectors5Environmental,SocialandGovernanceESG)
( Committee
, launch ?! large-scale operation4 centered around the ALL
BGI Genomics has established and continuously improved its sustainability governance structure. The Company has verticalapplications4toformasustainablecompetitiveadvantageandlong-termgrowthmomentum.
embeddedESGrequirementsintotheentireprocess,includingBoardofDirectors5supervision,specializedcommittee
deliberation,managementexecution,andfunctionaldepartmentimplementation.Thishasgraduallyformedaclosed- iGeneTPro:PromotingqualityandeIciencyinend-to-endgeneinterpretation
loopESGsystemwithclearresponsibilities,acompletechain,andtop-downintegration,providinginstitutionalsupport
fortheCompany5shigh-qualityandsustainabledevelopment.BGIGenomicscontinuestoadvancethedeepintegration Attheclinicalapplicationlevel,BGIGenomicshaslaunchediGeneTPro,aprofessional-gradeintelligentinterpretat
ofgene
existingcapabilitiesingenetictesting,geneticcounseling,andhealthmanagement,theCompanyfurtherenhancesits serialoperationstoanintegratedmodelofGle
AIproductmatrixbyfocusingonamultimodallargemodelforgenetictesting,anend-to-endintelligentinterpretation platform can perform multi-level bioinformatics analysis for SNV, CNV, and SV, and supports single sample uploa
platform,ageneticcounselingassistancesystem,researchsupporttools,andecosystemconnectivity.Thispromotesthe batch upload, re-analysis, and re-inference. Combined with AI-powered variant quality control, evidence integration,
upgradeofAIfromsingle-pointtoolapplicationstomulti-scenario,full-processcollaborativeempowerment.Withthe automated interpretation, and explainable decision- making capabilities, it reduces repetitive manual l
GeneTmultimodallargemodelforgenetictestingasitsfoundationalcapability,theCompanycontinuestoexpandits improves interpretation efficiency. Clinical validation results show that iGeneT Pro has accumulated a simil
productsandsolutions,includingiGeneTPro,ChatGeneT,GeneTAgent,GeneTStudio,andGeneTAPI,graduallyforming library, achieving a %8.9 recall rate for the top 03 prioritized variants in over 0,3 clinical validations. In terms of
anintelligentsystemthatcoversclinicalinterpretation,counselingassistance,researchsupport,datagovernance,and qualitycontrol,theaccuracyforSNPandExonCNVqualitycontrolhasreached.%3 9
capabilityoutput.
iGeneTProcoreapplicationsandadvantages
BGIGenomics5digitalintelligenceproductmatrix
Geneticanalysisandgeneticcounseling
End-to-endgeneinterpretationsystem:
Aone-stopservicefromvariantanalysis
tointelligentreporting
Customizedreport *Routinereportscanbefullygenerated Proprietarymodeltraining
iGeneTPro ChatGeneT GeneTAgent GeneTStudio GeneTAPI interpretationsolutions end-to-endbyiGeneTPro,whilecomplex
Comprehensivesolutions API&plugins
reportsrequireexpertreview
End-to-endgene Geneticcounseling GeneticCounselingAgent
Comprehensivevariant Developcustomer-
interpretationplatform assistancesystem interpretationreportsystembased proprietarymodelsusing
Bioinformaticsalgorithm Digitalintelligence- Taskdecomposition Digitalintelligence- CapabilityAPIcalls onpopulationcharacteristics, exclusivedatatooptimize
acceleration basedinformation assistedreading clinicalindications,and regionallyadaptedanalysis
Dataretrieval Flexiblepluginaccess
summarization personalizedneeds results
Digitalintelligence-based Assisteddatacleaning
MCPaccess Integrationwithhospital
variantqualitycontrol Informationretrieval
Clinicaldatagovernance systems
Informationaggregation Literatureevidence Privatemedicaldata
Locusrating Full-processconsultation
Customizedsolutions Connectinghospital- integration warehouseconstruction
enhancement
In-depthinterpretation sidedata
andreasoning Intelligent
AIratingcapability: Rapidestablishment
recommendations
Systematicextractionof ofcustomizedcase
Reportpersonalization ACMGstandardevidence knowledgebasesbasedon
items.Ratingplatform: astandardizedclinicaldata
Ratingreviewand governancesystem
Core service
governanceplatform
GeneT multimodal large model for genetic testing Ratingdatabase:50,
genomicvariants
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
ChatGeneT:Geneticcounselingassistancesystemandtalentcultivationtool GeneTAgent:Intelligentagentfor
geneticanalysisscenarios
Toaddresspainpointsingeneticcounselingsuchastalentshortages,decision-makingoverload,informationfragmentation,
outdatedknowledge,andweakfollow-upmanagement,BGIGenomicscontinuouslyimprovestheChatGeneTgenetic TheGeneTAgentiscapableoftaskdecomposition,
counselingassistancesystem,promotingtheempowermentoflargeintelligentmodelsacrossallstagesofconsultation! databaseretrieval,consultationenhancement,self-
before,during,andafter.Thesystemsupportspre-consultationwithapatient-facinglargeintelligentmodel,automatic reflection, and pathogenicity analysis. It can call
extractionoftestresults,andgenerationofstructuredconsultationchecklists.Fordoctors,itoFersfunctionslikeknowledge uponGeneT-relatedscenariocapabilitiesinaone-
queries,consultationassessment,treatmentsuggestions,andcommunicationadvice,helpingtoimproveconsultation stopmanner,identifyuserneedsthroughtask-based
eIciencyandquality.Additionally,ChatGeneTcansupportre-analysisofgenetictestingreports,similarcasequeries,and decision-making,conductpersonalizedconsultations,
educationaltrainingscenarios.TheeducationalversionofChatGeneTassistsindoctortrainingandtalentdevelopment intelligentlydetectconflictingdataanddynamically
throughmethodslikesimulatingpatientdialogueswithalargeintelligentmodel,enhancingpersonalizedconsultations,and optimize,automaticallyretrieveliteratureevidence
providingmulti-dimensionalcapabilityassessments,furtherexpandingtheapplicationboundariesofartiGcialintelligencein to rate pathogenicity in real time, and aggregate
thegeneticcounselingecosystem. information from professional databases to meet
moreflexibledemandsforgeneticcounselingand One-stopaccesstothefull-scenariointerfaceofGeneT
ApplicationparadigmoftheChatGeneTgeneticcounselingassistancesystem
intelligentanalysis.
Patientsprinttheirownmedical Geneticcounselingbydoctors
GeneTStudioGeneT
& API:ExpandingtheboundariesofscientiGcresearchandecosystemempowerment
Patientmedical
Patientsbringtheir recordsarestoredin
recordstothedoctor theHISsystem
Traditional
GeneT Studio is a solution focused on scientific research and data governance scenarios. It integrates capabilities
intelligent literature reading, rapid data retrieval, data cleaning, and structured normalization. Through colla
Patientsseekdirect Doctorsmultiple
+ knowledgebasewebsites
Unstructureddata amongGeneT,Genos,andgenerallargelanguagemodelsLLMs)
( it, supportstaskssuchasgene!?phenotypeassociation
medicalconsultation
Medicalrecordsareautomatically Structuredmedicalrecordsstorage Research analysis,variantpathogenicityassessment,historicalcasemining,diseaseprogressionprediction,andknowledgegraph
senttothepatient enrichesthepatientcaselibrary applications
Newdiscoveries construction,drivingthetransformationofexistinglifesciencedataintohigh-valueresourcesthatareusable,analyzab
Patientsupload basedonbig andtranslatable.
materialsonline,andAI Similarpatientcases datamining
automaticallygenerates providemoreevidencefor Meanwhile,GeneTAPI,asacapabilityoutputinterfacelayer,furtherstrengthensecosystemconnectivityandhospital-side
ChatGeneT
treatmentsuggestions decision-making enablement.ItsupportsAPIcalls,pluginintegration,andconnectionstohospitalsystems,facilitatingtheembedding
relevantmodelsandanalyticalcapabilitiesintothebusinessworkHowsofhospitals,testinglaboratories,andpart
Patient+ Doctor+AI Structuredpatientcase
Thisenhancesproductadaptability,deployability,andscalability,reinforcingthedevelopmentofanopen,collaborat
questionnaire BGI5s Re- library
database
External analysis Genetic digitalintelligenceecosystemforprecisionmedicine.
Software
knowledge
prediction counseling
bases
trainingbased
Educational
onAI+bigdata
Continuousfeedbackfromfollow-upresultsenrichesthecaselibrary AccuracyoftheGenoshumangenome GeneT+Genos+LLMjointmulti-large-model
applications
foundationmodel dataanalysismechanism
Variantpathogenicityprediction
Multi-omicsanalysis
(Pathogenic/Benign)
Historicalcasemining
Multimodallargemodelfor
genetictesting
Gene!?phenotype
association
Evo21B
Variantpathogenicity
assessment
Humangenomefoundation
Evo27B model
Diseaseprogression
prediction
REVEL+SpliceAI
Knowledgegraph
construction
Generallargemodels
!
Accuracy
ChatGeneTeducationeditionapplicationcases
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Good Governance for a Solid
Foundation and Steady Progress
BGI Genomics has always regarded high-quality governance as the fundamental guarantee for sound operations and
long-termvaluecreation.Wearecommittedtobuildingasolidfoundationfordevelopmentthroughastandardizedand
transparent governance system, safeguarding strategic execution with prudent and forward-looking risk awareness,
andfosteringinternalandexternaltrustthroughhonestandcrediblebusinessethics.Wecontinuouslypromotemutual
reinforcementandcoordinatedenhancementbetweengovernancecapabilitiesanddevelopmentquality.TheCompany
deeplyrecognizesthatgoodgovernanceisnotonlyaninherentrequirementforlawfulandcompliantoperationsbutalso
akeyenableroforganizationalresilience,stakeholderrightsprotection,andsustainabledevelopment.TheCompanywill
continuetostrengthenitsgovernancefoundationandenhancegovernanceeFectivenessandaccountabilitytohigher
standards,providingasolidguaranteeforsteady,long-termprogressandthecreationofenduringsocialvalue.
Corporategovernance
Businessethics
Riskandcompliancemanagement
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Corporate governance
Key performance
In205,theCompanyheld 3Shareholders5Meetings;
Company
BGIGenomicsstrictlycomplieswithlawsandregulationsincludingtheLawofthePeople5sRepublicofChina,
the SecuritiesLawofthePeople5sRepublicofChina,
andtheCodeofCorporateGovernanceforListedCompanies,
to
establisharobustcorporategovernancestructureandasoundinternalcontrolandriskmanagementsystem,ensuring 4
TheBoardofDirectorsconvened meetings,withanaverageattendancerateof %. 100
standardizedoperationsandscientiGcallyinformeddecision-making.
Operation of the "Two Meetings and One Level"
In 205, BGI Genomics revised institutional documents including the Rules of Procedure for Shareholders5 Meetings
Board diversity and independence
and the Rules of Procedure for the Board of Directors, continuously strengthening the corporate governance system Working
BGI Genomics revised institutional documents including the System for Independent Directors
, the System
in which the Shareholders5 Meeting, the Board of Directors, and senior management perform distinct roles, operate for Special Meetings of Independent Directors
, and the Remuneration Management System for Directors and Senior
in coordination, and maintain eFective checks and balances. By standardizing mechanisms for meeting convening, Management. The Company has continued to synergistically enhance the Board5 s diversity, independence, and
proposal deliberation, resolution implementation, and record retention, the Company continues to enhance the professionalism,andhascontinuouslyoptimizedtheBoardcompositionintermsofgender,educationalbackground,
legalityandcomplianceofdecision-makingprocedures,governancetransparency,andsupervisoryeFectiveness. industryexperience,andprofessionalexpertise,therebystrengtheningtheBoard5scomprehensivecapacitytoidentify
risks,anticipatetrends,andsupportstrategy.Concurrently,theCompanyhasfurtherimprovedthesupportsystemfor
Corporategovernancestructure
independent directors to fulfill their duties, enhancing their ability to independently and lawfully perform the
ensuringtheyeFectivelycontributetodecision-makingparticipation,oversightandchecksandbalances,andprofessional
advisoryfunctions,thusfurtherreGningastandardizedandtransparentgovernancemechanismtobettersafeguardthe
Internal Audit and
Shareholders' Meeting
Company5soverallinterestsandthelegitimaterightsofminorityshareholders.
Audit Committee Internal Control
Department
BoardofDirectorsdiversiGcationatBGIGenomicsCo.,Ltd.
Nomination Committee
Board of Directors Corporate
Finance
Remuneration and Appraisal Committee
Name Directorcategory Education/professionaltitle Sectorexpert management
expert
Office of the Board of Directors
expert
Environmental, Social and Governance WangJian Chairman Master5sdegree G G
CEO (ESG) Committee
ZhaoLijian Director Bachelor5sdegree G
Securities Department
Operations and Management Team
LiNing Director Doctoratedegree G G
ZhuShida Director Doctoratedegree G G
Employee
Zhang
representative Bachelor5sdegree G
Guocheng
director
Marketing Regional Theater
Solution Business Unit
Big Data & Intelligence
Production & Delivery
Product R&D System
Master5sdegree,ChineseCertiGed
Precision Medicine
Marketing System
Support System
WangYujue Director PublicAccountant, G G
Business Unit
Business Unit
SeniorAccountant,SeniorEconomist
System
Independent
DuLan PhD,SeniorEconomist G G
director
Independent
YuLisheng Doctoratedegree G
director
Independent
HouZhibo Doctoratedegree G
director
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Key performance
Key performance
In 2 0 2 5 , the Company held
In 20 5, the Company5s Board of Directors comprised female director,
meetings of the Audit Committee;1 meeting of the Remuneration and Appraisal Committee,
accounting for11.11%ofthetotal; 3independentdirectors,accounting33.33
for % of the
and1meetingoftheESGCommittee.
total;Thisyear,
Board of Directors effectiveness evaluation
Development of specialized committees of the Board of
Directors
BGI Genomics continuously improves its Board eFectiveness evaluation mechanism, advancing Board performance
from standardized operation toward efficient and accountable fulfillment of duties. This consistentl
capabilities in scientiGc decision-making, professional oversight, and strategic leadership, laying a solid found
Working
In accordance with internal institutional documents such Rules for the Audit Committee of the Board
as the
forelevatedcorporategovernanceandsustainabledevelopment.
of Directors
, the Working Rules for the Nomination Committee of the Board of Directors
, the Working Rules for the
RemunerationandAppraisalCommitteeoftheBoardofDirectors,
andthe WorkingRulesfortheEnvironmental
, Social
andGovernanceESG)
( CommitteeoftheBoardofDirectors ,BGIGenomicsenhancesthedepthofresearchandquality
BGIGenomics5directorevaluationmethodsandpractices
of decision-making by the Board on matters such as financial review, talent selection, remuneration incentives, and
sustainability.Thisisachievedbyclarifyingtheresponsibilitiesandoperationalprotocolsofspecializedcommittees!
Alldirectorsconductaself-evaluationoftheirperformanceatyear-end
including audit, nomination, remuneration and appraisal, and ESG!thereby promoting more refined, prudent, and Self-evaluationNon-independentdirectorspreparetheAnnualReportontheWorkoftheBoardofDirectors
eIcientboardgovernance. ofdirectors5
performance IndependentdirectorspreparetheIndependentDirectors5DebrieGngReportandpresentitat
theannualShareholders5Meeting
FunctionsofBGIGenomics5specializedcommittees
Formulateselection Comprehensive TheBoardcombinesself-assessmentmaterialswithactualperformancethroughouttheyear
ReviewGnancial company
criteriaandprocedures Focusonmeetingattendance,proposaldeliberation,andprovisionofprofessional
informationandits evaluation
fordirectorsandsenior recommendations
disclosure
management
Superviseandevaluate Nomination
AuditCommittee Screen,review,andmake
internalandexternal Committee recommendationson
auditactivitiesand
candidatesandtheir Performance
internalcontrols EvaluatetheoperationalperformanceoftheAuditCommittee,NominationCommittee,
qualiGcations evaluationof
specialized RemunerationandAppraisalCommittee,andESGCommittee
committees Focusontheirrolesinproposaldeliberation,oversight,anddecision-supportfunctions
Formulateappraisal Reviewsustainability
standardsfordirectors strategies,policies,and
Remuneration
andseniormanagement ESGCommittee disclosuredocuments
andAppraisal ConductevaluationsbasedoninternalsystemssuchastheWorkingSystemfor
Reviewremuneration MonitorESGrisks IndependentDirectorsandtheSystemforSpecialMeetingsofIndependentDirectors
Committee Systemand
policies,decision-making andopportunities StrengthenperformanceincentivesandconstraintsthroughtheRemuneration
resource
processes,andclawback andprovide ManagementSystemforDirectorsandSeniorManagement
assurance
arrangements recommendations RegularlyorganizedirectorstoattendexternaltrainingsessionshostedbytheSZSEand
theShenzhenPublicCompaniesAssociationtoenhanceperformancecapabilities
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Investor relations management Case
study
Conducting investor engagement activities to enhance market communication and
value recognition
InaccordancewithlegalandregulatorydocumentssuchastheGuidelinesfortheManagementofInvestorRelations
of Listed Companies and the Company5 s Articles of A ssociation, BGI Genomics has formulated institutional In February 2 0 5 , BGI Genomics hosted a research visit by Goldman Sachs and overseas institutional investors.
documents including the Investor Relations Policy, the Information Disclosure Policy, the Internal Reporting System Company management provided a systematic overview of its core business layout, technological inn
for Material Information, and the Registration and Filing System for Insiders of Inside Information. The Company progress, exploration of intelligent large model applications, and future growth directions, and engaged in in-d
discussions with investors on operational performance. This visit enhanced the capital market5s understandin
continuously refines its investor relations and information disclosure management mechanisms, constantly
enhancingitsabilitytocommunicatetransparentlyandrespondappropriatelytothecapitalmarket. the Company5s strategic transformation and long-term development logic, improved transparency in informa
communicationandinvestortrust,andsupportedtheCompany5seFortstodeepeninternationalmarketrecognition
Meanwhile, the Company adheres to the principles of compliance, equality, proactivity, and integrity, promoting
andshapeitslong-termvalueproposition.
integrated efforts in investor communication, grievance handling, information disclosure, and shareholder rights
protection. This continuously deepens investors5 understanding of and confidence in the Company5 s strategy,
operations, and governance. The Company strictly implements its information disclosure management system,
continuously improves disclosure quality, and promptly addresses investor inquiries through multi- channel
communicationmechanismstosafeguardinvestors5righttoinformationandlegitimateinterests.
BGIGenomics5investorrelationsmanagementsystem
Management
principles responsibilities
Principlesofcompliance,equality,proactivity,andintegrity
TheBoardSecretaryservesastheheadofinvestorrelationsmanagementandisalsoresponsible
forimplementingrelevantmanagementmeasures,organizingspecializedtraining,andmonitoring
Management
feedbackfrommediaandonlinechannels
BGI Genomics hosts a research visit by Goldman Sachs and overseas institutional investors
TheSecuritiesDepartmentisthefunctionalunitresponsibleforplanning,organizing,and
executingvariousinvestorrelationsactivities
Key performance
partiesandcontent channels
Communicationtargetsincludeinvestors,securitiesandindustryanalysts,Gnancialmedia,and
Communication
otherrelevantinstitutions In 2 0 5 , the Company held
Communicationcontentincludesdevelopmentstrategy,businessoperations,materialevents,
environmentalandsocialgovernanceinformation,culturalinitiatives,waystoexerciseshareholder
rights,investorgrievancehandling,andriskchallenges onlineinstitutionalresearchsessions, 2
oJineroadshows(includinginstitutionalstrategy
Communicationisprimarilyconductedviaannouncements,Shareholders5Meetings,earnings
Communication
calls,investorsurveys,roadshows,sitevisits,telephone,fax,email,theCompanywebsite,andthe 20
conferences),andorganizedorparticipatedin oJineresearchactivities.
Hudongyiplatform
Investorcomplaintsprimarilyconcernmatterssuchasinformationdisclosure,corporate
governance,andinvestorrightsprotection;theBoardOIcecoordinateshandling,withtheBoard
SecretaryastheresponsibleoIcer
Complainthandling
Theprocessfollowsacceptance,recording,veriGcationandinvestigation,formulationofhandling
opinions,andresponsetothecomplainant.Handlingiscompletedwithintheprescribed
timeframe,andaclassiGedledgerismaintainedforarchiving
Forimproperlyhandledmattersorthoseinvolvingillegalacts,accountabilityisenforcedper
theaccountabilitymechanism;disputesareresolvedthroughthird-partymediationorlegal
proceedingswhennecessary
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Risk and compliance management
BGIGenomics5internalcontroldevelopmentandmanagementmeasures
BGI Genomics places great emphasis on risk management and compliant operations. The Company continuously
enhances its integrated risk and compliance management system covering risk identiGcation, compliance control, · Formulate
theInternalControlDevelopmentPlanandProgramtoclarify
Launchand theimplementationbackground,scope,workplan,andotherelements,
audit supervision, and corrective improvement. Legal and compliance requirements are embedded throughout
planning servingasthebasisforsubsequentactivitiesandestablishingtheinternal
governance decision-making, business operations, and employee conduct. Adhering to the principles of prevention controlorganizationalstructure.
first, balanced control, and continuous improvement, the Company steadily strengthens its capabilities to
identify, respond to, and remediate various operational and compliance risks, promoting synergistic deepening of
standardized operations and sound business practices, thereby establishing a robust governance foundation for
high-qualitydevelopment.
Risk management · Based
Internal
ontheBasicStandardforEnterpriseInternalControlandits control
supportingguidelines;
· Comprehensively
review
reviewtheCompany5spoliciesandconductinterviews
BGI Genomics continuously refines its compliance and internal control system covering risk identification, audit withallbusinessdepartments.
supervision, and corrective improvement. Risk management requirements are integrated into the entire process of
governance decision-making and business operations. The Company adheres to the principles of prevention Grst,
balanced control, and continuous improvement, steadily enhancing its ability to identify, respond to, and remediate
operationalrisks,therebyestablishingasolidgovernancefoundationforhigh-qualitydevelopment.
Identifying · DrawingonbestpracticesandtheEnterpriseInternalControlGuidelines,
Risk management governance structure internal methodssuchasbenchmarking,interviews,processmapping,and
control walk-throughtestingareusedtoassessthedesignandoperational
deGciencies eFectivenessofcontrolmeasuresandidentifycontroldeGciencies.
Internal
In accordance with institutional documents such as the Control Management Policy and the Internal Audit
Management Policy,
BGI Genomics has established an internal control system covering all business processes. It
regularly conducts internal control evaluations and audits and drives closed-loop rectiGcation of identiGed issues.
Risk management requirements are embedded into strategy, governance, and daily operations. Systematic internal
control procedures and necessary internal oversight mechanisms are implemented from the corporate level down
to individual business processes. The Company has established an Internal Audit and Internal Control Department · InresponsetoidentiGedinternalcontroldeGciencies,theinternal
responsibleformanaging,evaluating,inspecting,andsupervisinginternalcontrolactivities,reportingdirectlytothe Formulationand
controlteamproposesimprovementrecommendationsfortheissues
implementation
BoardofDirectorsandtheAuditCommittee. found,clearlydeGningimplementationstepsandtherelevantpersonnel
ofrectiGcation
involved.TheserecommendationsaretrackedforrectiGcationafter
plan
approvalbytheresponsiblemanager.
Risk management mechanism
BGI Genomics continuously enhances its risk management and internal control framework, organically integrating
risk identiGcation, process control, supervision and evaluation, and cultural development. The Company promotes
the integration of compliance requirements into daily business management, steadily improving standardized
operational capabilities and sound development performance, thereby providing assurance for stable operations
andhigh-qualitygrowth.
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Compliant operation Compliance and internal control culture building
BGI Genomics consistently treats compliance culture building as a critical foundation for enhancing gov
strengthening risk defenses, and ensuring sound operations. The Company continuously reinforces organizatio
BGIGenomicscontinuouslyenhancesitscompliancemanagement
wide compliance and accountability awareness, fosters a positive environment of knowing, observing, and apply
system covering compliance control, corrective actions, and
regulations, and steadily improves its capacity for lawful and compliant operations, providing a solid found
continuous improvement. Guided by the principles of 4 good
high-qualitydevelopment.
governance,applicability,integrity,transparency,accountability,
and sustainability4 and the policy oflawful
operations; full participation, continuous improvement, 4 the 4 BGIlianjie4 ( BGI Integrity) WeChat official account, releases integrity and compliance-themed posters du
Company steadily strengthens its ability to identify, respond to, holidays, and organizes compliance training at headquarters and regional offices to reinforce organizatio
andremediatecompliancerisks,promotingsynergisticdeepening complianceawarenessthroughmultipledimensions.
Case Participating in global compliance summits to exchange cutting-edge practices and
ofstandardizedoperationsandsoundbusinesspractices.In, 5 2 0
theCompanysuccessfullypasseditsrecertiGcationauditwithan BGI Genomics is certified to the ISO 37301 study strengthen compliance governance capabilities
compliance management system
outstandingresultofzero
Compliance management mechanism
In April 2 0 2 5 , BGI Genomics participated in the 4 China Global
ComplianceSummitheld
and learning on frontier topics including evolving international
businessenvironments,corporategovernanceandsustainability,ESG
ComplianceManagementManual
Inaccordancewiththe the
, Companyhasestablishedacomprehensivecompliance compliance, ethical compliance culture, international compliance
management system, integrating compliance requirements into its strategy, governance, and daily operations, and management systems, data security and compliance, cross-border
continuouslyenhancingitsstandardizedoperationalcapabilitiesandsounddevelopmentperformance. investmentcomplianceriskmitigation,anddigitalimplementation
of compliance. This enhanced the Company5s understanding of
internationalcompliancetrends,standardframeworks,andregulatory
BGIGenomics5compliancemanagementmeasures
changes,providingstrongsupportforcontinuouslyreGningitsinternal
compliancesystem,deepeningcomplianceculture,andstrengthening
Complianceobjectivemanagement RiskidentiGcationandassessment soundoperationalcapabilities. BGI Genomics participated in the China Global
Compliance Summit 2025
Periodicallyreviewlawsandregulations
Decompose,monitor,andtrackannual inaccordancewithISO3701compliance
complianceobjectives managementsystemrequirements
Key performance
FocusonmanagementeFectivenessregarding Identifycomplianceobligationsandrisksin
majorpenalties,riskhandling,andincident
response
conjunctionwithbusinessactivities,establish
aComplianceRiskRepository,anddevelop
In205,theCompanyconducted 27compliancetrainingsessions;
categorizedresponsemeasures
The number of incidents involving major public opinion crises or losses exceeding
%
Monitoring,evaluation, Complianceculturebuilding
andcontinuousimprovement
of the Company5s annual revenue (based on audited revenue from the most recent Gscal
ContinuouslyevaluatesystemeFectiveness
Promotecomplianceculturebasedonpolicies year)duetoadministrativepenaltieswas
; 0
suchastheEmployeeCodeofBusinessConduct
throughmonitoringandmeasurement,
andProhibitedEmployeeConduct The timely handling rate for high-compliance-risk cases, the response rates for information
internalaudits,managementreviews,andgoal
achievementassessments
Dynamicallytrackandimproveresponsesto
?Continuouslyreinforceorganization-wide
complianceawarenessthroughnew-hire securityincidents,complianceincidents,andlegalproceedingswere
%. all 100
orientation,compliancetraining,ISO3701all-
high-compliance-risksituationsandcompliance
staFexaminations,internalcompliancetraining,
incidents
andexternalseminarsandexchanges
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Business ethics
Additionally, to identify and pre vent conflicts of interest between employees and the Compan
managementrisks,protectmutualinterests,upholdinternalfairness,andpreventcorruption,theCompanyrequir
employeestodeclareandupdatetheirconHict-of-intereststatus.TheCompanyusesholisticdataanalysistoidenti
at- risk individuals, strengthens supervision and control, continuously enhances employee integrity aw
Anti- Fraud
BGI Genomics has established institutional documents including theManagement Policy
, the Anti-
and deepens its corporate integrity culture. During the reporting period, the completion rate for conHict-of-inter
Corruption and Anti-Commercial Bribery Management Policy
, the ConHict of Interest Management Policy
, and the
declarationswas10%.
Integrity Agreement
. The Company continuously refines its integrity management system covering governance,
Whistleblowing and whistleblower protection
business operations, and employees. Adhering to a 4zero tolerance4 governance approach, it integrates integrity
into systems, processes, oversight, and accountability mechanisms, steadily strengthening end- to- end anti-
corruptiongovernancecapabilities!frompreventivemeasuresatthesourceandprocesscontrolstooutcome-based
Whistleblower Protection and Reward Policy,
BGI Genomics has established the maintaining open internal and
accountability!andcontinuouslyreinforcingbusinessethicstobuildarobustintegrityGrewall.
external reporting channels and strengthening the acceptance, investigation, handling, and feedback on corrup
Anti-commercial bribery and anti-corruption system
and non- compliance leads, striving to build a supervisory ecosystem where whistleblowers feel safe to
investigations are thorough, actions are stringent, and protections are robust. Through arrangements su
BGI Genomics has always upheld the principles of transparent operations and ethical conduct, establishing direct investigation by the Internal Audit and Internal Control Department, strict confidentiality of wh
a comprehensive anti- commercial bribery and anti- corruption system covering all employees and upstream/ information, and zero tolerance for retaliation, the Company further enhances the timeliness of issue detection an
downstream partners. Through four key measures! system development, supervision and control, training and thecredibilityofitsoversightmechanisms.
communication, and whistleblower protection!the Company continuously enhances its anti-commercial bribery BGI Genomics5 end- to- end whistleblowing acceptance, investigation, handling, and feedbac
andanti-corruptionmanagementframework. mechanism
BGIGenomics5anti-commercialbriberyandanti-corruptionsystem Multi-channelacceptance
Multiplereportingchannelsareavailabletoemployees,
Core Zerotolerance suppliers,distributors,customers,andotherpartners
principles Equal emphasis on prevention and
punishment Closed-loopfeedback Standardizedregistrationand
Internal and external collaborative onoutcomes acceptance
oversight
Forreal-namereports,the Reportsmustbefact-based.While
whistleblowerisinformedof real-namereportingisencouraged,
Governance Anti-FraudManagementPolicy investigationandhandling anonymousorpseudonymous
level InternalAuditManagementSystem outcomeswithin3!?6months, reportingispermittedtorespectthe
dependingoncaseprogress whistleblower5spreference
InternalControlManagementPolicy
Casehandlingislinkedwith Whistleblowersshouldprovideas
Anti-CorruptionandAnti-Commercial
correctiveactionsandinternal muchinformationaspossibleabout
BriberyManagementPolicy controlimprovementsto thereportedindividual,violationfacts,
establishaclosed-loopoversight evidence,andvalidcontactdetails
BGI Genomics was honored as an Excellent Supporting Unit
by the Enterprise Anti- raud Alliance in 2025
system Forreal-namereports,theInternal
AuditandInternalControlDepartment
Business IntegrityAgreement respondswithacceptancestatuswithin
level ConHictofInterestManagementPolicy Categorizedhandlingand 3daysofreceipt;foranonymous
reports,aninvestigationisinitiated
Partnerintegrityclauses accountability
within3daysofreceipt
ForveriGedreports,violatorswillbesubjectto
appropriatedisciplinaryaction IndependentinvestigationandveriGcation
Violatorswillbeheldaccountablein
Employee EmployeeCodeofBusinessConduct accordancewithpoliciessuchastheCadre TheInternalAuditandInternalControlDepartmentisthe
AccountabilityPolicy,theEmployeeHandbook, Company5sdesignatedunitauthorizedtoinvestigateacts
level ProhibitedEmployeeConduct
andtheEmployeeDisciplinaryRegulations. ofcorruption,reportingdirectlytotheGeneralManager
Commitment,training,and Casesinvolvingsuspectedcriminalactivity ItconductsinvestigationsandveriGcationsonreported
accountabilitymechanisms willbereferredtojudicialauthoritiesforlegalmatters,ensuringtheindependenceandintegrityofthe
proceedings acceptanceandinvestigationprocesses
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
BGIGenomicsreportingchannels BGIGenomics5businesspartnerintegritycontrolmechanism
Reportingchannels
ReportviaWeChatOIcialAccount:
onboarding engagement management andclosed-loop
Reportbyphone: 075-362 improvement
Reportbyemail:P_IA@genomics.cn Makeintegrity SigntheIntegrity Conducton-siteintegrity Stricthandlingof
commitmenta Agreementandembed awarenessvisits violations,internal
Reportbymail:EastIZone,F,9 MainBuilding,BGICenter,No.Yunhua
partnership contracts education,enhancement
Administerintegrity
Reportinpersonbyappointment ofbusinesspartner
perceptionsurveys
onboardingmechanisms,
Othermethodsdeemedappropriatebythewhistleblower implementationofin-
depthbackground
checks,andupgrading
ofsystemaudittrail
BGIGenomicswhistleblowerprotectionpolicy capabilities
Case Participating in the Youth Integrity Salon to build consensus on integrity governance
StrictconGdentiality Strictprohibitionof Specialprotection Protectionofreporting Partnerprotection
management retaliation foridentiGed rights mechanism study
whistleblowers
Whistlebloweridentity Anyformofdirect, Implementspecial Enhancedprotections Partnerswho
informationand indirect,orretaliatory protectivemeasures forinternal proactivelyreportand
In April 20 5, BGI Genomics was invited to participate in the 4Youth Voices on Integrity4 ESG-themed salon. The
reportingmaterialsare actionisexplicitly foridentiGed whistleblowing activelycooperate Company engaged in in-depth discussions with corporate representatives, professional institutions, and media o
keptstrictlyconGdential prohibited whistleblowers employeesregarding withinvestigations
topics including integrity risk prevention for young employees, corporate anti-fraud system development, and
Breachesof Suchbehaviorswillbe Dedicatedpersonnel rewarddisbursement, willbeprotectedin
jobtransfers,etc. accordancewithlaws requirements.ThiseventhelpedbroadentheCompany5sperspectiveonintegritygovernance,promotingsynergistic
conGdentialitywillbe dealtwithseriouslyin manageinformation,
rigorouslyinvestigated accordancewithlaws coordinate Preventadverse andregulations eForts among institutional constraints, technological safeguards, and cultural guidance, thereby oFering v
andheldaccountable andregulations communications,and consequencesarising Relevantliabilities insights for cultivating an ethical workplace environment for young professionals and reinforcing the found
implementprotections fromwhistleblowing maybemitigatedor
waiveddependingon sustainabledevelopment.
circumstances
Anti-corruption culture building
The Company emphasizes integrity culture promotion and integrity awareness education, standardizing employees5
ethical mindset and conduct from the outset. It comprehensively strengthens integrity culture through various
approaches, including new- hire and specialized training, participation in integrity and compliance conferences,
dissemination of integrity reminders via its official account, and organizing integrity education and promotional
activities.
Supervision of business partners
BGI Genomics continuously extends its integrity requirements to suppliers, distributors, and other partners.
Through arrangements such as pre-engagement commitments, in-contract constraints, on-site visits for awareness
promotion, questionnaire sur veys, and corrective actions, it advances partner integrity management from
contractual obligations toward full- process collaboration. The Company regards business partner compliance
management as a critical extension of its business ethics framework, consistently fostering a cooperative ecosystem Youth oices on Integrity ESG-themed salon
groundedintransparency,integrity,mutualtrust,andsharedsuccess.
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Case Building an integrity dialogue platform to foster industry-wide co-governance
consensus
BGIGenomics5anti-monopolyandfaircompetitionriskcontrolmeasures
study
In 2 0 5 , the 4 Integrity Ecosystem Empowering the Development of the Biopharmaceutical Technology Industry
Exchange Meeting,4 hosted by BGI Genomics and co-initiated with support from the Enterprise Anti-Fraud Alliance,
was successfully held at the Spatio-Temporal Center, attracting representatives from 23 leading biopharmaceutical
Institutionalnorms RiskidentiGcation
technology companies. The meeting featured in- depth exchanges on building an integrity ecosystem, analyzing
industry trends, and innovating practical approaches, facilitating experience sharing and consensus- building
among enterprises, and providing strong support for addressing integrity governance challenges and promoting Clarifyfaircompetitionmanagement Identifyrisksinkeyscenariossuchascompetitive
standardized,healthyindustrydevelopment. requirementsandbehavioralboundariesbased conHicts,improperbeneGttransfers,misuseof
onpoliciessuchastheConHictofInterest insiderinformation,androleconHicts
ManagementPolicy
In-process control
Declarationandapproval In-processcontrol
Establishonboarding,proactive,andannual Continuouslystrengthencontroloverkeyrisk
Group photo of the Integrity Ecosystem Empowering the Development of the Biopharmaceutical Technology Industry Exchange eeting declarationmechanismstoenhancedynamic itemsthroughcross-departmentalreview,
managementofconHict-of-interestmatters remediationtracking,andinformation
Key performance
In,5the
with
,% 100.%
thesigningrateoftheIntegrityAgreementbysupplierswas
Oversightandfeedback Accountabilityandenforcement
Business ethics audit and oversight Maintainopenconsultationandreporting Strictly address undeclared, unremediated, or
Regarding internal audits of business ethics, the Company5 s Internal Audit and Internal Control Department channels,promptlyaccept,verify,anddrive non- compliant behaviors in accordance with
focuses on ethical practices in business decision- making, employee conduct, supply chain management, and closed-loopresolutionofissues laws and regulations to reinforce institutional
anti- corruption. During the reporting period, internal audit results demonstrated the Company5 s outstanding constraints
performance in business ethics. Both management and employees strongly endorsed and voluntarily adhered to
relevantrequirements,providingrobustsupportforinternalcontrolsandsustained,sounddevelopment.
Anti-monopoly and fair competition management
Key performance noincidentsofunfaircompetitionoccurredwithintheCompany.
BGI Genomics strictly complies withAnti-
the Unfair Competition Law of the People5s Republic of China,
the Anti-
Monopoly Law of the People5 s Republic of China
, and related regulations and standards. It has established the In,520
Employee Code of Business Conduct, Prohibited Employee Conduct
, and Conflict of Interest Management Policy,
continuouslyintegratingfaircompetitionprinciplesintoemployeeconductstandards,conHict-of-interestprevention,
and partner management. The Company has built clear institutional boundaries to prevent unfair competition,
focusing on integrity, intellectual property protection, insider information safeguards, and avoidance of competitive
conHicts.
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Quality First, Intelligence for Life
Guided by the mission 4 Omics for All, 4 BGI Genomics upholds the public health principle of 4 prevention over
cure, accessible to all4 for inclusive and precise disease prevention and control. The Company deeply integrates
technological innovation with global expansion, driving genomics innovation in precision medicine through new
modelsandtechnologies.Committedtobreakingdowngeographicalbarriers,BGIGenomicsstrivestomakegenetic
testing fairly accessible worldwide, transforming scientiGc innovation into an inclusive force for health equity and
contributing enduring momentum to the global community of health for all. To achieve this, the Company has built
a comprehensive quality management system, ensuring end-to- end quality control to safeguard human health
and safety through genomics. It has also innovated a digital customer service platform, leveraging rapid-response
mechanisms and encrypted privacy data to simultaneously enhance service value and customer trust. Furthermore,
the Company deepens green supply chain development, collaborating with upstream and downstream partners to
build a resource-eIcient, environmentally friendly industrial ecosystem. With an open approach, it promotes co-
Productsafetyandquality
Supplychainmanagement
Innovation-drivendevelopment
Customerservice
developmentofindustrystandardsandtechnologysharing,leadingsynergisticadvancementinthebioeconomyera
sothatthebeneGtsofscientiGcprogressreacheverylife. Datasecurityandcustomerprivacy Industrycollaboration
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Product safety and quality
Management system
The Company places paramount importance on the quality management of its products and services, steadfastly
adhering to the principle that 4 to lead the industr y, one must first lead in quality. 4 Grounded in the unique
characteristics of the life sciences Geld, it has established a clear quality strategy and rigorously follows the quality
Quality
policy of 4impartiality, scientiGc rigor, accuracy, and timeliness.4 By formulating core policies including the BGIGenomicsplacesexceptionalemphasisonqualitymanagement,treatingqualityasitslifeblood.Itadherestot
Management Manual, Product Quality Control Procedures, and Adverse Event Handling Procedures
, the Company principle 4to lead the industry, one must Grst lead in quality4 and strictly follows the quality policy of 4impart
hasachievedcomprehensivequalitycoverageacrosstheentireproductlifecycle. scientific rigor, accuracy, and timeliness. 4 The Company has received numerous domestic and internatio
Governance
quality awards, with its quality achievements widely recognized by third- party institutions. According
from accreditation bodies and industry peers, BGI Genomics is among the few organizations in gene sequencing
covering reproductive health, oncology, infectious disease, and multi- omics big data, and simultaneously
Governance structure
comprehensive accreditations including
ISO 13485, ISO 1589, ISO/IEC 17025, CMA, ISO 3701, ISO/IEC 2701, ISO
to obtain ISO 15 89, ISO/IEC 17025, ISO/IEC 270 1, and ISO 37 01 accreditations. During the reporting period, its
BGIGenomics5productqualitygovernancestructureoperatesunderBoardoversight,withtopmanagement!ledby
subsidiaries continued participating in domestic and international proficiency testing programs, includ
the CEO!deGning the quality strategy. An independent Compliance and Quality Department has been established
from the National Center for Clinical Laboratories ( NHC) and the European Molecular Genetics Quality Network
to implement end-to- end quality management standards, while functional departments fulfill their respective
(EMQN),achievingperfectscoresinover80testsandmaintainingleadershipinlaboratorytestingquality.
responsibilitiestoensureproductquality.
BGIGenomics5productqualitygovernancestructure BGIGenomics5comprehensivequalitymanagementframework
Continuous improvement of quality
Occupationalhealthandsafety Environmentalmanagement
Qualitymanagementsystem
managementsystem system
BoardofDirectors ISO901:25
ISO4501:28 ISO140:25
InformationSecurity Personalinformation
LevelIIIClassiGedProtection
ManagementSystem managementsystem
ofInformationSecurity
ISO/IEC2701: ISO/IEC2701:9
CEO
Medicaldevicequality Medicallaboratoryquality InformationSecurity
managementsystem managementsystem ManagementSystem
ISO13485:206 ISO1589:20 ISO/IEC2701:
OIceoftheBoardof
AuditCommittee ScientiGcand
Directors Customer Customer
MedicalDevices Medicalservices technological
needs satisfaction
services
Mandatory Medicaldeviceregistration/GlingcertiGcates,medicaldevicemanufacturing/
thresholds distributionlicenses,medicalinstitutionpracticelicenses,biosafetyGlings,
Production& Sales&after- Compliance& Support&
Supplychain ProductR&D PCRGlings,humangeneticresourcesGlings,proGciencytesting,etc.
delivery sales quality safeguard
functional functional
functional functional functional functional Compliancemanagementsystem
departments departments
departments departments departments departments ISO3701:2
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Strategy
BGI Genomics has always regarded product quality and safety as the cornerstone of its business operations an
sustainable development. The Company continuously evaluates the impact of quality management acti
spanning R&D, production, delivery, and service! from a full-life-cycle risk prevention perspective on comp
operations, customer trust, brand competitiveness, and long- term growth. It integrates end- to- end q
governance capability with technological innovation and business scale- up, evolving quality manage
baseline compliance assurance toward enhanced operational resilience, brand value creation, and leader
high-qualityindustrydevelopment.
Risk/ Impact
SpeciGcdescription Financialimpact Responsestrategy
Opportunity duration
Corerisk
BGI Genomics certified to ISO 9001 quality management BGI Biotechnology Wuhan Co., Ltd. certified to ISO 13485
system medical device quality management system
Mayincreasecostsrelated
Keystages!includinggenesequencing, Implementstandardizedend-
toreview,rectiGcation,
analysis,interpretation,andreport to-endoperationsandmulti-
Compliance customercommunication,
issuance!demandhighlevelsof Short-to- stagereviewmechanisms,
risksintest andcompliance
professionalismandstandardization. medium enhanceclosed-loopreport
resultsand management,and
Inadequatemanagementandreview term recallmanagement,and
reports exertpressureonbrand
mayaFecttestresultaccuracy,report strengthenerrorcontrolacross
reputationandbusiness
compliance,andcustomertrust. allprocesses.
expansion.
TheR&D,production,delivery,andafter- Mayincreasecosts
Strictlyimplementcorequality
saleschainislongandrequireshigh relatedtorework,quality
Medium- managementsystems,achieve
Fulllife coordination.DeGcienciesinquality improvement,and
and fulllife-cyclequalitycontrol
cyclequalitystandardexecutionandprocesscontrol operationalcoordination,
long- coverage,andconductregular
controlrisks mayaFectproduct/servicestability, andexertpressureon
term internalqualityauditsand
customerexperience,andoperational markettrustandbusiness
inspections.
eIciency. stability.
BGI Genomics certified by C A Wuhan BGI Technology Service Co., Ltd. Wuhan BGI Clinical Laboratory
accredited to ISO IEC 17025 accredited to ISO 15189
Coreopportunities
Externalqualitymanagementawards
ContinuouslyreGnetheend-to-end Deepenthequalitystrategy,
Reducedlossesfrom
Opportunitiesto qualitycontrolsystemtodeliverhighly
Medium- buildahigh-qualityend-to-end
qualityincidents,
enhancequality, reliableandcompliantproductsand and controlsystem,andstrengthen
enhancedcustomerloyalty
brand,andmarket services,strengthencustomertrust long- corebrandcompetitiveness
andbrandpremium,and
IntheTianjinBinhaiNewAreaQualityImprovementCompetition,won3 competitiveness andbrandreputation,solidifyindustry
term throughcompliantoperations
sustainedrevenuegrowth.
Grstprizes,2secondprizes,10thirdprizes,and10excellenceawards; leadership,andexpandmarketshare. andsuperiorservice.
AttheShenzhenQualityManagementGroupTrustworthyTeam
AchievementExchangeandTrainingConference,won1gold,1silver,2 Opportunities
Throughqualityinitiatives,
bronze,and4excellenceawardsforQCgroups; forquality Encouragequalityinnovation
technicaloptimization,andprocess
enhancement, Reducedqualitycostssuchandtechnicalbreakthroughs,
InWuhanQualityAssociationQCgroupactivities,won4thirdprizes; improvements,theCompanycan Short-to-
cost asreworkandretesting, conductregularQCgroup
eFectivelyreduceretestingrates,error
medium
InHebeiProvinceQCgroupactivities,won1second-classachievement reduction,and
rates,andqualitylosses,enhancing term
andenhancedbusiness activities,andinstitutionalize
operational capacityandproGtability.qualityimprovementsinto
award. operationaleIciencyandlowering
eIciency standardizedprocesses.
quality-relatedcosts.
improvement
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Impact, risk, and opportunity management R&Dpilottrial Focusedonpilotandsmall-scaletrials,enhancingproducttraceabilityanddocumentation
andtraceability
The Company emphasizes risk management for its products and services, regularly conducting risk identiGcation, compliancethroughoptimizedcoding,documentcompletion,test/processoptimizationrequests,
management
enhancement andfeedbackondocumentationissues,ensuringeIcientR&Dandpilot-scaleadvancement
analysis,evaluation,andtreatmenttocontrolrisksaFectingtestresultqualityandpatientsafety,therebypreventing
andmitigatingadverseimpactsandpotentialissues.Additionally,ithasestablishedaqualityobjectiveandindicator
monitoring system. By regularly tracking deviations from control limits, it monitors QMS performance, analyzes
data trends to promptly detect anomalies, and implements preventive actions. To ensure the continued adequacy Coreproduct
process FortheNIFTYextractionkitproductionprocess,usedtechnicalcontroltoolstooptimizeliquid
and eFectiveness of the QMS, the Company employs a multi-dimensional oversight mechanism!including routine
optimization dispensinginbuFerpreparationandpost-aliquotingpackaging,reducingcumulativeproductionerror
inspections, unannounced audits, and system reviews! and drives continuous improvement through the PDCA (NIFTYextraction by80%,signiGcantlyimprovingdispensingaccuracy,andincreasingproductioneIciency20-fold
cycle. kit)
Indicators and targets Coreproduct
process FortheNIFTYsequencingkitproductionprocess,optimizedstaIngandworkHow,reducing
optimization personnelbyoneinthesampleloadingplatealiquotingstep,increasingaliquotingeIciencyby%,24
(NIFTY
sequencingkit) anddecreasingper-kitproductiontimebyapproximately2.5%
Quantitativeindicatordisclosureitem Unit 205data
Productconformityrate % 9.5 Case study Quality Control (QC) group activities
From April to November 20 5, the Company organized a seven-month BGI Genomics Quality Control (QC) Group
Product quality improvement initiatives
activity centered on the core goal of 4full participation and continuous improvement.4 Following the PDCA (Pl
Do-Check-Act) cycle and systematically applying quality management theories and statistical methods, the initia
engaged employees throughout the entire quality improvement and innovation process. This activity effect
To continuously strengthen product quality foundations and enhance operational and R&D eIciency, the Company enhanced organization- wide quality awareness and delivered tangible results in reducing quality
systematically advanced quality improvement initiatives across Gve
production
dimensions:
site compliance, end- improving production eIciency and economic returns, driving continuous advancement in the Company5s quality
to-end standardization, management efficiency, R&D traceability, and core productThrough
processes.
targeted managementcapabilities.
optimizations, significant improvements were achieved in production compliance, operational standardization,
management efficiency, and core product output. Concurrently, Quality Control ( QC) group activities further
reinforcedtheend-to-endqualityassurancesystem.
Productqualityimprovementmeasures
Productionsite Optimizedeighttypesofproductionlabelingandworkshoplayoutstoimprovecomplianceand
andcompliance uality onth Tianjin Group photo of the Integrity Ecosystem Empowering the Development
of the Biopharmaceutical Technology Industry Exchange eeting
spaceutilization,eFectivelyreducingcontaminationrisks
management
optimization
End-to-end AchievedeIcient,standardizedend-to-endproductioncontrolthrough10improvements,including
standardized dedicatedequipmentdeployment,optimizedconsumableselectionandaliquotingprocesses,and
productioncontrolstandardizedoperatingprocedures
Managementprocess IntroducedintelligentoIcetoolsandoptimizedissuecollectionmechanismsanddocumenttemplates
andoIceeIciency tostreamlineinformationHow,enableclosed-loopissuemanagement,andstandardizerecord-keeping,
enhancement
uality onth Pipetting Competition uality onth nowledge uiz
comprehensivelyenhancingproductionandqualitymanagementeIciency
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
End-to-end closed-loop quality testing and control mechanism Medical device vigilance management
The Company has establisheda closed- loop quality testing and control mechanism
all
covering
processes and MedicaldevicevigilanceisacorecomponentoftheCompany5sfulllife-cyclequalitymanagementandakeymeasu
nodes! pre- analytical, analytical, and post-analytical! throughout the full life cycle of medical testing services.to protect public safety in medical device use and fulGll its social responsibility in healthcare. The Company s
This mechanism implements standardized and refined controls over all factors affecting test result accuracy, Regulations
aligns with domestic and international regulations and standards, including the for the Supervision and
comprehensivelyensuringthecompliance,accuracy,andreliabilityoftestresults. Administration of Medical Devices
and the Measures for Monitoring and Re-evaluation of Medical Device Adverse
Events Post-
. It has established core management procedures such as the Market Surveillance Control Procedure
,
Vigilance System Control Procedure
, and Medical Device Adverse Event Monitoring and Re- evaluation Control
Procedure,clearly defining management requirements, execution standards, and role responsibilities acros
Pre-analyticalprocessqualitycontrol entire process! including adverse event collection, monitoring/reporting, investigation/analysis, risk ev
control/measures, product re-evaluation, and system audit/optimization. This institutionalizes, proceduralizes, an
Focus on the testing origin by standardizing the entire process!from test ordering and sample collection to standardizesend-to-endvigilanceactivities,providingrobustpolicyandsystemicsupportforcompliantoperat
transport and receipt!with clear operational protocols and acceptance/rejection criteria to ensure sample
complianceandintegrityfromtheoutset,rigorouslycontrollingqualityatthetestingentrypoint. Medical device vigilance system
The Company strictly complies with domestic and international medical device regulatory requirements, priorit
Analyticalprocessqualitycontrol product safety risk management, and has established and continuously improves a medical device vig
managementsystemcoveringtheentirepost-marketlifecycle.
Anchorcoretestingstagesandestablishmultiplequalitydefenselines.Rigorouslyvalidateandverifytesting
methods to ensure clinical suitability. Implement full life- cycle management of instruments, reagents, MedicaldevicevigilancemanagementstructureofBGIBiotechnology(Wuhan)Co.,Ltd.
and consumables, with robust metrological traceability and performance verification to maintain stable,
compliant testing conditions. Deploy a dual quality control system combining internal QC and external
EQA for routine process monitoring, triggering immediate corrective actions upon anomalies. Enforce strict Responsibleforapprovingadverseevent-relatedmanagementsystems;
personnelauthorizationandcompetencycontrolstomitigateoperationalrisksatthesource. General Responsibleforapprovingexternalcommunications;
Decision- manager Approve investigation and handling reports for adverse events and major
makinglevel
qualityincidents.
Responsible for developing and refining procedures for adverse event
Post-analyticalprocessqualitycontrol
Quality reportingandmonitoring;
Management Responsiblefor organizinginvestigation,analysis,evaluation,and handling
Strictly safeguard the result delivery stage and standardize the entire post-analytical process. A rigorous
Management Department ofadverseevents;
result review and release mechanism ensures all results are reviewed by authorized personnel before
level manager
Responsible for periodically organizing internal or external QMS audits
issuance.AreportmanagementprocessguaranteesimmediateclinicalnotiGcationtoprotectpatientsafety.
coveringadverseeventmonitoring.
Reportcorrectionsandtraceabilityarestandardizedtotightlycontrolresultapplicationrisks.Post-analytical
sampleretentionanddisposalprotocolsbalanceretesting/traceabilityneedswithbiosafetycompliance.
Collect adverse event information per procedures and promptly report to
drugregulatoryauthorities;
Adverseevent
Product recall management
monitoring Participate in investigation, analysis, evaluation, and handling of adverse
Execution specialist e v e n t s a n d m a j o r q u a l i t y i n c i d e n t s ; co m p l e te p e r i o d i c p r o d u c t r i s k
level
evaluationreports.
The Company adheres to its quality control baseline by establishing
comprehensive
a product recall mechanism
and strictly implementing specialized procedures including the Product Recall Management Procedure, Recall
Management Procedure, and Result Modification and Report Recall Procedure, standardizing the closed- loop
Includes heads of core departments! Technical, QC, Sales, Production,
operation of recalls. For testing services, it has built an end-to- end traceability system centered on sample IDs, Headsof
Engineering, and Supply & Sales! who lead their teams in coordinated
fully recording information across all stages! including submitting units, testing workflows, report generation, relevant
Coordination departments executionofvigilancetasks.
and modifications/ recalls! achieving
full life- cycle traceability
from sample receipt through report delivery and layer
subsequenthandling,eFectivelysafeguardingcustomerrightsandservicequality/safety.
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Operation of the medical device vigilance system
The Company fully implements the 4 Three Proactive4 management requirements, establishing a multi- channel,
comprehensiveadverseeventinformationcollectionnetwork.
Adverseeventmonitoringactivitiesrequiredofmedicaldeviceregistrants
Proactivedisclosureofcontactinformation
Disclosecontactdetailsincludingphone,mailingaddress,email,andfax;designatea
contactperson.
Individual Groupmedical Periodicrisk Keymedical Productre-
medicaldevice deviceadverse evaluationreport device evaluation
adverseevent eventreport monitoring
report report
(Innovative
Proactivecollectionandreporting products)
Organizationand Proactivelycollectadverseeventinformationfrom
personnel distributors,userfacilities,andend-users.
Responsibilities)
(
Medical device vigilance training and management effectiveness
BGI Genomics places high priority on compliance management and professional capability developm
Proactivereportingandevaluation medical device vigilance, integrating relevant training into its routine quality management program to cont
Directly report and evaluate suspected adverse events via the national monitoring enhance compliance awareness and expertise across roles, ensuring vigilance requirements are implement
informationsystem,andsubmitgroupincidentinvestigationreportsandperiodicrisk the post level and executed by individuals. In July 2 0 5 , the Quality Department of BGI Biotechnology ( Wuhan)
evaluationreportsasrequired. Co., Ltd. conducted a specialized training session on Medical Device Adverse Event Monitoring and Re-evaluation,
covering supervisors and above from Production, as well as staF from Quality Management, Technical, and Sale
Management departments. The session systematically covered regulatory requirements, management syst
operationalprocedures,androleresponsibilities,comprehensivelystrengtheningparticipants5complianceexe
capabilities.
Forpost-marketmedicaldevices,theCompanysystematicallyconductsGvecoremonitoringandreportingactivities,
In terms of compliance eFectiveness, the Company5s medical device vigilance system continues to operate in f
comprehensively covering
individual adverse event reports, group adverse event reports, periodic risk evaluation
alignmentwithdomesticandinternationalregulatoryrequirements,withthestandardizationandeFectivenessof
reports, key monitoring reports (for innovative products), and product re-evaluations,
ensuring that adverse events
management practices recognized by regulators. In 205, BGI Biotechnology (Wuhan) Co., Ltd. underwent a routine
andproductsafetyrisksofvaryingtypesandrisklevelsaremonitoredandaddressedcomprehensively,consistently,
inspectionbytheHubeiMedicalProductsAdministration,receivingzeronon-conformitiesinmedicaldevicevigilanc
andprecisely,achievingseamlessrisksurveillanceformarketedproducts.
andadverseeventmonitoringmanagement,fullyvalidatingthesystem5scomplianceandmaturity.
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Customer service
The Customer Service Center fully aligns with ISO 901, ISO 140, ISO 4501, ISO 3701, ISO/IEC 2701:, ISO/
IEC 27 01: 9, and ISO 15 89 requirements, actively pursues certiGcations, and rigorously implements standard
clauses. It enhances ser vice efficiency through quality management, builds customer trust via in
BGI Genomics5 Customer Service Center is among the earliest established in China5s genomics industry. Adhering security and privacy protection, standardizes service conduct through compliance management, ensures ser
to the service philosophy 4 Empathy and Understanding, Catering to Your Needs, 4 it is committed to delivering sustainability with green and safe operations, and strengthens professional support with medical l
professional, efficient, and comprehensive technical support and services, positioning customer service as the service standards. By consolidating business, relationship, data, and team assets, it continuously optimizes serv
core nexus between the Company and its clients. In 20 5, the Company continued enhancing its service system, processes and customer experience, fulfilling the mission 4 Omics for All4 through systematic operatio
upgrading capabilities, and optimizing experiences. By consolidating four core assets! business, relationships, continuous improvement. Below are the certiGcation systems the center has participated in and passed, along with
data, and team!it solidiGed customer trust, provided essential support for sustainable development, and faithfully relevantauditclauses(departmentsprimarilyresponsibleforauditsareindicatedinredfont):
fulGlleditsmission4OmicsforAll.4
Customer service management system
Systemname Mainclausesinvolved
The Company has built a hierarchical, dual-track, closed-loop collaborative
customer service management system. expectationsofinterestedparties
ISO 37301 7.3Awareness
Guided by the top- level vision 4 Creating Wings for Customer Service, 4 the business layer focuses on iterative 4.5Complianceobligations
refinement of service processes and standards, the capability layer emphasizes implementation of intelligent 4.6Complianceriskassessment
systems, and the foundation rests on comprehensive customer service empowerment, forming a standardized
servicemanagementsystemcoveringallscenariosandprocesses. 4.2Understandingtheneedsand
ISO 27001:2022 expectationsofinterestedparties
BGIGenomics5customerservicemanagementsystem 6.12Informationsecurityriskassessment
ISO 27701:2019 expectationsofinterestedparties
Hierarchicalprogression 5.412Informationsecurityriskassessment
Deepintegrationofgeneralandspecializedcapabilities
Creating Businesslayer authorities 7.4Communication
wings for Continuousimprovement Capabilitylayer
ISO 9001
customer In-depthapplicationand 6.2Qualityobjectivesandplanningto 9.1Monitoring,measurement,analysisand
ofoperatingprocessesand
service standards practiceofintelligentagents achievethem evaluation(9.12Customersatisfaction)
Customer All-scenario Customerintent
Preciseproblem Intelligentagent
Datastatisticsand
authorities 7.3Awareness
inquiries responsiveness classiGcationand applicationand ISO 14001
handoF analysis 6.2Environmentalobjectivesandplanning 7.4Communication
handling feedback
toachievethem
Customer
Research!?Planning!?Execution!?Standardization!?Implementation!?Supervision!? 7.3Awareness
follow-up Results!?Assessment!?Incentivization!?ContinuousImprovement ISO 45001 6.2OH&Sobjectivesandplanningtoachieve
them
Latest
Customer
Latest Latestproduct Latestlaws, Latestinternal 4.1Impartiality activities)
strategiesand
service
operating andservice regulations,and contact ISO 15189 4.2ConGdentiality 6.2Personnel
organizational
empowerment
procedures processes safetystandards network
structure 5.6Riskmanagement 8.5Actionstoaddressrisksand
opportunities
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
The Company is committed to delivering 4 accurate, professional, and reliable4 medical and scientific research CustomerSatisfactionSurveyManagementProcedure
services. By establishing standardized service protocols and defining response timeframes across all service
scenarios, it has implemented an efficient and robust service response mechanism to effectively address diverse
customerinquiriesregardingthetestingprocess.
Determiningsurvey
Designingand
Servicetype SpeciGcitems Committedprocessingtime DeGningsurvey DeGningsurvey objectives,
implementingsurvey
scope content establishingsurvey
questionnaires
procedures
Inquiringabouttestingprogress,
registeringcustomerinformation
updates,applyingforreportmailing, 1businessday
andprocessingdonationwithdrawal
requests
Consultation Followinguponcustomerintentions
andconductingdissatisfactionfollow- 1!?2businessdays
ups
Donationwithdrawalprocessed Within5businessdays Collectionofsurvey
Follow-up
questionnaires,and
Dataanalysis onnegative
qualitycontrolof
evaluations
Acceptingcomplaints 1businessday questionnairedata
Providingcomplaintprogressupdates 2businessdays
Complaints
Post-resolutioncustomersatisfaction
follow-up Formulating Implementing Reportwriting
service andsupervising andconclusion
Investigationandhandlingofservice- improvementplans improvementplans sharing
relatedcomplaints
Others SMSconGguration 1businessday
Case study Early colorectal cancer screening: seizing the window for life
Customer Service Capability Improvement InFebruarythe
, 5 2 0 Companylaunchedashareholderappreciation
initiative,oFeringtheColotectcolorectalhealthtesttoshareholders
Customer satisfaction enhancement
as a demonstration of its commitment to stakeholder well-being
throughgenomics.ShareholderMr.Hanparticipated,receivedatest
kit, completed sampling, and received results indicating positive
The Company has establisheda 7 × 2 4 - hour, uninterrupted, omni- channel customer service system
, leveraging methylationinthreegenes.Hepromptlyunderwentacolonoscopy
diverse touchpoints such as telephone and online channels to rapidly respond to inquiries, comprehensively permedicaladviceandwasdiagnosedwithintramucosalcarcinoma
address customer needs, and eIciently resolve issues through closed-loop management!continuously delivering of the sigmoid colon. Thanks to the precise early detection, the
professional,convenient,andtrustworthyservices. lesion was identified before cancer spread, and he made a full
Simultaneously, the Customer Service Center has established a regular customer satisfaction survey mechanism, recoverypost-surgery.Mr.Hanlatersentaheartfeltthank-youletter
designing tailored questionnaires for different products and conducting periodic surveys and proactive follow-andacommemorativebanner,sincerelyacknowledgingtheclinical
ups via phone, email, WeChat, and other channels. This enables comprehensive collection of customer feedback valueoftheCompany5sproductandpowerfullyvalidatingthereal-
on products, services, and delivery quality, which is compiled into dedicated reports to continuously reGne service worldimpactofBGIGenomics5mission:Omics
quality,enhancecustomerloyaltyandlong-termretention,andsupportsteadybusinessgrowth.In205,agent-level
customersatisfactionremainedconsistentlyabove9%,maintainingindustry-leadingservicequality.
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Digital and intelligent service transformation
Key performance
In 2 0 5 , the Company collected 1,094 customer satisfaction survey responses, achieving a
satisfactionrateof99%. To continuously enhance service quality, efficiency, and digital intelligence, the Company iterativel
its end-to-end customer service support system. In 20 5, it updated its knowledge base with over 10, entries,
solidifyingthefoundationforexpertservicedelivery.Internally,itenhancedtheDingTalkappMedical
to enable enterprise- wide knowledge sharing and reuse, empowering frontline staff. Externally, it upgrad
intelligentagent4Gene,4which!throughspecializedlarge-modeltraininganddynamicupdatesfromitsproprietary
Customer service quality control management knowledge base! achieved a 7 0 % AI reception rate in 2 0 5 , enabling precise, detailed, and natural interactions
with customers. This steadily advances the deep integration and innovative application of AI in customer serv
continuouslyoptimizingtheuserexperiencethroughtechnologicalinnovation.
The Company treats customer service quality as a key performance indicator, implementing end-to- end refined
control through an intelligent quality assurance system. This includes an AI-powered quality inspection platform
covering phone, online, and other channels, conducting daily proportional checks and re- inspections on every
agent5 s interactions. Intelligent technologies enhance voice training and standardize service delivery. Real-time
monitoring of agent blind spots, regular service philosophy training, and sharing of exemplary cases minimize
performance variance. Customer feedback drives a closed- loop process optimization mechanism that rapidly
translates improvements into standardized operating guidelines. Additionally, a four- tier quality inspection
workflow! agents, inspectors, re- inspectors, and quality supervisors! ensures closed- loop management from
service record generation, sampling, re-inspection, feedback and coaching, training implementation, to aggregated
optimization!ultimatelyenhancingbothserviceeIciencyandcustomerexperience.
CustomerServiceCenterQualityInspectionManagementProcess
Continuous development of a professional customer service team
Agent Qualityinspector Re-inspector Qualitysupervisor
Drawing on years of operational experience, the Company has built a professional, stable, and highly qualiGed core
service team with 14 years of deep industry expertise. As of the reporting period end, it has served over 4.6 million
Reviewqualityinspection Providere-inspection
outcomes feedback individuals,providingstrongtalentassuranceforhigh-qualityservicedelivery.
NumberofcertiGed
QualiGcationcategory Professionalvalue
individuals
Aggregate
andanalyze
Servicerecord Sampleforquality Re-inspectquality inspection
inspection results results;propose Provideprofessionalhealthmanagementconsultationand
NationalSeniorHealthManager 23
processand guidancetoclients
material
optimizations
NationalSeniorPublicNutritionist 14 Provideprofessionalnutrition-relatedconsultationservices
Deliverqualityinspection
resultswithguidance
NationalSeniorCustomerService Ensurestandardizationofserviceprocessesandqualitycontrol
Manager ofservices
Providefeedbacktotraininglead
forcoaching
Junior/IntermediateGenetic Provideprofessionaltechnicalservicessuchasgenetic
Counselor counselingandreportinterpretation
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Management
TheCompanyprioritizesbuildingafuture-readytalentteam.Ithasformulated the MeasuresforPublic Customercomplainthandlingprocess
Customer Service Training in the Customer Service Center and the Competency Verification Plan for Long-term
Employees
. Regular systematic training and assessments are conducted to continuously enhance the professional
competence of the customer service team, fully empowering them to meet diverse role requirements. The Company Processnode Coreworkrequirements Committedtimelimit
formulatesadetailedannualtrainingplanatthebeginningofeachyear,conductsyear-endcompetencyveriGcation,
andmakesmonthlyadjustmentsbasedonactualconditionstoensurecustomerservicepersonnelcomprehensively Complaint
Receivecustomercomplaintsthroughallchannels,
completecomplaintassessmentandclassiGcation,and
master product knowledge, communication skills, and system operations, thereby delivering high- quality and acceptanceand 1businessday
transfertothecorrespondingresponsibledepartment
eIcientservicestocustomers. transfer
andpersonnel
Case Conducting customer service training and competency verification to solidify the
study foundation of service professionalization Process
Synchronizephasedcomplainthandlingprogresswith
CompletetheGrstprogressfeedback
thecustomerandpromptlycommunicatethehandling
feedback within2businessdays
status
In 2 0 5 , the Company organized specialized training,
co m p e te n c y v e r i f i c at i o n , a n d o n - s i te a s s e s s m e n t s
focused on enhancing customer service capabilities. By FordiFerentcomplainttypes,suchasservice-related Completeinvestigationandhandlingof
Investigation
andquality-related,conductspecialinvestigations,service-
event relatedcomplaintswithin5!?10
integrating centralized lectures, directive rollouts, and andhandling
grading,andformulateandimplementresolutionplans businessdays
practical evaluations, it strengthened customer service
personnel5s understanding and application of business
Aftercomplaintresolution,completeacustomer
p r o ce s s e s , s e r v i ce sta n d a r d s , a n d co m m u n i c a t i o n Follow-upafter
satisfactionfollow-uptoconGrmthecustomer5s 1businessday
resolution
requirements, promoting the translation of training acceptanceoftheoutcome
outcomes into on- the - job performance and further
solidifying the professional capabilities and ser vice Conductrootcauseanalysisofthecomplaint,drive
The Company organizes on-site customer service training and
Closed-loop Continuousfollow-uptoachieve
qualityfoundationofthecustomerserviceteam. relevantdepartmentstoimplementcorrectiveactions,
competency assessment and verification
optimization systematicoptimization
andtracktheeFectivenessofimprovements
Key performance
Key performance
In 20 5, the Company conducted
customerservicepersonnel. In 205, the Company received 35 customer complaints, amounting1 to
complaint per RMB 10
millioninrevenue.Thecustomercomplaintresolutionratewas .100%
Customer complaint handling
Management
The Company has formulated the
Responsible marketing
Regulations for Handling Medical Customer
Complaints
clarifying
, standardsandtimelimitsfor
the entire complaint handling process to ensure
customer concerns are addressed promptly, in a
Advertising
BGI Genomics strictly complies with relevant laws and regulations, including theLaw of the People5s
standardized manner, and through a closed-loop
Republic of China
, the Anti-Unfair Competition Law of the People5s Republic of China
, and the Law of the People5s
process.Thecoreprocessisasfollows:
RepublicofChinaontheProtectionofConsumerRightsandInterests
.TheCompanyrigorouslyadherestoregulatory
redlinestoensureallmarketingactivitiesareconductedwithinthelegalframework.Itdeeplyintegratestheco
of responsible marketing into its entire business operations, establishing a comprehensive, end-to-end marketin
compliance management system. Marketing practices are strictly regulated to resolutely eliminate violat
as false advertising and unfair competition, fully committed to fostering a fair, transparent, and trustworthy
environment, safeguarding consumers5 legitimate rights and interests, and promoting the healthy and ord
developmentofthegenomicsandhealthindustry.
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Routine closed-loop management of marketing activities
The Company has established a routine, full-process control mechanism of pre-
post-review4toimplementfull-lifecycle,closed-loopmanagementofmarketingactivitiesandcomprehensivelymitigate
marketingcompliancerisks. Intermsofbuildingthesciencecommunicationcontentsystem
Pre-review Centered on its core business areas!including reproductive health, cancer prevention and control,
TheCompanyhasestablishedastringent,multi-tieredmarketingcontentreviewsystem,stipulatingthatallexternally infectious disease prevention and control, and chronic disease management! the Company has
releasedmarketinginformation,promotionalmaterials,andadvertisingcontentmustundergoadual-reviewprocess: developed a professional, rigorous, and accessible science communication content system. This
preliminaryreviewbythebusinessdepartmentfollowedbyspecializedreviewbythecomplianceandlegaldepartments. system covers multiple dimensions such as disease prevention knowledge, principles of genomic
Thefocusisonverifyingtheauthenticity,scientiGcvalidity,andcomplianceofpromotionalcontent.Exaggeratedclaims, technology, product application scenarios, and test result interpretation, ensuring all con
falseadvertising,absolutelanguage,ordistortedfactsarestrictlyprohibited,ensuringallexternalmarketinginformation
is backed by authoritative scientific research and clinical data, and avoiding any exaggerated or
issupportedbyauthoritativescientiGcevidence.Nocontentmaybepublishedexternallywithoutpassingthisreview.
misleadingstatements.
In-processmonitoring
The Company conducts routine dynamic monitoring of published marketing content and ongoing campaigns, Intermsofsciencecommunicationchannelsandformats
establishinganomni-channelmarketingbehaviormonitoringmechanismcoveringonlinenewmediaplatforms,oJine
promotionalevents,academicengagements,andchannelpartnerships.ThisenablestimelyidentiGcationandhandling
Online, the Company leverages new media channels such as its official WeChat Official Account,
ofnon-compliantpromotionalactivities,swiftlycontainingriskpropagation.Simultaneously,theCompanystrictlyabides
bylawsandregulationsgoverningmarketcompetition,prohibitingunfairpracticessuchasimproperbeneGttransfers, video channels, and live streaming platforms to continuously publish popular science artic
commercialbribery,orunduepromises.Italsoprohibitssuppliersfromseekingprocurementadvantagesormonopolistic expert interview videos, and short science videos, creating a series of science communication IPs to
positions through improper means like benefit transfers or special returns, fully committed to maintaining a fair and provide the public with convenient and accessible health knowledge services. It has also launched
orderlymarketcompetitionenvironment. the ChatGeneT professional genomics consulting platform, which offers the public knowledge
on genetic diseases, genetics education, and personalized health advice based on a professional
Post-review knowledge base, lowering the cognitive barrier to understanding genomic technologies and related
products.
TheCompanyhasestablishedamarketingcomplianceriskreviewandrectiGcationmechanism.Forcomplianceissues
and potential risks identified in marketing activities, it conducts root cause analysis to identify underlying problems OJine, in conjunction with health-themed days such as National Ear Care Day, World Thalassemia
and assign rectification responsibilities, formulates targeted optimization measures, and concurrently updates review Day, Cancer Prevention and Control Promotion Week, and World Gut Health Day, the Company
standardsandcontrolrequirementstoestablishaclosed-loopmanagementsystem,continuouslyreGningthemarketing collaborates with local health commissions, medical institutions, and public welfare organizations
compliancemanagementframework. to conduct free clinics, health lectures, grassroots science outreach tours, and public welf
Conduct regular responsible marketing training
screenings. These activities reach deep into communities and primary healthcare institutions,
providing face-to- face explanations of genomic health knowledge and the value of its products
The Company incorporates responsible marketing and compliance communication training into its company-wide and services. Simultaneously, through academic marketing activities, it engages in professional
trainingsystem,conductingregular,tieredspecializedtrainingformarketing-relatedpersonneltocontinuouslystrengthen academic exchanges and product knowledge dissemination with clinical experts to enhance
enterprise- wide compliance awareness and the philosophy of responsible marketing, solidifying the ideological scientiGcunderstandingofitsproductswithintheprofessionalcommunityandpromotethedelivery
foundationformarketingcompliance.Adoptingablendedonline-oJinetrainingapproach,itachievesfullcoverageof
ofstandardized,scientiGchealthknowledge.
personnelacrosstheentiremarketingchain,includingtheCustomerServiceCenterandMarketingCenter.Compliance
marketing training is also included as a mandatory component of new employee onboarding, ensuring new hires are
familiarwithmarketingcomplianceredlinesandpolicyrequirementsfromdayoneandcanonlycommenceworkafter Others
passingrelevantassessments.
Deepening product and service popularization education Throughout the entire product promotion and customer ser vice journey, the Company has
established a full-cycle consulting service system, with professionals providing one-on-one product
TheCompanyconsistentlyadherestotheprincipleofscience
productandservicepopularizationeducationthroughoutthemarketingprocess.Itdeliversmulti-format,multi-channel explanations,reportinterpretations,andhealthadvicebefore,during,andaftertesting.Thisensures
genomicsandhealthknowledgedisseminationtocustomersandthepublic,helpingthemscientiGcallyunderstandthe customers gain a comprehensive and accurate understanding of relevant product and servic
principles,applicablescope,value,andlimitationsoftheCompany5sproductsandservices.Thisbreaksdowncognitive information, enabling them to make informed consumption decisions, truly empowering marketing
barriers,eliminatesmisleadingpromotions,andeFectivelysafeguardsconsumers5righttobeinformedandtheirrightto throughsciencecommunicationandsafeguardingpublichealthwithasenseofresponsibility.
choose.
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Innovation-driven development MajorR&D
Projectpurpose Projectprogress Intendedgoals
R&D and innovation
projectname
Domestic Achievedomesticsubstitutionof
Completedreplacementtesting
substitution majorrawmaterialswhileensuring
The Company continues to deepen the standardization of its R&D system, focusing on full lifecycle management ofallimportedrawmaterials
fortheNIFTY Achievedomesticproductionof producttestingperformanceand
of R& D center projects. It has unified and standardized management requirements across the entire chain! intheNIFTYreagentkitwith
non-invasive allrawmaterialsforthereagent stability,signiGcantlyreducing
domesticreagentsandinitiated
including project initiation, execution, process monitoring, tech transfer, and project closure! to vigorously prenataltesting kit testingcostsandimprovingthe
theregistrationforrawmaterial
(NIPT)product stabilityandcontrollabilityofraw
advance the transformation and full-cycle management of R&D outcomes. The Company strictly implements the changes
reagentkit materialsupply
R& D Center Project Management Methodology to ensure R& D outputs are highly aligned with the Company5 s
strategic development needs, project progress meets design objectives, and R&D cost control satisGes accounting
re q u i re m e n ts , d r i v i n g t h e co m p re h e n s i v e , sta n d a rd i ze d , s c i e n t i f i c , a n d e f f i c i e n t i m p l e m e n tat i o n o f R & D Completedthedevelopment Establisha4Five-pre4product
Developcarrierscreening,
management. oflocalizedproductsfor systembasedontheWGS
Development prenatalscreening,newborn
R&D and innovation management structure
carrierscreeningandnewborn technologyplatformtoprovidea
of4Five-pre4 screening,preimplantation
screeningbasedonthe one-stop,comprehensive,high-
productsbased genetictesting(PGT),andother
WGStechnologyplatform, levelsolutionfortheentirebirth
ontheWGS technologiesbasedontheWGS
Based on the actual operational eFectiveness of its R&D management system, the Company continuously reviews andreleasedlocalizedWGS defectpreventionandcontrol
technology platform,completingafull-
testingsolutionsbasedonthe system,coveringpreconception,
and optimizes its R&D management regulations and systems, establishing a research management organizational platform lineupgradeofthe4Five-pre4
MGISEQ-20andDNBSEQ-T7 prenatal,preimplantation,and
products
structurewithcleardivisionsoflaborandwell-deGnedresponsibilitiesandauthorities,constantlystrengtheningthe platforms preschoolstages
foundationalbedrockfortheCompany5sinnovationcapabilities.
Advancemodularand
BuildamodularandpluggableWGS
HeadoftheR&Dcenter Disciplineleader containerizedR&DforWGS Promotestandardizeddatabase
bioinformaticsanalysisplatform
R&Dofa bioinformaticsdataanalysis R&Dbasedonstandardmodular
Overseetheoverallstrategicdirectionof Participateintheapprovaland thatsupportsrapiditerationand
modularand toenablerapiditerationand processes,achievestandardized
theR&Dcenterandberesponsiblefor decision-makingforcorestages hotupdatesofclinical-grade
containerized agileglobaldeploymentofWGS iterativemanagementofWGS
theholisticresourcecoordinationand ofR&Dprojects,suchasinitiation, analysispipelines;developa
bioinformatics products;simultaneouslyimprove
productsanddiversiGedprocess
allocationoftheR&Dsystem. change,techtransfer,andclosure. multi-modaldeploymentsolution
analysis analysisspeedandreduce interfaces,andrapidlydeploy
coveringon-premisesservers,
platformfor computingandstoragecosts, expressWGS,carrierscreening
privateclouds,andpublicclouds
R&Dteam WGS facilitatingthecomprehensiveWGS,andnewbornscreening
tomeetcompliancerequirements
oftheR&D promotionandaccessible WGS
acrossdiFerentglobalregions
center applicationofWGStechnology
Projectmanagementposition PBUleader
Doesnotdirectlyparticipateinfrontline LeadtheentireR&Dprocessfor
R&Dwork.Thecoreresponsibilityisto PBUprojectsandassumefull
assisttheprojectteaminachievingR&D responsibilityforexecutionand Continuouslyexpandthedetection
goals,provideprofessionalsupportfor outcomesthroughouttheproject5s scope,optimizedetection
theentireprojectexecutionprocess, lifecycle. performance,andimprovethe
andconducttracking,monitoring,and detectionrateofmonogenic
Optimization DeployexpresstestingforWGS
controlofprojectexecution. Optimizethemoleculardiagnostic diseasetestingproductsthrough
PBUmembers andupgradeof productsandreleasealocalized
productportfolioandimprovethe iterativeexperimentaltechnologies
WESandWGS expressWGSsolutionbasedon
CollaboratetocompletevariousR&D overalldetectionrate andoptimizationofproprietary
products theDNBSEQ-T1+sequencer
executiontasksaccordingtoproject analysisalgorithms;enhancethe
R&Dneedsanddivisionoflabor. functionalityofthecloud-based
interpretationplatformtosupport
productlocalization
Major R&D projects during the reporting period
BGI Genomics adheres to an innovation-driven strategy, focusing on key technological breakthroughs and modular Optimization
Achievemorecomprehensive
andupgrade Releasesingle-molecule
upgrades of its sequencing platforms. By strengthening the domestic sourcing of core raw materials and enhancing Developsingle-molecule thalassemiagenetestingand
ofthalassemia thalassemiatestingproducts
thalassemiatestingproducts productiterationthroughsingle-
bioinformatics analysis eIciency, the Company not only solidiGes its foundation of technological self-reliance but genetesting andlocalizedsolutions
moleculesequencingtechnology.
products
also continuously optimizes its product portfolio, effectively supporting sustainable business growth and global
expansion.
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
R&D and innovation achievements Case Launching the ChatBGI intelligent assistant to enhance the accessibility of precision
TheCompanyactivelyleadsorparticipatesinthedevelopmentofstandardsatalllevelsinGeldssuchasreproductive study health services
health,cancerpreventionandcontrol,infectionpreventionandcontrol,andmulti-omicsbigdata.Asoftheendofthe
I n F e b r u a r y 2 0 2 5 , B G I G e n o m i c s I n t e r n e t H o s p i ta l
reporting period, the Company has cumulatively led or participated in the development of 12 standards, including
officially launched ChatBGI, providing users with
issuanceandimplementationofthesestandardshavefurtherstandardizedtheclinicalapplicationscenariosofgenetic
consultation, product inquiries, report interpretation,
testingtechnologiesandprovidedcriticalsupportforthequalitycontrolofrelatedproductsandservices.Meanwhile,the
andhealthmanagementadvice,coveringscenariossuch
Companyisdeeplyinvolvedintheestablishmentofnumerousdomesticandinternationalindustrystandardorganizations
as reproductive health, cancer prevention and control,
andindustrialalliances,playingasigniGcantroleinpromotingtheformulationandimplementationofgloballyleading
chronic disease management, and infection prevention
standardsandcontributingtothehigh-qualitydevelopmentoftheindustry.
andcontrol.
IntheGeldofdeepintegrationbetweenartiGcialintelligenceandprecisionmedicine,BGIGenomicscontinuestodeepen
Leveraging the synergistic capabilities of a professional
external collaborations and achievement transformation. The Company has established partnerships with leading
knowledgebaseandlargelanguagemodels,thisplatform
institutions including Peking Union Medical College Hospital, the National Clinical Research Center for Laboratory
has enhanced ser vice response efficienc y and user
Medicine at the First Affiliated Hospital of China Medical University, the Obstetrics & Gynecology Hospital of Fudan
BGI Genomics Internet ospital launches ChatBGI intelligent
experience, providing support for the implementation
University,PengChengLaboratory,andZhejiangLab,focusingonjointresearchinareassuchaslargemodelsforrare
diseases,AIdemonstrationbases,multimodalmodels,bioinformaticscomputingcompression,andintelligentAgentR&D.
of 4 AI + testing services4 and the democratization of health management assistant
precisionhealthmanagement.
TheCompany5srelatedAIsolutionshavereceivedmultipleindustryrecognitions,anditspatentandsoftwarecopyright
portfolioaresteadilyexpanding.
Case Exhibited at international technology fairs, showcasing innovative capabilities in
study localized AI-powered testing
HospitalandscientiGcresearchcooperation
In June 20 5, BGI Genomics participated in the 1 th China (Shanghai) International Technology Import & Export
Fair ( CSITF) , showcasing the 4 SIRO High-throughput Gene Testing Localized Medical Solution4 and presenting it
as a representative achievement at the CSITF press conference. This platform integrates standardized labora
workHows, AI-powered intelligent analysis, and localized deployment, achieving a closed-loop 4sample-in, report
out4 process. It demonstrates the Company5s technological prowess in intelligent testing for precision med
Engageinin-depthcollaborationwith CollaboratewiththeObstetrics
PekingUnionMedicalCollegeonlarge
modelsforrarediseases,including
JointlyapplywiththeNationalClinical
ResearchCenterforLaboratory &GynecologyHospitalofFudan CooperatewithPengCheng
LaboratoryinGeldssuchas
and provides a new pathway for bringing gene testing to grassroots levels and enhancing the accessibility of cl
University inShanghaitoapply
co-authoredpublicationsandjoint MedicineattheFirstAIliatedHospital bioinformaticscomputing
applicationsforclinicalandtranslational fortheShanghaiScientiGc
ofChinaMedicalUniversitytoestablish Intelligence compressionandlifescience services.
ReserveProject,with
projects,andpresentGndingsatthe2nd anartiGcialintelligencedemonstration largemodels;cooperatewith
AnnualConferenceonRareDiseasesofthe base in-depthcooperationonprenatal ZhejiangLabonAgentR&D
multimodal largemodels
ChineseMedicalAssociation
HospitalandscientiGcresearchcooperation
Theintelligentintegratedgenetesting
iGeneTProwasrecognizedasthe4Annual solutionforprecisionmedicinewon 6corepatentsaccepted,
Sci-techInnovationPracticeCase4atthe thirdprizeintheHealthBigData iGeneTProwontheBGIGenomics 3softwarecopyrights
Conference theXiong5anMedicalandHealth applicationspending
TechnologyApplicationCompetition
BGI Genomics showcases SIRO high-throughput gene testing localized medical solution at CSIT
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Case Host the International Conference on Genomics, building consensus on innovation in Case study Specialized training on trademark protection
study omics and AI
In October 205, the 20th International Conference on Genomics (ICG-20) was held in Hangzhou, gathering over 10 To comprehensively enhance the Company5 s professional capabilities in trademark application and prote
expertsandscholarsfrom19countriesandregionsforin-depthdiscussionson4TheFutureofOmicsandAI.4During and mitigate brand risks in business operations, the Intellectual Property Department held a 4Specialized Train
the conference, BGI Research and Zhejiang Lab jointly launched Genos, the world5 s first universal foundational on Trademark Protection4 in April 2 0 5 . The training covered fundamental trademark knowledge, registration
model for the human genome with tens of billions of parameters. This showcased the Company5 s cutting- edge application procedures, examination criteria, as well as practical matters such as trademark usage guidelin
exploration at the intersection of omics and artiGcial intelligence and injected new momentum into global scientiGc evidencecollection,aimingtoempowerthedevelopmentofnewqualityproductiveforcesthroughhigh-qualityan
collaborationandtheinnovativedevelopmentofprecisionmedicineandlifesciences. eIcientIPprotection.
The 20th International Conference on Genomics The specialized training on trademark protection
Key performance
Key performance
In205,R&DinvestmentamountedtoRMB In205,acumulativetotalof802patentswereheld.
R&Dinvestmentaccountedfor 13.71%ofoperatingrevenue. 919
Acumulativetotalof softwarecopyrightswereheld.
Intellectual property protection
Acumulativetotalof
BGIGenomicsadherestoinstitutionaldevelopmentasakeydrivertopromotethestandardizationandnormalization
of its intellectual property ( IP) management. The Company has formulated and continuously refined internal
IP Reward Measures,
regulations, including the IP Transfer Management Measures, Patent Management Measures,
Trademark Management Measures, and Technical Secrets Management Measures
, forming a hierarchical and well-
integrated institutional system. Concurrently, the Company has established an Intellectual Property Department
as a Grst-level unit, directly overseen by the General Manager, to ensure the deep integration of the IP strategy with
the Company5s overall business objectives, achieving seamless alignment from top-level design to on-the-ground
execution.
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Ethics of science and technology Building a culture of ethics of science and technology and social participation
BGI Genomics has always been guided by its corporate vision of 4 Omics for All. 4 Deeply aware of the symbiotic The Company actively promotes the building of a culture of science ethics, primarily through training and soc
relationship between technological advancement and ethical governance, the Company adheres to the principle of engagement. By conducting regular training on the ethics of science and technology, it enhances employees5 ethical
advancing scientific and technological progress, the Company is committed to fully protecting participant rights, requirements.Simultaneously,BGIGenomicsemphasizessocialengagement,proactivelycommunicatingwithregulatory
safeguarding personal privacy, and upholding social fairness and justice, thereby achieving a harmonious unity bodies,researchinstitutions,andthepublic,sharingpracticalexperienceinscienceethics,andparticipatinginindustry
betweentechnologicaldevelopmentandethicalconstraints. standardsettingandresearchprojectstofosterethicalconsensusandsocialresponsibilityinthelifesciencesGeld.
Uphold the core philosophy of 4 Omics for All4 and make 4 tech for good4 the starting
Case study Symposium on "Intelligence Leading the Future, Ethics Walking Alongside"
Vision
pointforallinnovation
In April 20 5, the BGI Science and Technology Ethics Committee held its annual meeting and the symposium on
Ethical Adhere to 4responsible innovation4 and uphold bioethics and the ethics of science and Intelligence
principles technologyascorevalues
biotechnology. Experts from universities, research institutes, and medical institutions discussed frontier topic
as algorithmic bias, data privacy, and human-machine collaborative responsibility, analyzing the balance betw
While advancing scientific and technological progress, protect participant rights, technologicaladvancementandethicalconstraintsfromaninterdisciplinaryperspective.Themeetingreachedmulti
Development
goals safeguardpersonalprivacy,andupholdsocialfairnessandjustice consensuspoints,includingimprovingreviewstandards,establishingriskearly-warningmechanisms,andstrengthening
ethics training. This reflects BGI Genomics5 commitment to integrating ethical considerations into technolo
Management system and structure for the ethics of science and technology
innovation, leveraging an open platform to gather collective wisdom, and providing practical approache
responsibledevelopmentofemergingtechnologies,demonstratingtheCompany5sleadershipandsocialresponsibilityin
BGI Genomics has established an ethics management structure centered on the Science and Technology Ethics theGeldofscienceandtechnologyethics.
Bioethics
Committee and the Compliance Department, and has formulated institutional documents such as the
ManagementMeasuresandEthicsManagementRegulations
The
. Company5sScienceandTechnologyEthicsCommitteeis
responsibleforconductingethicalreviews,riskassessments,andcomplianceconsultations.Itsmembersincludeexperts
fromGeldssuchasethics,law,andmedicine,ensuringtheprofessionalism,impartiality,andindependenceoftheethical
reviewprocess.Meanwhile,theComplianceDepartmentoverseeskeyareasincludinglifescienceethics,datasecurity,
andhumangeneticresourcesmanagement.Itformulatesrelevantnormsandregulations,conductsriskassessments,
compliancetraining,andsupervisionandinspectiontoensurethecompliantdevelopmentofallCompanyoperations.
BGIGenomics5managementmechanismfortheethicsofscienceandtechnology
Ethics training and consultation
The Science and Technology Ethics Committee provides ethics training courses for BGI employees and
accepts daily ethical consultations to help BGI employees enhance their awareness of the ethics of science
and technology
Daily management mechanism
Establish a graded and classified project management system and implement an ethical risk assessment
mechanism
Collaborative compliance management
The Science and Technology Ethics Committee collaborates with multiple departments, including the
Compliance Department, R&D management, and Legal Affairs, to conduct joint oversight, effectively
preventing and promptly addressing potential ethical risks
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Data security and customer privacy
the Level III assessment and certiGcation under China5s
ClassiGedProtectionofCybersecurityframework
Cybersecurity
BGI Genomics strictly complies with relevant laws and regulations, including the Law of the People5s
Republic of China
, the Data Security Law of the People5s Republic of China,
and the Personal Information Protection Cybersecurity
Law of the People5 s Republic of China
. Adhering to the principle of coordinating development and security, the classiGed
Nameofassessedsystem
protection
Company consistently treats data security and customer privacy protection as a critical foundation for ensuring assessmentlevel
businesscontinuity,safeguardingcustomerrights,reinforcingcooperativetrust,andsupportingdigitaltransformation.
ChatGeneTGeneticCounselingAssistance
It promotes the establishment of a secure, controllable, standardized, transparent, and clearly accountable data System,iGeneTEnd-to-EndGeneInterpretation
governance system, providing robust support for the stable operation and long-term value creation of its precision Platform,BGIZhihuiHealthManagement
System,UniGedIDSystem,WhaleCloudReport
medicinebusiness.
Governance
System,PETASystem,BirthDefectPrevention
LevelIII andControlSystem,HALOSAll-in-OneGene
SequencingSystem,GovernmentPublic
LivelihoodTestingProjectInformationSystem,
Implementing
BGI Genomics has formulated internal policies and systems, including the Rules for Data Security BGIGenomicsMedicalMall,Cloud-basedPublic
BGI Genomics certified with ISO IEC 27001
Management, Management Measures for Data Security Classification and Grading, Management Measures for LivelihoodPlatform,BGICancerEarlyScreening
Information Security anagement System
System,BGIMedicalTestingPlatform
Privacy Policies,
and SpeciGcations for Personal Privacy Data Processing
. The Company continuously enhances its
data security governance system covering the full chain of decision-making, supervision, execution, and business
Strategy
usage. Data protection requirements are embedded into all aspects of business development, R& D innovation,
delivery operations, and external collaboration, driving the shift of data security from passive defense to proactive
governance. This provides foundational support for the Company5s stable operations, technological innovation, and
compliant development. In 205, the Company obtained ISO/IEC 2701 Information Security Management System
certiGcationandimplementedtheISO/IECPrivacy
standardizedmanagementofdatasecurityandcustomerprivacy. The Company continuously assesses the impact of data processing activities on business continuity, cus
trust, and long-term development from a risk prevention and control perspective. It advances security gover
BGIGenomics5governancestructurefordatasecurityandcustomerprivacyprotection capability building in synergy with digital business expansion, extending data management from basic compli
assurancetowardenhancedoperationalresilienceandvaluecreationsupport.
BGI Genomics5 identification and response to risks and opportunities related to data security and
DataSecurityandPersonalInformation
customerprivacy
Decision-making level ProtectionCommittee
DataCommitteeOIce Risk/Opportunity SpeciGcdescription Impactduration Financialimpact Responsestrategy
Management and
Compliance Legal Quality Management
Risk
supervision level
Department Department Department
Human Genetic Resources
TheCompanyhandles
Information Security
importantdata,genetic Strengthendataasset
Execution level Administration Office identiGcationdata, Increasedinvestmentinventorymanagement
(Ministry of Science and Management Department Compliancerisk andsensitivepersonal incompliance andimplement
Technology) classiGcation,
( grading,information.Inadequate Medium-and remediation;potentialclassiGcation,grading,
andmanagementof dataassetinventory, long-term riseinpenalties,audit,highest-standard
importantdata) classiGcation,grading,or andlegalresponse adherence,and
diFerentiatedprotection costs. tieredprotection
IT 部 Internal Audit and Internal
内审内控部 Process and IT
流程与信息化部
IT Department
mayleadtocompliance requirements.
Control Department Department
Other
breachesandliabilityrisks.
participating levels Supply Chain Department Human Resources ......
Department
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Risk/Opportunity SpeciGcdescription Impactduration Financialimpact Responsestrategy
Indicators and targets
BGI Genomics places high importance on data security and customer privacy protection, consistently treating it
Implementprinciples a vital foundation for ensuring stable operations, maintaining customer trust, and supporting sustainable b
Riskssuchasleakage,
ofminimumnecessity, development. The Company adheres to the principle of balancing compliance management with business growth,
Operational tampering,unauthorized Businessinterruption
permissioncontrol,
risks(collection, access,andusebeyond losses;increased continuously enhancing its data governance capabilities and privacy protection standards, and is comm
Shortand securetransmission,
transmission,use, authorizedscopeexist costsforcustomer
mediumterm logretention,data buildingasecure,standardized,andtrustworthydatamanagementenvironment.
andpermission indatacollection, compensationand
desensitization,
management) transmission,use,and trustrestoration.
andapproval-based
export. Keyperformance
authorization.
Indicator Unit 205data
Opportunities
Numberofincidentsrelatedtodatasecurityandcustomerprivacybreaches Cases 0
Monetaryvalueinvolvedinincidentsofdatasecurityandcustomerprivacybreaches
RMB 0
Continuouslyimproving
systems,certiGcations, Continuouslyadvance CustomerinformationsecurityandprivacyprotectiontrainingconductedSessions 8
Reducedlossesfrom
Opportunities training,andred-blue systemoptimization,
majorincidents; Participationincustomerinformationsecurityandprivacyprotectiontraining
Person-times 52
forgovernance teamexercisesenhances Medium-and certiGcation
enhancedpartnership
maturityandtrust governancematurity, long-term maintenance,training
stabilityandbrand Informationsecurityemergencydrillsconducted Sessions 2
enhancement customertrust,and anddrills,andsecurity
trust.
digitalbusinesssupport culturebuilding.
capabilities. Participationininformationsecurityemergencydrills Person-times 50
Full life-cycle data security management
TheCompanyisadvancing
BGI Genomics implements full life- cycle data security management, with data classification and grading
OmicsDB,auniGeddata cornerstone.TheCompanyestablishesbaselinerulesfordiFerentiatedprotectionbasedondataattributes,busines
Expandedrevenue Continuously
securitymanagement purposes, aFected subjects, and impact severity. Limited security resources are prioritized for high-sensitivity, high-
fromdataproducts, promoteplatform-
platform,andadataasset
improvedoperational basedmanagement, impact scenarios to align management requirements with protection intensity, thereby enhancing the precision o
Opportunitiesfor managementsystem
Medium-and eIciencyof standardized
dataassetizationand totransformdatafrom datagovernanceandtheeIciencyofresourceallocation.
long-term dataassets,and accumulation,
productization aresourceintoassets,
strengthenedgrowth compliantdata
products,andservices,and
driversfornew circulation,anddata
hasbegunexploringdata
businesses. productdevelopment.
BGIGenomics5closed-loopmanagementforfulllife-cycledatasecurity
productcommercialization
andvaluerealization.
Collection stage Transmission stage
Clearly define the purpose, scope, method, and legal Utilize secure transmission channels, encryption,
basis of data collection, implementing transparency integrity verification, and access control to prevent
and the principle of minimum necessity. data leakage during transmission.
Impact, risk, and opportunity management
Deletion and destruction stage Use and sharing stage Storage stage
BGI Genomics has established a closed-loop management system for impacts, risks, and opportunities centered on
optimization and improvement. 4 The Company embeds data security and personal information protection destroy data that has fulfilled its the authorized scope, validity desensitization, access control,
processing purpose or reached period, and purpose. Export of backup and recovery, and
requirements into key scenarios including scientific research, testing, delivery, system development, and cross- its storage period, ensuring the highly sensitive data is generally storage period management in
border collaboration. While mitigating risks such as data leakage, non-compliant cross-border transfers, and system entire process is traceable and restricted, and any use beyond alignment with classification
auditable. the original purpose requires re- strategies.
approval.
anomalies, it continuously strengthens the compliance support capabilities, operational resilience, and value
conversionfoundationofitsdigitalbusiness.
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Cross-border data transfer management BGIGenomics5specializedcontrolmeasuresforgeneticdatasecurity
BGI Genomics regards cross-border data transfer management as a critical boundary control measure for aligning DeGnekeyscope
domesticcompliancerequirementswithglobalbusinesscollaboration.Centeredoncompliancereview,tieredGling, Includehumangeneticresourcesinformation,rawgenesequencingdata,andgenetic
and prudent approval, the Company has established a cross-border data transfer control mechanism, strengthening identiGcationdataaskeyprotecteddatacategories.
identiGcation and process management for outbound transfers of personal information, important data, and gene-
related data. This ensures cross-border business operations are conducted lawfully, transparently, and controllably,
andthatallcross-borderdatatransferscomplywithapplicablelawsandregulations. Strengthencollectioncompliance
Implementinformedconsent,legalsourceveriGcation,andwrittenauthorizationrequirementsto
BGIGenomics5controlmeasuresforcross-borderdatatransfer
standardizepre-collectionmanagementofgeneticdata.
Implementapproveddelivery
ImplementtieredreviewforR&D,scientiGcresearch,andcustomerrequestscenarios,with
OutbounddataidentiGcation TieredGling
responsibilitiessharedamongthebusinessdepartment,HumanGeneticResourcesAdministration
OIce,DataCommittee,ITDepartment,andDeliveryCenter.
Clearlyidentifyoutbounddata ImplementGling,approval,or
subjects!includingpersonal escalateddecision-makingforcross-
information,importantdata,genetic borderdatatransferscenariosof Strictlycontroltheboundariesofuse
identiGcationdata,andhumangenetic varyingscaleandtype. Datauseislimitedtotheapprovedpurposeandscope;transfertothirdpartiesorchangesinuse
resourcesinformation!andenforce
theprincipleof4whoevertransfers, withoutauthorizationareprohibited.
declares,andisresponsible.4
Strictlyadheretotheredlineforcross-bordertransfer
ImplementGling,approval,andspecializedreviewrequirementsforcross-bordertransfer
ofgeneticdata;forcasesinvolvinghumangeneticresourcesinformation,followprescribed
supervisoryapprovalprocedures
Specializedreview Recordreview
Data security emergency management
IndividualcaseswithunidentiGablerisks Continuouslyverifyoutbounddata
aresubmittedtotheDataCommittee contentagainstactualtransmissions Emergency Plan for Data Security Incidents
In accordance with the , BGI Genomics continuously refines its data
forapproval;casesinvolvinghuman throughGlingforms,approvalforms, security incident response system, treating emergency management as essential support for business conti
geneticresourcesinformationundergo monthlyreports,andannualreviews.
customerprivacyrightsprotection,andcompliancebaselineintegrity.Throughproactiveplanning,uniGedrespo
specializedapprovalproceduresas
requiredbyregulations. protocols, and coordinated incident handling mechanisms, the Company extends data security management from
routine protection to resilience capacity building, enhancing rapid response, resource mobilization, and im
containment capabilities during emergencies. This minimizes adverse eFects on operations, brand reputation, and
Specialized control for genetic data security
stakeholdertrust,providingassuranceforthesteadydevelopmentofitsdigitalbusiness.
Privacy protection management
BGIGenomicsdesignatesgeneticdatasecurityasapriorityareawithinitsdatagovernanceframework,implementing
specializedmanagementforhighlysensitiveandhigh-impactdatasuchashumangeneticresourcesinformation,raw
BGI Genomics integrates privacy protection throughout information system development, business process design
gene sequencing data, and genetic identiGcation data. The Company strengthens lawful collection, classiGcation and
and personal information processing activities. Focusing on compliant notification, minimum necessity, e
grading,approveddelivery,usageconstraints,andcross-bordertransfercontrols,establishingadedicatedgeneticdata
consent, data desensitization, and anonymization, the Company continuously improves its personal informati
security control mechanism. It enhances human genetic resources management and ensures genetic data protection
protection mechanisms to balance legitimate data utilization with privacy rights safeguards, thereby strengt
requirementsareintegratedacrosskeyscenarios!includingscientiGccollaboration,productR&D,testingdelivery,and
stakeholders5trustinitsdatagovernancecapabilities.
cross-border cooperation!continuously solidifying the compliance and trust foundations for its precision medicine
business.
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Supply chain management system and regulations
Case Conduct red-blue team exercises to enhance practical data security protection
study capabilities
In November 2 0 5 , BGI Genomics organized a two- week professional red- blue team cyber exercise, simulating
Guided by the management principles of 4 standardization, efficiency, collaboration, and controllabil
real- world attack scenarios in a controlled environment to systematically test critical areas including identity Procurement
Genomics has formulated institutional documents including the Management System, Supplier
authentication, access control, network segmentation, and supply chain security, identifying and exposing potential Management System, Supply Chain Bidding and Procurement Management System, and Engineering Project
vulnerabilities. The exercise directly drove the implementation of security enhancements such as uniGed identity Procurement Management Measures
. Through cross-departmental collaboration and SRM system implementation,
authentication, multi-factor authentication, and network zoning, further improving the speciGcity, operability, and the Company has evolved supply chain management from transactional procurement to a full-process governa
cross-team coordination of emergency response plans, and continuously strengthening the Company5 s overall system encompassing demand initiation, sourcing and pricing, contract signing, order execution, and performanc
cybersecurityposture. review,continuouslyenhancingsupplychainresilienceandmanagementprecision.
Case Conduct data security training to solidify the privacy protection line of defense across
BGIGenomics5supplychainmanagementgovernancestructure
study the industry chain
SupplyChainDepartment
In 2 0 2 5 , BGI Genomics held 8 specialized data security
training sessions, with approximately 542 participants and Coordinates supply chain procurement, supplier management, and performance
abouthours
execution,servingasthecoremanagementunitforthesupplychain.
coverage of medical business compliance, data security, and
customer privacy protection, systematically explaining data BusinessExecutionUnit
classiGcationandgrading,personalandsensitiveinformation SourcingGroup
protection, full life- cycle security management, and legal
Responsible for categor y strateg y formulation, procurement sourcing, suppli
responsibilities, reinforced by case studies to strengthen risk
development and admission initiation, and organizing on-site factory visits, sample
awareness and protective measures. The training enhanced validation,technicalcompatibilityassessments,andpricingprocessadvancement.
t h e co m p l i a n ce a n d p r i va c y p r ote c t i o n c a pa b i l i t i e s o f
DemandManagementGroup
employees and partners, jointly fortifying the supply chain5s
data security defenses and fostering a secure, trustworthy O r d e r M a n a ge m e n t G r o u p : R e s p o n s i b l e f o r o r d e r c r eat i o n , d e l i v e r y t ra c k i n g ,
collaborationenvironment.
coordination of goods receipt and payment milestones, handling returns, exchanges,
and replenishments, and recording deliver y and quality deviations in supplie
On-site data security training
performance.
SupplierManagementGroup
Supply chain management
ResponsibleforsupplierqualiGcationreview,admissionassessment,dailymonitoring,
performance evaluation, suspension and exit, Gle maintenance, and risk monitoring;
servesastheleadunitforsupplierfulllife-cyclemanagement.
BGI Genomics adheres to the supply chain management philosophy of 4 collaborative win- win and sustainable
CollaborativeSupportUnit
Bidding
development, 4 strictly complying with relevant laws and regulations Law
such of
as the People5 s
the
Republic of China
. The Company has built a comprehensive supply chain management system and continuously Legal AFairs Department:Responsible for legal risk review and approval of contract
advances the standardization of the end-to- end process! including procurement sourcing, bidding execution, andagreementclauses.
supplieradmission,performanceevaluation,exitmanagement,andGleupdates.Quality,eIciency,compliance,risk ? F i n a n ce D e pa r t m e nRe
ts: p o n s i b l e fo r p ro v i d i n g i n p u t o n co m m e rc i a l te r m s ,
control, and collaborative win-win principles are integrated across all supply chain activities, promoting synergistic processingpaymentrequests,andsupportingpaymentapprovals.
development, and steadily enhancing supply stability, business continuity, and procurement transparency, thereby R e q u e s t i n g D e p a r t m eAn
s tt: h e o r i g i n a t o r a n d u s e r o f p r o c u r e m e n t n e e d s ,
layingasolidfoundationfortheCompany5shigh-qualitydevelopment. participates in supplier quality evaluation and provides feedback on performanc
issues.
Internal Audit and Internal Control Department:
Responsible for monitoring process
execution,investigatingviolations,andrecommendingblacklisting.
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Supplier ESG evaluation, admission, and due diligence Supplierdynamicassessmentandexitmechanism
BGI Genomics treats supplier ESG evaluation, admission, and due diligence as a key lever to enhance supply chain
quality,resilience,andresponsiblegovernance,continuouslyembeddingsustainabilityrequirementsattheoutsetof Dailymonitoring Semi-annualperformance GradedandclassiGed
partnerships.
Collecttransactiondatainrealtimevia Conductperformancereviews ClassifysuppliersintoGvetiers
theSRMsystemtotrackperformance everysixmonths,scoring (S,A,B,C,D)basedonscoring
ofallsuppliers;conductfocused acrossGvedimensions:quality, results,distinguishingexcellent,
monitoringofcoresuppliersandkey delivery,cost,service,and good,qualiGed,emergency
BGIGenomics5supplierESGevaluation,admission,andduediligencemechanism materialsuppliersaccountingforthe technology. backup,andnon-conforming
top80%ofprocurementspend. suppliers.
ClassiGedadmissionmanagement BasicqualiGcationreview
ImplementdiFerentiatedadmission Conductpreliminaryreviewsfocusingon
RectiGcationandguidance Suspensionandexit RectiGcationandguidance
criteriabasedonprocurement legalentitystatus,operationalcompliance,
scenarios,collaborationfrequency, supplycapability,andperformance
andprocurementvaluetoenhancethe fundamentalstoestablisharobust Issueimprovementrequirementsvia Forsupplierswithnotransactionsfor Issueimprovement
relevanceandstandardizationofsupplier cooperationentrythreshold. emailorphonetoemergencybackup twoconsecutiveyears,unsatisfactory requirementsviaemailor
management. andnon-conformingsuppliers, performance,majorincidents,orlegal/ phonetoemergencybackup
conductingon-sitereviewswhen Gnancial/audit/compliancerisks,initiate andnon-conformingsuppliers,
necessary. suspension,review,exit,orreinstatement conductingon-sitereviewswhen
perestablishedprocedures. necessary.
Supplier ESG assessment management
RectiGcationreviewandclosure EmbeddingESGrequirements
ImplementrectiGcation Incorporateenvironmental
trackingandveriGcation responsibility,labor
foridentiGedissues, andhumanrights,and BGI Genomics embeds green development requirements throughout procurement and collaboration management,
ensuringeFectivelinkage businessethicsinto establishing a green procurement system and prioritizing environmentally friendly materials and e
amongadmissionreview, supplierevaluationand
issueremediation,and contractualobligations, Through environmental admission reviews, environmental clauses in contracts, socio- environmenta
continuousimprovement. extendingresponsibility assessments, and environmental responsibility commitments from partners, the Company ensures procureme
requirementstothefront
activities balance business needs with environmental impact control, promoting the integration o
endofprocurement.
conservation,environmentalfriendliness,andsupplychainsustainability.
BGIGenomics5supplychainESGassessmentmanagementmechanism
Keyon-siteduediligence TechnicalandqualityveriGcation
Admission-
Organizecross-departmentalon-site Ensurestableproductquality,technical Beforenewsuppliersareaddedtothesupplierdatabase,theyundergocomprehensiveevaluation on
side
reviewsforcorematerialsandkey compatibility,anddeliveryfeasibility quality,environment,cost,delivery,andservice. embedding
supplierstocomprehensivelyverify throughsampletesting,pilottrials,and
productioncapacityassurance,quality trialproductionvalidation. Contractual Requiresuppliersinprocurementcontractstocomplywithapplicableenvironmentalregulationsand
control,andservicecapabilities. constraints explicitlyprohibitsuppliedproductsfromcausingenvironmentalpollution.
Supplier evaluation, assessment, and exit
Assessment-side
Identifysupplychainenvironmentalrisksandimprovementopportunitiesthroughsocial and
implementation
environmentalimpactassessments.
BGI Genomics extends supplier management from 4static admission4 to a closed-loop mechanism encompassing Cooperation-
side
Integrateenvironmentalresponsibilitywithdailysuppliermanagementtostrengthenpartners5
Through hierarchical and tiered management, it strengthens supply risk early warning and performance correction,
ensures security of core material supply, improves the overall quality and traceability of the supplier base, and Promotesustainedimplementationofgreenrequirementsthroughframeworkagreements,standard/
Management-
non-standardcontracts,andannualcontractmaintenancemechanisms. sidesupport
shifts supply chain management from reactive handling to proactive prevention and continuous optimization. The
Companyrigorouslyselectshigh-qualitysupplierstoensureastableandreliablesupplychain.
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Supplier communication and cooperation Industry collaboration
BGI Genomics views supplier communication and cooperation as a key driver for enhancing supply chain stability, BGI Genomics is committed to promoting high- quality industr y development through open collabora
advancing technological progress, and strengthening quality assurance. Through mechanisms such as technical consistently treating sectoral cooperation as a key enabler for deepening technological innovation, ac
exchanges, framework collaborations, joint reviews, on-site visits, and rectification re-inspections, the Company
achievement translation, expanding application scenarios, and elevating the industry5s overall developm
encouragessupplierstoevolvefromtransactionalpartnerstocollaborativepartners,continuouslyenhancingsupply
Leveraging its multi- omics technology platforms, clinical research resources, and global service ne
chainco-innovationcapabilitiesandqualityco-governance. Company actively engages with industry associations, medical institutions, research institutes, academic all
and international partners, continuously deepening collaboration in technical exchange, expert consensus b
BGIGenomics5suppliercommunicationandcooperationmechanism
industry-academia-research synergy, and international cooperation. This accelerates the transition of fronti
science technologies from research exploration to clinical application, public health practice, and inclus
Suppliertechnical Arrangesuppliertechnicalexchangestojointlyadvancetechnologicalinnovationandquality services, continuously injecting momentum into standardized industry development and precision m
exchanges improvement. ecosystembuilding.
BGIGenomics5sectorcollaborationmanagementmeasuresandachievements
Frameworkagreement Prioritizeframeworkagreementsforhigh-spendorhigh-frequencyprocurementcategoriestoreinforce
cooperation long-termcollaboration. Buildingacollaborativenetworkinthesector
BGI Genomics continues to expand its collaborative network, operating in over 10 countries and regions globally
Negotiation
Standardizecommunicationandselectionthroughquotationcomparison,competitivenegotiation, It partners with over 2,0 research institutions and 2,40 medical institutions in China, including more than 60
andbidding Grade- A Tertiary hospitals, and collaborates with over 3 , 0 overseas medical and research institutions, having
andprocurementbidding.
communication
establishedrelationshipswithhealthauthoritiesinmorethan30countriesandregions.
Medicalinstitutioncollaborationandlocalizedimplementation
Jointon-sitevisitand Conductcross-departmentalon-siteexchangesfocusingonproductioncapacity,quality,service,and
exchange technicalcompatibility. BGI Genomics continues to advance localized implementation in hospitals, having established partnerships w
over 2,40 medical institutions in China, including more than 1,0 collaborating through the localized laboratory
Case Host the "Inclusive Technology for a Healthy Life" conference to promote co-
model.TheCompanycontinuouslyupgradesitsSIROhigh-throughputgenetestingAI+localizedsolution,whichnow
study construction of a precision health ecosystem
providestechnicalsupportformultipletestingproductsincludingnon-invasiveprenataltesting(NIPT)andCNV
Clinicalresearchandtechnicalcollaboration
InMarch205,BGIGenomicsparticipatedintheGrstHealthyPartners
BGI Genomics has partnered with multiple leading medical institutions nationwide to launch a multi-center st
Conference hosted by BGI Group at the BGI Center, inviting over on PTseq ! targeted high-throughput sequencing for mycobacteria and initiated a clinical multi-center study
nationwide. The e vent systematically showcased achie vements institutions.Asoftheendofthereportingperiod,PMseqandPTseq !productshavedeliveredover560,teststo
in precision health, cell storage, smart handheld ultrasound, and clinicalpatients.
home health monitoring, with on- site signing of agreements with Professionaltrainingandcapacityempowerment
approximately 30 partners. The conference facilitates the extension
BGI Genomics organizes comprehensive training on the full workHow of high-throughput sequencing for pathogenic
of cutting-edge life science technologies into household settings and
microorganisms and continuously delivers specialized training for KOL clients on topics including pa
public health services, deepens industrial synergy and ecosystem co- microorganisms, CNV-seq, carrier screening, and WES. This enables partners to develop dry-lab testing and analysis
construction, and promotes the dissemination of proactive health capabilities,enhancingtheircomprehensiveservicedeliveryandprofessionalstandardsforendusers.
The first ealthy Partners Conference hosted by
concepts and the practical application of scientiGc and technological
BGI Group Keyspecialtycollaborationandclinicalapplication
innovations.
In oncology diagnosis and treatment, BGI Genomics collaborates with over 50 Grade-A Tertiary hospitals in China
and has successfully piloted multiple oncology high-throughput sequencing laboratories, delivering over
Keyperformance tumor-relatedgenetictests.Inchronicdiseasemanagement,theCompanypartnerswithnearly10Grade-ATertiary
hospitals and has provided genetic testing for hereditary cardiovascular diseases to over 5,0 individuals throug
multi-centerprograms.
Indicator Unit 205data
Publicwelfareprojectsandpublichealthcollaboration
Totalnumberofcompanysuppliers Counts 2,180
BGIGenomicscontinuestoadvancetheimplementationofpublicwelfareprogramsbasedongenetictesting,having
Localizationratio % 78 launched over 120 such initiatives across more than 20 provinces, autonomous regions, and municipalities, with
cumulative screenings exceeding 30 million individuals. Among these, a newborn genetic screening service program
Localprocurementratio % 96
waslaunchedinOrdos,andafreecolorectalcancerscreeningprojectwasimplementedinShijiazhuang.
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Case Deepening industrial synergy to advance innovative brain health diagnostics and Case Launching the i99 Smart Health System to advance the precision health management
study therapeutics study model
In March 205, BGI Genomics signed a cooperation agreement with Vazyme to deepen collaboration in life sciences In April 205, BGI Genomics launched the 4i99 Smart Health4 multi-omics health management system at the 13th
and in vitro diagnostics, focusing on early screening, precision diagnosis and treatment, and efficacy evaluation West Lake International Medical Forum. The Company systematically articulated a new paradigm for preci
for chronic diseases such as Alzheimer5s disease, and promoting coordinated implementation of technology R&D, health management and, in collaboration with over ten institutions, established a 4Precision Health Management
product application, and clinical translation. This partnership helps integrate domestic industrial chain resources, Consortium,4 while simultaneously initiating expert consensus development on multi-omics health managemen
refine integrated brain health solutions, and enhance capabilities for early detection and precise intervention of This initiative accelerates the translational application of multi-omics technologies in health management
relateddiseases. and drives the industry5s evolution from traditional physical examinations toward a more precise, proactiv
personalizedhealthmanagementmodel.
On-site view of the 13th West Lake International edical orum
Case Releasing genetic data products and deepening strategic collaboration to drive value
study realization from precision medicine data
In June 205, BGI Genomics entered into a strategic collaboration with the Shenzhen Data Exchange and launched
its Grst precision medicine data products: the 4Hereditary Tumor Variant Knowledge Base4 and the 4Tumor Somatic
Signing ceremony of the cooperation agreement between BGI Genomics and azyme
Mutation and Drug Therapy Knowledge Base.4 This initiative pioneers the deep integration of genomic data assets
with precision diagnosis and treatment scenarios, Glling a domestic gap in tumor precision medicine data product
Case Supporting the International Conference on Genomics to promote collaborative
and oFering a new pathway for compliant medical data circulation, data value realization, and innovative upgra
study development of maternal and child health
ofthebiopharmaceuticalindustry.
In April 205, BGI Genomics supported the Symposium on
Clinical Applications in Reproductive Health at the 2 0 th
InternationalConferenceonGenomicsheldinShenzhen.The
event brought together over 30 global experts in maternal
and child health and attracted nearly 60, participants
online and offline. Discussions centered on breakthroughs
in genetic testing technologies, innovative multi- omics
applications,andoptimizationofbirthdefectpreventionand
control.Thesymposiumalsolaunchedtwoindustrystandard
On-site view of the Symposium on Clinical Applications in
development projects for clinical interpretationReproductive
guidelines, ealth at the 20th International Conference on
contributingtoenhancedmaternalandchildhealthservices Genomics
On-site view of the strategic collaboration signing and product launch ceremony between BGI Genomics and the Shenzhen Data
andstandardizedsectordevelopment. Exchange
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Green Innovation for Shared
Ecological Benefit
BGI Genomics regards green development as an intrinsic requirement for high-quality corporate growth. Deeply
aligned with ecological civilization, China5 s 4 dual carbon4 goals, and global sustainability trends, the Company
integrates the principles of respecting, adapting to, and protecting nature throughout its business management and
value creation processes. Environmental management is upheld as essential to maintaining compliance baselines
and ensuring stable operations. The Company continuously improves resource allocation efficiency, enhances
developmental resilience, and builds long-term core competitive advantages. Looking ahead, BGI Genomics will
further advance the synergistic co- creation of economic, environmental, and social value, solidifying its green
foundation through more responsible practices and contributing corporate strength to building an eco- friendly
Environmentalcompliance
management
Addressingclimatechange
Energymanagementand
circulareconomy
Ecosystemandbiodiversity
conservation
societyandachievingharmonybetweenhumanityandnature. Pollutantandwastemanagement
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Environmental compliance management
BGIGenomics5environmentalcompliancemanagementgovernancestructure
CEO(Ultimate
! Oversees the overall environmental and energy management functions of th
ResponsiblePerson) Company.
Environmental
BGI Genomics strictly complies with laws and regulations including the Protection Law of the
People5s Republic of China
, the Water Pollution Prevention and Control Law of the People5s Republic, the
of China
EHSManagement
Air Pollution Prevention and Control Law of the People5s Republic, and
of China
the Law of the People5s Republic ! Coordinatescompany-wideenvironmentalandenergymanagement.
Committee
of China on the Prevention and Control of Environmental Pollution by Solid Waste closely monitors
. The Company
evolving environmental regulations to ensure full compliance. It systematically embeds environmental protection,
! The general manager is responsible for implementing environmental protection
resourceconservation,andgreenoperationsintoallstagesofR&D,production,testing,andlaboratorymanagement,
plans, monitoring pollutant emissions, conducting facility inspections, liaising w
progressively establishing an integrated environmental management system that links institutional constraints, Environmental regulators,managingemergencies,organizingtraining,andmaintainingrecords.
organizational implementation, risk identification, monitoring and control, and emergency response! thereby ProtectionWorkingGroup ! T h e e n v i r o n m e n ta l p r ot e c t i o n s u p e r v i s o r i s r e s p o n s i b l e f o r i m p l e m e n
enhancingcorporatereputationandmarketcompetitiveness. environmental protection plans, monitoring pollutant emissions, conduc
Governance
facility inspections, liaising with regulators, managing emergencies, organizin
training,andmaintainingrecords.
Procedures
EnvironmentalManagementManualandWasteManagement
BGIGenomicshasestablishedcorepoliciessuchasthe
Quality,
, supplemented by supporting documents including the Environment, and Occupational Health
Strategy
& Safety Management Manual, Laboratory Waste Management Regulations, and Waste Disposal Management BGI Genomics consistently integrates environmental compliance into business management through the len
Regulations.
The Company continuously reGnes its environmental management requirements, pollution prevention 4maintaining compliance baselines, preventing risks, enhancing capabilities, and enabling transformatio
measures, and emergency response capabilities, advancing environmental management beyond baseline Company identifies and assesses key environmental compliance- related risks and opportunities across
compliance toward refined, routine, and green operations. Environmental compliance is treated as a critical operational scenarios!including pollutant control, hazardous chemical management, standardized waste dispos
foundation for stable operations and mitigating environmental liability risks. Through alignment of group- levelstable facility operations, emergency preparedness, and green laborator y initiatives! and aligns
mandateswithon-siteexecutionbysubsidiaries,theCompanyensuresenvironmentalresponsibilitiesareeFectively operationalstability,costcontrol,brandreputation,andsustainabilityobjectives.Thisapproachshiftsenviron
assignedtoorganizations,systems,facilities,andindividualroles. compliancefrompassiveadherencetoproactivecapabilitybuilding.
BGIGenomics5identiGcationandresponsestrategiesforenvironmentalcompliance-relatedrisksand
opportunities
Risk/
Impact
opportunity SpeciGcdescription Financialimpact Responsestrategy
duration
type
Risk
Environmentalregulations,pollutant
!
Continuouslyupdate
dischargemanagement,hazardous
policydocuments;
Compliance wastetransfer,andenvironmental Increasedcostsfor
Medium- ! Implementpollutant
and emergencyresponserequirements complianceremediation;
andlong- dischargeregistrationand
supervision continuetotighten.Inadequate potentialriskof
term Glingmanagement;
risks implementationofsystems, administrativepenalties.
! Strengthentrainingand
recordkeeping,orGlingmaintenance
recordretention.
mayresultincompliancegaps.
! Establishroutine
Increasedcostsinfacility
Malfunctionsinwastewaterand inspectionandthird-party
Operational upkeepandemergency
exhaustgastreatmentfacilitiesor Short testingmechanisms;
risksof handling;higher
associatedmonitoringandemission and ! Enhancemalfunction
pollution expendituresonretesting
equipmentmaycauseabnormal medium contingencyplans;
control andremediation;partial
dischargesorserviceinterruptions, term ! Strengthenengineering
facilities disruptiontoproduction
disruptingnormaloperations. patrolsandfacility
operations.
maintenance.
BGI Genomics certified with ISO 14001 Environmental anagement System
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Risk/ Emergency response to environmental safety risks
Impact
opportunity SpeciGcdescription Financialimpact Responsestrategy
duration BGI Genomics has developed documents includingEmergency
the Response Plan for Environmental Emergencies
type
andconsistentlytreatsenvironmentalemergencymanagementascriticalsupportformitigatingenvironment
ensuring stable operations at key sites, and safeguarding environmental safety baselines. By reGning mechani
Increasedcostsfor for early warning, response, incident handling, reporting, and post-event review, the Company shifts environmental
Processesinvolvingchemicaluse,
Risksin complianthazardous EnforcestrictclassiGcation,
wasteliquidcollection,temporary risk management from reactive post-incident responses toward an integrated approach of pre-incident preventio
hazardous wastedisposal; packaging,andlabeling;
storageofmedicalwaste,and Short
chemicals
hazardouswastetransportationcarryand
Higherexpensesfor standardizetemporary in-incident control, and post-incident improvement. This continuously enhances rapid response and coordinate
and incidentresponseand storageareas;engage
risksofenvironmentalcontamination
medium incident handling capabilities at critical facilities, providing assurance for environmental compliance
hazardous cleanup; qualiGedthirdparties
andsecondaryincidents.Poor term continuity.
waste Potentialincrease fordisposal;conduct
managementmayleadtoleaks,loss,
Case
management inliability-related specializeddrills.
Conduct chemical spill emergency drills to enhance on-site response and coordinated
orsecondarypollution.
expenditures.
study handling capabilities
In June 205, the Company conducted an emergency drill simulating a dilute sulfuric acid spill causing injury. The
exercise covered the full response process! including incident reporting, site cordoning, reagent contai
Eventssuchasthunderstorms, IncreasedinvestmentinEstablishathree-tier
Risksfrom extremeheat,andHoodingmay Short emergencysuppliesandearlywarningandgraded medical aid, and personnel assembly!with all response teams arriving within three minutes and properly wearing
natural disruptfacilitystabilityandheighten
and rescueoperations; responsemechanism; protective gear. The drill effectively validated the feasibility of the chemical
disastersand environmentalmanagementrisks medium Higherfacilityrepair enhancetheenvironmental
emergencies relatedtowastewater,exhaustgas, term costs;increasedexpensesemergencyresponseplan; spill emergency plan, enhanced on- site coordination and safety protection
andhazardouswastestorage. foroperationalrecovery.conductrealisticdrills. capabilities, and laid the groundwork for improving protective inspections and
externalcoordinationmechanisms.
Opportunities
Advancing4zero-wastelaboratories,4
Reducedenergyand
Opportunities greenoIces,energy-savingretroGts, Promotegreenlaboratory
Medium- operationalcosts;lower
ingreen andresourceconservationhelps initiatives;advancesource
andlong- resourceconsumption;
laboratory reduceoperationalconsumption reductionandclassiGed
term improvedmanagement
construction andenhancestheprecisionof management.
eIciency.
On-site view of the chemical spill emergency response drill
environmentalmanagement.
Key performance
Standardizedenvironmental
Brandand
market
management,compliantemissions,
andcontinuousimprovement
Medium-
andlong-
Enhancedpartnership
trustandbrandvalue;
Continuouslydisclose
environmentalperformance;
addressESGratinggaps;
In 2 0 2 5 , the Company5 s total investment in environmental management was RMB 1.2195
opportunities
enhancetrustamongcustomers,
regulators,andinvestors,
strengtheningESGperformance.
term
Reducedreputational
damagerisks.
enhanceveriGabilityof
managementsystems.
million, withnoadministrativepenaltiesimposedbytheMinistryofEcologyandEnvironment
orother relevantauthoritiesduetoenvironmentalincidents;
Impact, risk, and opportunity management
A total of
EnvironmentalAspectIdentiGcation,Evaluation,
BGIGenomicshasestablishedmanagementproceduressuchasthe
and Control Management Procedure and the Emergency Preparedness and Response Management Procedure.
Centered on environmental safety, the Company has built a comprehensive mechanism covering identification, Indicator 205achievementstatus
assessment, monitoring, early warning, response, and post- incident review. Focusing on high- risk scenarios
in laboratories and production! including wastewater, exhaust gas, noise, hazardous waste, chemicals, and Zeromajorenvironmentalincidentsthroughouttheyear Achieved
emergencies! the Company continuously strengthens key activities such as environmental aspect identification, Monitoringresultsforwastewater,exhaustgas,andnoiseallmet
emission control, third- party testing, on- site inspections, and emergency drills, advancing environmental risk Achieved
emissionlimitrequirements
preventionandmanagementcapabilityintandem.
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Pollutant and waste management
BGIGenomics5wasterecyclingandutilizationmanagementmeasures
ClassiGcationandidentiGcation
BGI Genomics places high priority on managing toxic emissions and waste. The Company has established policy
documents includingLaboratory
the Environmental Monitoring Management Regulations, Exhaust Gas, Wastewater,
and Noise Management Procedures, and the Quality, Environment, and Occupational Health & Safety Management BGIGenomics5subsidiary,WuhanBiotechnology,distinguishesrecyclablefromnon-recyclableitemsin
Manualto strengthen end- to- end control of wastewater, exhaust gas, noise, and waste. By focusing on key itspolicies
processes! classified collection, standardized temporary storage, compliant discharge, outsourced disposal, and Recyclableitemsrefertouncontaminatedmaterialswithrecyclingvalue
third-party monitoring!the Company extends pollution and waste management beyond point-in-time compliance Non-recyclableitemsrefertouncontaminatedmaterialswithoutrecyclingvalue
toward full-process traceability, inspectability, and continuous improvement, solidifying the environmental safety
foundationinlaboratoryandproductionsettings.
Waste disposal and management
ClassiGedcollection
Laboratory
BGI Genomics has formulated policy documents including the Waste Management Regulations, Solid Generalsolidwasteiscentrallycollectedbycategoryandplacedindesignatedareas
Waste Management Procedures, Hazardous Chemicals Management System, Experimental Hazardous Chemical Hazardouswaste,medicalwaste,andliquidwasteareclassiGed,packaged,labeled,andtemporarily
Waste Management Process,
and Waste Disposal Management Regulations
to strengthen full life- cycle waste storedasrequired?
management!from generation, classiGcation, and packaging through temporary storage, transportation, and Gnal Mixing,co-loading,orrandomdisposalofdiFerentwastecategoriesisstrictlyprohibited
disposal. Aligning with management requirements for medical waste, chemical waste, liquid waste, and general
solid waste in laboratory and production settings, the Company advances waste governance from compliant
disposal toward source reduction, standardized handling, and auditable recordkeeping, continuously reinforcing
Recyclinganddisposal
environmentalsafetyfoundationsandsupporting4zero-wastelaboratory4initiativesandgreenoperations.
BGIGenomics5wasteclassiGcationmanagementmeasures
Othersolidwasteislegallytransferredtocapableentitiesforrecyclinganddisposal
Generalwasteisuniformlycollectedanddisposedofbytheparkormunicipalsanitationsystem
HazardouswasteislegallytransferredtoqualiGedentitiesforutilizationanddisposal
Generalwaste Hazardouswaste ClassiGcationandidentiGcation
!Disposebycategory;mixingwith !ClassiGedcollectionofinfectiouswaste,sharps,chemical
BGIGenomics5subsidiary,TianjinMedicalTestingLaboratory,advances4zero-wastelaboratory4
medicalorchemicalwasteisstrictly waste,liquidwaste,andwasteorganicsolvents
construction
prohibited !Usededicatedpackagingorsealedcontainersforstorage,with
BGIGenomics5subsidiary,WuhanBiotechnology,replacedfoaminsertsinNIFTYtestkitswithpaperpads
!Aftercentralizedcollectionby standardizedlabeling
atitsIVDproductionsite
departments,placeindesignated !Establishhazardouswastetemporarystorageroomswith
Reduceprocesswastegenerationthroughpackagingoptimizationandstandardizedmanagement
areasorcontainers time-limitedstorageanddedicatedpersonnelmanagementas
!Collectedanddisposedof required
Compliant pollutant discharge
uniformlybysanitationauthorities !Aftercompletingdeclaration,registration,orhandover
ortheindustrialpark procedures,transfertoqualiGedthirdpartiesforcompliant
!Strengthendailyinspections transportanddisposal The Company focuses on key aspects! pollution source identification, treatment facility operation
andcleanlinessmaintenanceat Maintain
! ledgerrecordscoveringtheentireprocess:collection, monitoring, and result verification! to gradually establish a pollutant discharge management
collectionpoints temporarystorage,sterilization,transport,andhandover encompassing daily control, periodic testing, and anomaly response. This enables key facilities to m
environmental compliance during stable operations, supporting the Company5s advancement in green operatio
capabilitiesandreGnedenvironmentalgovernance.
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Addressing climate change
BGIGenomics5managementmeasuresforcompliantpollutantdischarge
Wastewatermanagement
BGI Genomics integrates climate change response with
! AtBGIGenomics5subsidiary,WuhanBiotechnology,laboratorywastewaterfromBuildingB1istreatedbyan
green operations, energ y conser vation, low- carbon
integratedsewagetreatmentunit,andfromBuildingB2byacentralizedwastewatertreatmentplantpriorto
R&D, stable facility operations, and environmental risk
discharge;annualenvironmentalmonitoringinWuhanconGrmscomplianceforpH,COD,BOD5,suspended
solids,andammonianitrogen; mitigation. The Company closely monitors evolving
! GeneralwastewateratBGIGenomics5subsidiary,TianjinMedicalTestingLaboratory,undergoesquarterly requirementsandchallengesunderChina5sdual
third-partytesting,withallresultsmeetingemissionlimits. goals regarding corporate transformation and physical
climate risks. It has formulated the Carbon Emission
Management Measures, extending energ y-saving,
Wastegasmanagement emission-reduction,andgreentransitionprinciplesacross
the full life cycle of products and services. Subsidiaries
! AtBGIGenomics5subsidiary,TianjinMedicalTestingLaboratory,volatileorganiccompoundsfromnucleic
are actively implementing energy-saving and emission-
acidextractionaretreatedusinga4Glter+UVphotocatalyticoxidation+activatedcarbonadsorption4
reduction projects, and environmental equipment and
system;
! AtBGIGenomics5subsidiary,WuhanBiotechnology,exhaustfromtheB1qualityinspectionareaandB2pilot processes are prioritized in facility construction and
BGI Genomics non-invasive prenatal genetic testing service
testingareaiscollectedandtreatedviaactivatedcarbonadsorptionbeforedischarge;Wuhanmonitoring equipment procurement!enhancing energy efficiency
dataconGrmthattotalnon-methanehydrocarbonsandformaldehydemeetregulatorylimits; obtained a Product Carbon
while reducing carbon emissions and advancing low- ootprint erification Statement
! Keyemissionpointsareincludedinroutineinspectionsandmonitoringprograms. carbonproductmanagement.
Identifying climate change risks and opportunities
BGI Genomics continues to integrate climate change into core green operations and low- carbon transformat
Noisemanagement
strategies. Across the full life cycle of laboratory operations, production delivery, facility construction, a
! BGIGenomics5subsidiary,WuhanBiotechnology,implementssoundinsulation,vibrationdamping,and services, the Company identiGes climate-related risks and opportunities aFecting operational stability, energy c
noiseattenuationmeasuresfornoisesourcessuchasultrasoniccleanersandHVACunits;daytimeand environmental management, and green development. Key focus areas include physical risks from extreme weather
nighttimenoiselevelsattheIVDfacilityboundarycomplywithClass2standards;
disrupting environmental infrastructure and lab environments, transformation opportunities from energy e
! BGIGenomics5subsidiary,TianjinMedicalTestingLaboratory,maintainsroutinenoisecontrolin
andlow-carbonR&D,andthepositiveimpactofgreenproductsandoperationsonbrandimage,customertrust,and
laboratories,withanannualaverageofapproximately5dB,meetingemissionlimits.
long-term competitiveness. Climate change management is evolving from conceptual awareness toward pr
implementationandperformancevalidation.
BGIGenomics5climatechangeriskandopportunityidentiGcationresults
Keyperformance
Risk/
Impact
opportunity SpeciGcdescription Financialimpact Responsestrategy
duration
type
Indicator Unit 205data
Risk
Totalamountofhazardouswastegenerated Tonnes 136.5
e% DevelopaGrouplow-carbon
Nationalandlocalpolicieson transitionroadmapandintegrate
TotalhazardouswastegeneratedperRMB10millioninrevenue Tonnes 3.69
low-carbontransition,carbon carbonmanagementacrossthefull
reduction,andbiodiversity Increasedcompliance lifecycleofR&D,production,and
Totalexhaustgasemissions Cubicmeter 1,86432. Policyand conservationcontinueto Long- costs,penaltyexpenses, supplychain
legalriskstighten;failuretocomply term andriskofinternational? %e Monitordomesticandinternational
promptlymayresultin revenuedecline climatepolicyupdates,conduct
Totalamountofwastewaterdischarge Tonnes 6,72.5
regulatoryrestrictions,Gnes,or carboncompliancetraining,
projectapprovaldelays andestablishacarbonfootprint
Totalwaterwithdrawal Tonnes 6,140 accountingsystem
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Risk/
opportunity SpeciGcdescription
Impact
duration
Financialimpact Responsestrategy Energy management and circular economy
type
?%e Establishaclimatedisasterearly CircularEconomyPromotionLawofthePeople5sRepublicofChina
BGIGenomicsstrictlyadherestothe andrelated
Extremeheat,Hoods,
warningmechanismandshare Energy and
regulations. It has established policy documents including the Resource Consumption Management
earthquakes,andotherdisasters Facilityrepaircosts,
informationwithmeteorological Procedure and Energy Conservation Management System
, embedding energy management and circular economy
candamagelaboratories, revenuelossesfrom
Acute andemergencymanagement principles throughout business operations. The Company aligns resource and energy allocation wit
biobanks,andcold-chain Short- businessinterruption,
physical authorities
logisticsfacilities,leadingtoterm emergencyresponse development requirements, balancing energy eIciency, resource intensity, and process reduction outcomes. This
risk ? %e EnhanceoF-sitedisasterrecovery
data/samplelossanddisruption andsample enhances operational resilience to resource and environmental constraints, fostering a greener, more res
systemsforsamples/data,conduct
ofproduction/sequencing preservationexpenses eIcient,andsustainabledevelopmentmodelthatsupportslong-termstabilityandhigh-qualitygrowth.
regularemergencydrills,and
services
assessinfrastructureresiliencegaps
BGIGenomics5energyutilizationmanagementmeasures
Ongoingclimatewarming %e Adjustresearchportfoliosand
andecologicalshiftsalter IncreasedR&D strengthensequencingandearly-
pathogendistributionand realignmentcosts, warningresearchonemerging
Chronic samplecollectionenvironments, highersample infectiousandclimate-sensitive
Long- PolicyandaccountabilityControlofkeyenergy- Metering,monitoring,and Energy-eIcientoperations
physical reshapingdiseaseproGlesand acquisitionexpenses, diseases
term implementation consumingprocesses analysis optimization
risk researchpriorities;drought/ Huctuatingwatercosts,? %e Advancewater-savingretroGtsand
waterscarcityinsupplychain andriskofproject waterrecyclingsystemsinlabs;
regionsaFectsproductionwater termination optimizeecologicalresilienceof EstablishtheEnergy Prioritizenatural Implement OptimizeHVAC
reliability globalsamplecollectionsites
Conservation lighting meterreading coolingand
ManagementSystem UseLEDenergy- management heatingsystems
Opportunities Assignenergy-saving eIcientlighting Compile Improveenergy
responsibilities TurnoFequipment monthlyenergy utilization
forkeyareas whenunattended consumption eIciency
Climatechangedrivesdemand %e Developdiagnostickitsforclimate-
foremerginginfectiousdisease relateddiseasesandenvironmental (commonareas, Operateair reports Reduceair
Product surveillance,sequencingof genomicsmonitoringsolutions production,QA, conditioningon- Analyzeanomalies conditioning
Medium- Revenuegrowth,brand
andservice climate-sensitiveconditions, ?%e Create4climatehealth+gene R&D,warehousing) demandwith andreportGndings costsincommon
andlong- premium,andnew
innovation andenvironmentalgenomics technology4servicemodels andappointan temperature inregularmeetings areas
term marketexpansion
opportunities monitoring!creatinggrowth andparticipateinnationaland
overallenergy controls Developadditional
opportunitiesforrelatedtesting internationalclimate-health
conservationleadto energy-saving
andresearchservices researchinitiatives
ensuredepartmental measuresbasedon
androle-level anomalyanalysis
implementation
%e AdvancephotovoltaicretroGts
incampusesandprocuregreen
Opportunities Increasecleanenergyuseto
powerfordatacenterstoincrease
inenergy reducecarbonemissionsfrom Long- Lowerenergycostsand
renewableenergyshare
Resource utilization and circular economy
structure labsanddatacentersand term improvedcoststability
%e Optimizelabenergyconsumption
optimization mitigateenergypricevolatility
anddeployhigh-eIciency
equipment BGIGenomicscontinuestointegrateresourceeIciencyenhancementandcirculareconomyprinciplesintoitsgreen
operations framework, shifting resource management from basic operational support toward a balanced
Proactiveclimateaction on efficiency gains, cost optimization, and environmental value creation. Centered on laboratory and produ
Brandand LowerGnancingcosts, %e Developbrandcasesshowcasing
enhancescorporateESG operations, the Company adopts a full-process management mindset to coordinate resource conservation, sourc
ESG Long- strongercustomer 4genetechnologyempowering
performanceandbuildstrust
opportunities term loyalty,reducedmarket climateadaptation4toenhance reduction, and standardized utilization!continuously strengthening awareness of resource constraints and reGn
withinvestors,customers,and
accessbarriers corporatesocialvalue managementcapabilitiestodriveamoreintensive,low-consumption,andsustainabledevelopmentmodel,layin
thepublic
solidfoundationforgreentransformationandlong-termresilience.
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
BGIGenomics5keyresourcemanagementmeasures 关
键
绩 In205,totalenergyconsumptionwas 2,439.47tonnesofstandardcoal.
Management 效
Keymanagementmeasures
scope
Andpurchasedelectricityamountedto
!
User departments conduct daily inspections of water Gxtures in labs and production areas and promptly
Water
reportleakstotheengineeringdepartment;
conservation
! The property management team inspects water fixtures in common areas daily and repairs leaks
management immediately.
! Maximizenaturallighting;avoidartiGciallightingwhennaturallightsuIces;
! UseLEDenergy-eIcientlampstoreduceenergyconsumptionandextendservicelife;
! Turn oF personal computers, monitors, and meeting room equipment (projectors, audio systems) when
Energy leaving;
conservation! Selectenergy-eIcientoIceequipment,suchasENERGYSTARcomputers,printers,andairconditioners;
management ! Air conditioning in common areas is user- activated on demand, with summer settings no lower than
IVD production site is projected to save approximately RMB 30 , annually by discontinuing the park5s
Ecosystem and biodiversity conservation
centralizedHVACsystemandswitchingtoHitachilabunitsforheating/cooling.
! Promote double-sided printing, reduce document printing volume, and encourage electronic document BGI Genomics integrates its business characteristics into environmental impact control during operations, enga
circulationandstoragetoconserveresources; in ecosystem and biodiversity conservation. Through pollution prevention, standardized waste handlin
GreenoIce
! Leverage digital platforms; use DingTalk or Tencent Meeting for training and conferences to enable
mitigation,andgreenoperations,theCompanyminimizesdisturbancesfromlaboratoryandproductionactivitieson
paperlessoperationsandachieveenergysavingsandemissionreductions.
surroundingenvironments.
Meanwhile, leveraging its technological strengths, the Company advances environmental innovation by expl
biotechnologicalapplicationsinpollutionremediation!suchasbioremediationforsoilandwaterpuriGcation!a
employsgenesequencingtomonitorecosystemhealth.
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
People-Oriented: Inclusiveness for
the Common Good
B G I G e n o m i c s d e e p l y e m b e d s s o c i a l re s p o n s i b i l i t y t h ro u g h o u t i ts co r p o rate d e v e l o p m e n t , a n c h o r i n g i ts
commitments in safeguarding public health, protecting employee rights, and promoting inclusive industry growth.
Adheringtoapeople-centeredphilosophy,theCompanyhasbuiltafull-cycleemployeecaresystemcoveringhiring,
rights protection, training and development, and occupational health and safety!ensuring employees5 legitimate
rights and enabling shared growth with the organization. Simultaneously, leveraging its core expertise in genomics,
BGIGenomicsadvancesmedicalaccessibilityandequitablehealthcare,extendingcutting-edgegenetictechnologies
tobroaderpopulationsandactivelyfulGllingitscorporatesocialresponsibilitytosupportHealthyChinaandsocietal
Employeeemployment Protectionofemployeerights
E m p l o y e e t ra i n i n g a n d d e v e l o p m eOccupational
Medicalaccessibilityandequitablehealthcare
nt
healthandsafety
sustainability.
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Employee employment Byrank Byeducationalattainment
Labor
BGIGenomicssteadfastlyupholdsits4people-Grst4philosophy,strictlycomplying withLaw
theofthePeople5s 219
Republic of China
and related regulations, and resolutely prohibiting child labor, forced labor, and employment
discrimination. The Company has established a compliant employment management system spanning the full 1,086
employee lifecycle!from onboarding and attendance to contract fulGllment. Centered on the Employee Handbook,
it has developed a comprehensive policy framework, signed labor contracts with 10% of employees, and lawfully 1,081
contributed to the Gve social insurances and housing fund. Upholding principles of diversity and equal opportunity,
BGI Genomics attracts professionals from diverse backgrounds, building a robust talent foundation for innovative
growthonaplatformofcompliantoperations. 2,260
Employeecomposition 1,867
Numberofseniormanagementemployees Numberofemployeeswithdoctoraldegrees
Numberofmiddlemanagementemployees Numberofemployeeswithpostgraduatedegrees
Totalnumberofemployees Numberofjuniormanagementemployees Numberofemployeeswithabachelor5sdegree
Numberofgeneralemployees Numberofemployeeswithjuniorcollegedegreesorbelow
ComplianceanddiversiGedemploymentmanagementsystem
Including:Numberofnewlyhiredemployees
Anti-childlaborand Anti-discrimination
forcedlabor anddiversity
! TheEmployeeHandbookcontainsastrict ! TheCompanyfullyintegratestheprinciples
requirementthatalljobapplicantsmust ofdiversity,equity,andinclusion(DEI)into
beatleast18yearsofage;thoseunder18 allstagesoftheemploymentlifecycle.The
areautomaticallydeemedineligiblefor EmployeeHandbookexplicitlyprohibits
employment,therebyeliminatingchild anyformofdiscrimination,including
Bygender Byage laborriskattherecruitmentsource; butnotlimitedtodiscriminationbased
onlegallyprotectedcharacteristicssuch
Allformsofforcedorcompulsorylabor
! arestrictlyprohibited.TheCompany
origin,disability,maritalstatus,veteran
safeguardsemployees5personalfreedom
status,sexualorientation,orgender
andrighttovoluntaryemployment
throughouttheentirehiringand
aroutinemonitoringmechanism. employed5internationalstaFfrom
disabilities,achievingadiverseand
inclusiveworkforce.
关
键 100
绩
In205,thelaborcontractsigningrateforfull-timeemployeeswas %.
效
Numberofemployeesagedand
Numberofmaleemployees
Numberoffemaleemployees
Numberofemployeesagedto
Numberofemployeesaged51andabove
NoconGrmedincidentsofdiscrimination,childlabor,orforcedlaboroccurred.
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Protection of employee rights Employee care and communication
Employee care and two-way communication serve as vital links for BGI Genomics in fostering harmonious labo
ProtectingemployeerightsisacornerstoneforBGIGenomicstoattracttalentandachievesustainabledevelopment.
relations and cultivating a positive workplace culture. The Company follows a labor dispute resolutio
The Company places employee rights at the heart of its management philosophy and has built a comprehensive,
multi-tiered,andhuman-centeredprotectionsystemcoveringcoreneedsacrosstheentireemployeecareerlifecycle of 4prioritizing amicable negotiation, followed by internal mediation, with legal recourse as a last resort,4 law
through four dimensions: compensation and beneGts, communication and care, grievance response, and hardship addressing employee concerns to maintain stable labor relations. Communication channels!including emplo
support. Through a competitive and caring compensation and beneGts framework, the Company safeguards labor forums,suggestionboxes,andinternalplatforms!areestablishedtoroutinelygatherfeedback.Leveragingthelab
rights; it listens to employee voices via diverse communication channels, refines management practices through union, the Company builds a diversiGed platform for cultural and recreational activities and periodically l
scientific survey mechanisms, and conveys corporate warmth through a regularized support system! thereby interactive welfare initiatives to enrich employees5 lives and strengthen their engagement and sense of belo
upholding employees5 legitimate rights and enhancing their sense of belonging, well-being, and identiGcation with
ensuringhumanisticcarepermeateseverystageoftheircareerjourney.
theCompany.
Compensation and benefits protection Case
study
Rapid response to employee accidents and timely insurance payout to reinforce
support mechanisms
With the Employee Handbook as its institutional core, the Company strictly adheres to the principles of 4position-
In 20 5, an employee suffered a severe traffic accident while cycling, colliding with a motor vehicle, resultin
based grading, grade- based pay, person- job fit, and pay adjustment upon position change, 4 establishing an
injuries classified as Grade 1 0 disability. Immediately after the incident, the Company activated its commer
integratedfour-componentcompensationandbeneGtssystemcomprisingGxed 4 salaryvariable
+ performancepay+
long-term incentives + diversiGed beneGts.4 The compensation structure is position-based and performance-driven, insurance claims assistance process, assigning a dedicated coordinator to manage all steps!from initial repo
ensuring high performers are highly rewarded. For key talent, long-term incentive plans!including employee stock to final settlement! providing comprehensive support. In addition to statutory compensation, the emp
ownershipandrestrictedstockunits!areimplementedtoalignemployeeandcorporateinterestsforsharedgrowth. successfully received a RMB 30, disability payout under the commercial accident insurance policy. This Gnancial
Concurrently, the Company continuously enhances supplementary protections such as commercial insurance, support signiGcantly aided the employee5s subsequent rehabilitation, fully demonstrating the protective func
holidaybeneGts,andexpatriateallowancestocomprehensivelysafeguardemployeerightsandenablethemtoshare
the Company5s commercial insurance program and reHecting BGI Genomics5 commitment to humanistic care and
intheCompany5ssuccess.
safety-netsupport.
Commercialinsuranceprotection LifesupportbeneGts Employee satisfaction surveys
! Coverageincludesgroupaccidentinsuranceand ! HolidaybeneGtsaredistributedduringtheSpring The Company has established a dual- dimensional employee satisfaction sur vey system. Annual sur ve
overseasbusinesstravelinsurance,eFectivelyGlling Festival,InternationalWomen5sDay,andMid-Autumn conducted regularly to comprehensively assess employee perceptions across key areas including
gapsinstatutorysocialinsuranceandproviding Festival; management, compensation and beneGts, and career development. Daily pulse surveys are embedded throughout
GnancialsupporttoemployeesaFectedbyaccidents. ! Dedicatedteam-buildingbudgetsareallocatedtoeach
employeeservicetouchpointstocapturereal-timefeedback.Basedoninsights,theCompanyoperatesaclosed-loop
departmenttoenrichemployees5extracurricularlives;
! Dedicatednursingroomsareprovidedforpregnant
andlactatingfemaleemployees; employee suggestions. Guided by genuine employee needs, the Company continuously refines its management
! Anemployeegymisopen,oFeringGtnessprogramsto systems,drivingmutualenhancementofemployeeexperienceandorganizationalcapability.
comprehensivelymeetdailywellnessneeds.
Employeesatisfactionsurveymechanism
Special
non-statutory Annualsystematicsurvey(overallevaluation)
beneGts A comprehensive annual satisfaction survey is conducted each year, focusing on four core dimensions: busin
! satisfaction,serviceevaluationmetrics,onlineserviceplatformassessment,andimprovementsuggestions.
Providesemployeeswithonenewnon-cumulativepaid ! InnovativelylaunchedtheHuayitong4
sickdaypermonth; full-timeemployeesandtheirspousesandchildren
! Employeeswithonefullyearofserviceareentitledto withend-to-endsolutionsformajordiseaseprevention,
theleavemayreceiveafamilyvisitsubsidyofuptoRMB reimbursement; Real-time satisfaction surveys are administered following each service delivered by the Company5 s HR Sha
! Parentalandcaregivingleavescompliantwith full-timeemployeesandtheirimmediatefamilymembers level!enablingimmediatequalitymonitoring,dynamicfollow-up,andacontinuousserviceoversightmechanism.
localgovernmentregulationsareprovided,with Gvecomplimentarygenetictestingslotsannually,
clearguidelinescoveringaccrual,application,and extendingtheCompany5sgenomicsexpertisetoemployee Dynamiciteration
calculationprocedures. welfare. The survey system undergoes continuous optimization and expansion. OJine QR code rating channels have been
Comprehensiveleaveprotection SpecialhealthbeneGts added for scenarios such as onboarding /offboarding and talent applications, and the survey scope has
extendednationwidetoachievefullcoverageacrossbothservicescenariosandgeographicregions.
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
关
键 4.90 (on a 5-point scale), corresponding to a Employee training and development
绩
In 2 0 2 5 , annual employee satisfaction reached
效 BGI Genomics consistently regards talent as the primary driver of innovation and development. Placi
satisfactionrateof 98.03%. importance on employee capability enhancement and career progression, the Company has built a full-cycle tale
Dailyemployeesatisfactionscored ,andemployeeengagementreached 77.22%. Job such as the
development system that is horizontally categorized and vertically stratiGed. Anchored by policies
QualiGcation Management System and Training Management System
, it has established a dual-track 4management
+ professional4 career path to break through developmental ceilings. A layered, role- specific training
Assistance for employees in hardship
integrating learning with real-world application provides targeted growth opportunities for employees at a
and functions, aligning individual advancement with corporate strategy and fueling sustained innovation t
steadypipelineoftalent.
BGI Genomics has established a standardized employee hardship assistance system led by the labor union with
coordinatedsupportfromHRandrelevantdepartments.ItdeGnesmulti-dimensional,end-to-endsupportmeasures
Career development
to provide a safety net for employees facing accidents, illness, or family diIculties. Through diversiGed initiatives! Viewing talent as the core engine of innovation, the Company upholds the philosophy of 4developing talent through
including commercial insurance claim assistance, dedicated hardship funds, and compassionate outreach! the projects and driving growth through missions,4 establishing a strategy-aligned, systematic, and closed-loop tal
CompanydeliversGnancialaid,practicalsupport,andpsychologicalcounselingtoaddressemployees5urgentneeds, development mechanism. Precisely mapping core competencies required for strategic execution, it has buil
ensuringeveryindividualfeelstheCompany5scareandwarmth. end- to- end career development framework covering talent standards, assessment systems, decision- ma
planning, cultivation pathways, and career tracks. Key practices include: deGning competency benchmarks throug
Assistancemeasuresforemployeesinhardship job qualification criteria; identifying high-potential talent via multi-method assessments; optimizing depl
and development plans through talent reviews; enhancing capabilities through job rotation combined with hand
on projects; and guiding growth through dual-track career paths! ensuring talent development keeps pace wi
businessevolutionandsolidifyingtheCompany5stalentfoundation.
Talentcultivationsystem
Deliver OFerjob Provide Conduct
Gnancial coordination one-on-one periodic BGI's Grand Vision
assistance andemployment psychological follow-upvisits
through information counseling withassisted Type Curriculumsystem Curriculumsystem
dedicated tailoredtothe andemotional individuals
hardshipfunds employee5s support 1.Leadershipdevelopment EagleProgram,XingProgram,Super
Management 2.High-potentialtalentcultivation StemCell
andtemporary andfamily5s
competency
subsidies circumstances enhancement CultivationofInternational
Capabilityreservesofmanagementteamsforglobalexpansion
Overseas
/ JVoperationsleaders
② ProductknowledgeSalescompetency
training enhancement
Talent
development Professional Production
programs R&D LatestindustryGeneralcompetency
competency Marketing Support development
track trends
enhancement
关
键 In 205, the Company invested over RMB 1.31millioninemployeecommercialinsurancepremiums,
绩
Role-speciGconboarding:Historyandculture+CompanypoliciesandExperiencedhire!?Newemployee
效 100%coverage;
Newhire businessoverview+Productself-studyassessment+Mentorship training
achieving development
plan SpreadingWingstraining:Corporatehistoryandculture+BGIbusiness
Campusrecruitment!?SpreadingWings
immersion+Executivedialogues+Teamintegration Program
During the reporting periodJanuary
( 1, 205 to December 31, 205) no employees met the criteria for
①
Training Platformmanagement Coursemanagement Instructormanagement Fundingmanagement
hardshipassistance, resource
Development,delivery,recording, CertiGcation,empowerment,
system PeerAcademy Budgetingandexpenditurereview
publication,andpromotion promotion,andincentives
Therefore, noactualassistancecasesoccurred. ③
Training
operations
management
Trainingoperationsmanagementsystem:Needsanalysis,programdesign,implementation,andevaluation
system
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Dual-track4management+professional4careerdevelopmentsystem
Specializeddevelopmentforyounghigh-potentialtalent
Verticallystructureddualtracks:
Horizontally,careerpaths amanagementsequence(career
areorganizedintoGvejob Ahigh-potentialtalentprogramselectsoutstandingyoungprofessionalsgloballyeachyear,cultivating
progressionthroughteamleadershipand
families!Management, organizationalcoordination,assessed talentwithmulti-directionalpotentialthroughstrategicprojectimmersionandrotationalassignments.
Technology,Marketing, 4Management
+ professional4 onstrategicthinking,leadership,team
Production,andSupport! d u a l - t ra c k c a r e e r management,andbusinessacumen)anda
comprisingjob23 categories development
professionalsequencedeep
( specialization
and624positions. s y st e m
withinadiscipline,assessedontechnical Externaltraining
expertise,innovation,jobcontribution,
andprofessionalachievements).
Training system Includesexternalcompanyvisits,third-partytraining,andacademiccoursework.Employeesmustsubmit
advanceapplicationsforexternaltraining,whichrequiresmulti-levelapprovalpriortoimplementation
Centered on the Training Management System and supported by specialized policies such as the Internal Trainer
ManagementSystem,theCompanyhasbuiltafull-cycle,stratiGed,androle-basedtrainingframeworkthatintegrates
learning with real-world application. A standardized internal trainer certiGcation and management system ensures
professional instructional quality. The 4Peer Academy4 digital learning platform breaks time and space barriers,
oFering all employees accessible, bite-sized learning. Focused on three pillars!new hire integration, management
capability building, and technical empowerment! the Company delivers tiered development programs and
Case
Advancing high-potential programs to build long-term youth talent capacity
conducts business-aligned technical training, embodying the philosophy of 4developing talent through projects and
drivinggrowththroughmissions.4ThroughdiversiGedandprecision-targetedinitiatives,theCompanyenhancesjob study
proGciency and holistic competence, enabling mutual empowerment between employee growth and organizational
In 20 5, BGI Genomics focused on nurturing young high-potential talent
advancement.
by advancing the Super Stem Cell program, completing two cohorts during
Employeetrainingprogramsystem the year. This exclusive initiative aims to cultivate young professionals with
multi- directional differentiation potential and self- renewal capabilities,
Newemployeetraining
building a core talent reserve for long-term growth. Deeply embodying the
Afour-phaseonboardingsystemensuresnewhiresrapidlyintegrateandachieverolereadiness;
young talent globally and assigns them to strategic company projects with
Tailoredonboardingprograms:4FriendlyWings4forinternationalhires,4SpreadingWings4forcampus
signiGcant responsibilities, enabling rapid capability development through
recruits,andcustomizedonboardingforexperiencedhires.
real- world challenges and strengthening the foundation of the talent
pipeline.
On-the-jobemployeetraining
Role-speciGctechnicaltraining:Departmentsdelivertargetedprogramsonoperationalstandards,technical
skills,andproductknowledgealignedwithbusinessneeds;
Managementdevelopment:The4FlyingEagleProgram4formid-levelmanagersfocusesonstrategicthinking,
leadership,teammanagement,andbusinessacumenthroughablendedlearning-and-practicemodel.The
Leading
andGnancialliteracytosupporttheirshiftfrom4individualcontributors4to4teamleaders4;
Company-widefoundationaltraining:Mandatoryprogramsonindustryknowledge,professionalconduct,
compliance,andinformationsecurityfosteralearningorganization.
On-site training for the Super Stem Cell high-potential talent program
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Case Conducting specialized training on the SIRO integrated solution to strengthen Keyperformance
study employees' genomics testing expertise
Indicator Unit 205data
In 205, to facilitate the implementation and deep application of SIRO technology and help employees accurately
grasp the core features and application scenarios of related instruments, BGI Genomics organized a series of TotalnumberofemployeetrainingsconductedbytheCompany Sessions 477
specialized training sessions on the SIRO integrated solution for genetic testing. Aligned with practical technical Tenthousand
Totaltrainingexpenditure
yuan
needs, the training innovatively combined in- depth theoretical instruction, online assessments, and hands-
on practice in a progressive, multi-modal approach. This enabled employees to rapidly master critical technical Totaltraininghours Hours 66,827
competencies, significantly enhancing their practical expertise and laying a solid foundation of professional
capabilityforthesuccessfulrolloutandadvancedapplicationofSIROtechnologywithintheCompany.
Averagetraininghoursperemployee Hours 16.28
Employeetrainingcoveragerate % 100
Performance feedback and appeals
Centered on thePerformance Management System
, the Company has built a full-process, closed-loop performance
management framework that deeply integrates appraisal outcomes with the entire career development cha
includingbonusallocation,salaryadjustments,promotions,andtraining!torealizehigh
mobility based on merit. 4 For employees deemed not yet competent, individualized Performance Improvement
Plans(PIPs)aredeveloped,supportedbytargetedcoachingandtraining.Astandardizedandaccessibleperformance
appeal channel safeguards employees5 right to voice concerns and protects their legitimate interests, e
On-site training for the SIRO integrated solution
fairness,transparency,andcredibilityinperformancemanagement.
Case Implementing a stratified training plan to systematically enhance management
capabilities
Performancegoalsetting Performancecoaching
study
GoalsaresetusingtheOKRframework,cascaded Directsupervisorsandemployeesreviewgoal
In 2 0 5 , BGI Genomics continued its 4 cross- system
fromdepartmentalobjectivesthroughcollaborative progressatleastmonthly,analyzingperformance
integration4 management development programs! alignmentbetweenemployeesanddirect variances,designingimprovementactions,and
theLeadingWingsProgramandFlyingEagleProgram! supervisorstoensuredeepintegrationofindividual providingnecessaryresources.
applyingtieredstrategiesbyleadershipleveltoprecisely andorganizationalgoals.
enhance managerial competencies. The Flying Eagle
Program, for mid- level managers, uses a blended
learning-and-practice model over nine-month cycles,
focusing on four capability pillars including strategic
Resultfeedbackand
thinkingandcross-functionalleadership,complemented Performanceappeal Performanceappraisal
On-site training photo from the lying Eagle Program
reviewmeetings
by intensive workshops, value creation projects, and
EmployeesmayGleanappeal Followingthereview,direct Mid-yearandyear-end
review presentations to drive individual growth and
within5businessdaysafterthe supervisorsholdperformance performancereviewsare
team performance. The Leading Wings Program, for
feedbackmeetingdeadline; feedbackmeetingswith conducted,followinga
newly appointed frontline managers, delivers role- approvedappealstakeeFect, employeestocommunicate 4directsupervisorevaluation,
transition training through blended methods to build whileunGledappealsare results,analyzestrengths departmentheadreview4
teamleadershipandfinancialliteracy,supportingtheir deemedaccepted. andgaps,andco-develop process,withdepartment
evolutionfromindividualcontributorstoteamleaders performanceimprovement headsauthorizedtocalibrate
plans. results.
andstrengtheningthefoundationforhigh-performance,
cohesiveteams. On-site training photo from the Leading Wings Program
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Occupational health and safety
Employeephysicalandmentalhealthmanagementmeasures
Leveraging its genomics expertise, the Company has built a 4multi-omics!?based precision
health screening system.4 Building upon standard physical exams, it integrates life-omics
Work the
BGI Genomics strictly complies with laws and regulations including testing,digitalhealthrecords,andcellpreservationservicesfromtheChinaNationalGeneBank
Safety Law of the People5 s Republic of China and the Law of the People5 s to enable early diagnosis and intervention for major diseases, while rigorously protectin
employeehealthdataprivacyunderthehighestsecuritystandards.
Republic of China on the Prevention and Control of Occupational. Diseases
Actively promoting a culture of health and fitness for all, the Company designates
Adheringtotheprincipleofsafety
governance,4 the Company has established a holistic occupational health and physical assessmentsareorganizedinShenzhenandeligibleregions,coveringthreedimensions:body
safety management system encompassing work safety, occupational disease health composition, physical function, and physical Gtness. Complementary activities such as hiking
prevention,andphysicalandmentalwell-being,andhassuccessfullyobtained management andtrekkingchallengesareheldtoencourageemployeestoembracehealthylifestyles.
ISO 4501 certification. The Company implements a 4whoever is in charge is TheCompanyhaslaunchedtheCaring
professional counselors to provide psychological support on themes such as emotiona
responsible4 accountability system, cascading occupational health and safety
regulation,self-exploration,andfamily-of-origindynamics;
responsibilities to every department and position. Through multi-dimensional
efforts! including system development, facility provisioning, training and
education,emergencypreparedness,andhealthsupport!theCompanynotonly The Company is certified under the ISO On-site one-on-one psychological counseling services are offered, with exclusive monthly
fortiGesarobustdefenseagainstworkplacehazardsandoccupationaldiseases anagement System
Professional and family, parenting, and anxiety/grief support!to comprehensively safeguard employee
butalsobuildsasupportiveecosystemforemployeewell-being,comprehensively
mental mentalhealth.
safeguardingemployees5healthandlives.
health
services
Occupationalhealthandworksafetyassurancemechanism
Case Hosting the 99 Health Festival hiking event to empower employee well-being and
study strengthen team cohesion
In September 205, to celebrate its 26th anniversary, BGI Genomics simultaneously hosted the 49 Health Festival4
For high-risk roles in laboratories and production involving occupational hazards, a dedicated
o cc u pat i o n a l h ea l t h p rote ct i o n m e c h a n i s m i s i m p l e m e n te d to sta n d a rd i ze o p e rat i o n a l hikingeventatitsShenzhenheadquartersandregionalsites,advancingitscommitmenttoemployeewell-being.The
Prevention procedures and provide employees with nationally compliant personal protective equipment Shenzhenmainvenuefeaturedtworoutes!akm
andcontrolof
occupational
(PPE);regularoccupationalhealthandsafetytrainingandemergencydrillsareorganized. varying fitness levels. The event fully embodied ESG green principles by promoting 4 leave- no-trace hikin
diseasehazards
was supported by comprehensive medical aid, volunteer services, and shuttle transportation to ensure safet
order. By integrating outdoor activity with teamwork, the event eFectively enhanced physical Gtness, reinforced th
corporateethosof4Iownmyhealth,4andsigniGcantlystrengthenedorganizationalcohesion.
Reinforcing safety accountability across all staff: All employees sign individual work safety
responsibility agreements that clearly define departmental and role- specific safety duties,
strengtheningawarenessandownershipthroughformalacknowledgment;
Enhancing emergencysciencecommunication:Specializedtrainingonvariousemergencyresponse
topicsisconducted,focusingoneveryone
elevateorganization-widesafetyliteracy;
Conductingself-inspectionsandcorrectiveactions:Smoking,unauthorizedelectricalconnections,
improper use of high- power appliances, and non- compliant equipment operation are strictly
Full-process
worksafety prohibitedinproductionandoIceareas;regularhazardinspectionsandrectiGcationsarecarried
management out, and clear emergency response protocols are established to maximize protection of employee
lives;
End-to-end emergency drills: Specialized fire emergency exercises are conducted, covering fire
alarmactivation,fullevacuation,high-riseGreGghting,ladderrescue,cardiopulmonaryresuscitation
( CPR) , automated external defibrillator ( AED) use, and the Heimlich maneuver! significantly
enhancingemployees5hands-onemergencyresponsecapabilities.
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Case Conducting scientific, organization-wide fitness assessments to holistically empower 关
study employee well-being 键
绩 In 2 0 2 5 , the Company invested RMB 39,700 in specialized occupational health and safety
In 205, BGI Genomics conducted annual, organization-wide Gtness assessments in Shenzhen and eligible regions, 效 initiativesforemployees.
deepening its holistic approach to employee health. Distinct from routine medical check- ups, this assessment
scientifically evaluates physical capacity across a broad age range ( 2 0!? 7 9 years) , using age- stratified models to
comprehensively assess body composition, cardiopulmonary endurance, strength, flexibility, and other fitness 213
The Company organized specialized occupational disease screenings for
employees in high-risk
indicators. Complementary activities!including mountain hiking and trekking challenges!were organized to help positionsacrossmultiplelocationstocomprehensivelymitigateoccupationalhealthrisks.
employees translate health awareness into daily practice, signiGcantly raising health management consciousness
andfosteringavibrantworkplaceculture. Nomajororhigher-levelworksafetyaccidentsoccurredthroughouttheyear.
Medical accessibility and equitable
healthcare
Medical accessibility and inclusive healthcare are central to BGI Genomics5 mission of 4 Omics for All4 and a k
contribution to the 4 Healthy China 2 0 3 4 strategy. Leveraging its genomics leadership, the Company drives the
democratization and accessibility of advanced medical technologies. It empowers precision medicine in Belt
Road countries and implements public health programs in China for birth defect prevention and early c
screening. Simultaneously, it enhances primary care capacity through rare disease relief and nationwide hea
education. Through innovation, aFordable pricing, and philanthropy, BGI Genomics extends precision medicine to
morepeopleglobally,safeguardinguniversalhealth.
Case
Hosting multi-themed psychological salons to strengthen mental health safeguards
study
Inthe
, 5 2 0 BGIGenomicsLaborUnionfocused
on mental health management, hosting nine
psychologicalsalonsessionsthroughouttheyear
to foster positive mindsets, work-life balance,
Expandingproductaccessibility Reducinghealthcarecosts
and creativity among employees. Centered
on core themes! emotional regulation, self-
! Expandedaccesstogenetic ! Implementedhealth
exploration,andfamily-of-origindynamics!the
testingingrassroots povertyalleviationprojects,
salonsinnovativelyblendedlectures,interactive
healthcaresettingsto providingfreeorsubsidized
games,art,andwriting.Professionalcounselors
strengthenlocalservice genetictestingservicesto
were specially invited to guide participants in
capacity; underservedregions;
exploringinnerworlds,listeningtopsychological
! Deliveredmobilemedical
needs, and addressing personal challenges. ! Conductedpublichealth
servicestoimprove
Throughevidence-basedpsychologicalinsights scienceoutreachto
healthcareaccessibility.
andexperientialengagement,thesalonshelped enhanceawarenessand
employeeseFectivelymanageemotions,restore understandingofgenomics;
mental- physical equilibrium, solidify mental
health resilience, and cultivate an uplifting
workplacepsychologicalclimate.
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Belt and Road Initiative Healthcare accessibility
Case Empowering precision medicine in Central Asia and advancing equitable genomics Case Participating in centralized procurement of genetic testing services and securing
study along the Silk Road study insurance reimbursement to significantly reduce public healthcare costs
InBGI
, 5 2 0 Genomics,throughitsUzbekistanjointventure In 205, BGI Genomics actively engaged in national centralized procurement policies, driving price adjustments to
Genscreen, deployed advanced genomic technologies in lower the cost of genetic testing through volume-based pricing and improving access to birth defect preve
CentralAsiatosupportinclusivehealthcareandimprove services. The Company participated in Jiangsu Province5 s NIPT centralized procurement! the nation5 s first f
medical access. The lab led a pilot newborn genetic diagnostic services! achieving multiple systemic breakthroughs. Prices dropped by over 70%, and as of January
diseasescreeningprogram,implementingNOVAinherited NIPT
,520 wasoIciallyincludedinJiangsu5sClassBmedicalinsurancewithminimalout-of-pocketcosts,beneGting
metabolic disorder screening and NIFTY non-invasive hundredsofthousandsoffamiliesannually.InGuangdong,theCompanysupporteda62.7%pricereductionforNIPT
prenataltestingNIPT)
( enabling
, earlydiagnosisofmultiple and advocated for its inclusion in maternity insurance, enabling insured pregnant women to access the servi
treatable rare diseases and securing critical treatment 4zeroout-of-pocket4cost.ImplementedacrossmultiplePearlRiverDeltacities,thispolicyhassubstantiallyred
windows. Genetic literacy was continuously promoted theGnancialburdenofprenatalcare.
via social media, clinical training was provided to local
Case
Launching Proactive Health Kiosks to enhance access to precision health services
physicians,andAI-drivensolutionsintegratinglarge-scale
genetic data were explored. These efforts systematically study
enhanced local genomic service capacity, advancing
In December 20 5, BGI Genomics established a Proactive Health Promotion Center (also known as the Proactive
universal access to cutting-edge testing in Central Asia
Health Kiosk) at Zhuhai People5 s Hospital, bringing precision health management and genomics directly to the
Dr. ediakov shared the advantages of non-invasive prenatal
and empowering the 4Healthy New Silk Road4 through
genetic testing
public. Powered by BGI5s multi-omics precision health system, the center oFers accessible services!including basic
genomics.
healthscreeningsandcomplimentaryskinanalysis!blendingengaginghealthexplorationwithprofessionalmed
assessments. This initiative moves genomics out of the lab and into everyday life, making precision health service
moretangible,promotingproactivehealthbehaviors,andsigniGcantlyenhancingtheinclusivenessandaccessib
ofhealthcare.
Case
Localizing precision health systems to enable inclusive healthcare in Thailand
study
In 2 0 2 5 , BGI Genomics, through its Sino-Thai joint venture
Bangkok Genomics Innovation Public Company, localized its
multi-omics precision health management system for Thailand.
Aligningwithlocalhealthcarerealities,theteamadaptedtesting
methodologies, redesigned referral pathways, and developed
cost- effective test panels under the 4 global solutions + local
wisdom4 approach. Following the successful model of NIPT!
initially launched in private clinics and later integrated into
national insurance!the system first validated efficacy through
premium services, with the ultimate goal of integration into
Thailand5s public health system. Early screening programs now
spanmultipleprovinces,andhereditarycancertestinghasgained
public trust. By emphasizing 4prevention before illness,4 the
initiativeshiftsthehealthfocusupstream,embeddingproactive
Bangkok Genomics Innovation Public Company, BGI
health concepts in Thailand and advancing inclusive healthcare
Proactive ealth iosk
acrossSoutheastAsia. Genomics joint venture in Thailand
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Case
study
Launching free "two cancers and four highs" screening in Harbin to enhance Public awareness and inclusivity
grassroots healthcare accessibility through genomics
In November 20 5, BGI Genomics5 Harbin public welfare project for 4two cancers and four highs4 screening was
selected as a 20 5 People5s Enterprise Social Responsibility Action Case. The project provides free screening for
digestive tract cancers and the 4four highs4 (hypertension, hyperlipidemia, hyperglycemia, and overweight/obesity) Case Implementing multi-dimensional public welfare initiatives to promote precision
to 2.4 million residents, utilizing Colotect fecal DNA methylation technology. Deployed through over 30 urban and study medicine and health awareness
rural primary healthcare facilities, it employs an online booking and at-home sample collection model, drastically
In 20 5, BGI Genomics focused on birth defect prevention! a key public health priority! and leveraged national
lowering participation barriers. As of July 205, over 80, appointments had been made, eFectively advancing
health awareness days to drive science communication and public service campaigns, promoting widesp
early cancer detection. The Company has also rolled out maternal-child and oncology screening programs across
adoptionofprecisionhealthconcepts.OnInternationalRareDiseaseDay,NationalEarCareDay,WorldThalassemia
multipleprovinces,extendingthebeneGtsofgenomicstobroadergrassrootspopulations.
Day, National Eye Care Day, and World ALS Day, the Company collaborated with local health commissions, disabled
persons5 federations, medical institutions, and NGOs to deliver targeted initiatives. On National Ear Care Day
free clinics offered genetic testing and counseling for hereditary deafness. On World Thalassemia Day, a pa
story campaign reinforced that thalassemia is preventable. On Birth Defect Prevention Day, 13 medical partners co
hosted clinics with genetic testing and counseling, and expert-led educational videos were produced to dissemina
preventionknowledge,fosteringbroadsocietalengagement.
BGI Genomics arbin two cancers and four highs public welfare screening project was successfully selected as a 2025 People s
Enterprise Social Responsibility Action Case
Case Advancing Phase III of the ALS public welfare gene testing project to empower
study inclusive care and research for rare diseases
Birth Defect Prevention Day activities
In 20 5, BGI Genomics partnered with AskHelpU ALS Patient Platform to advance the public welfare gene testing
project for amyotrophic lateral sclerosis (ALS) to Phase III. Co-initiated by both organizations5 founders, the project
receives full technical and financial support from BGI to provide free genetic testing and data analysis for ALS
patients, signiGcantly improving access to rare disease care. Utilizing BGI5s proprietary single-molecule long-read
nanopore sequencing technology! which covers complex genomic regions! it aims to identify ALS pathogenic
variants missed by short-read sequencing. A large-scale patient genomic database is being built to uncover ALS-
speciGc genetic signatures through BGI5s analytical and research capabilities, generating critical insights for novel
therapeutictargetdiscoveryandadvancingsolutionstoALSdiagnosisandtreatmentchallenges.
Case collection and promotional posters for public health awareness days
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Case Deepening thalassemia relief through comprehensive public welfare practices Case Advancing public welfare services for rare diseases and cancer prevention to shift the
study study health defense line forward
In March 20 5, BGI Genomics deepened its thalassemia relief efforts by establishing a full-chain support system
backed by dedicated funds and distinctive charitable activities. Supported by the Guang Foundation and Hua In 205, in alignment with the Healthy China 203 Plan,
Foundation, the Company hosted the 8th 4Born to the Sun, Walking with Love4 charity concert, partnering with BGI Genomics advanced public welfare programs for
Shenzhen NGOs and disability associations to create a performance platform for individuals with Down syndrome, rare disease and cancer prevention, moving the health
thalassemia, visual impairments, and hearing loss. Funds raised aided thalassemia and hereditary eye disease intervention frontier upstream. For rare diseases, the
patients, fostering public support for birth defect prevention. Additionally, through the Hua Foundation and World CompanypartneredwithAskHelpUALSPatientPlatform
Without Thalassemia Fund, the Company provided HLA typing, transplant surgery, and gene therapy support, to offer free genetic testing and interpretation for ALS
deliveringtangiblerelieftoaFectedfamilies. patients, leveraging its capabilities to uncover genetic
proGles of Chinese ALS patients and generate leads for
noveltherapeutictargets.Bythereportingperiod5send,
Phase III launched with a technology upgrade featuring
BGI5s proprietary 4CycLoneSEQ long-read sequencing4
toprobeALSpathogenesis.Incancerprevention,during
National Cancer Prevention Week, the Company co-
hosted eight 4Community Health Public Welfare Tours4
for anti- cancer education, collected 1 7 real patient
stori es th rough an onl i ne campai gn, and h el d four
expert-led livestreams on colorectal cancer screening!
Born to the Sun, Walking with Love Charity Concert promoting the principle that 4 prevention outweighs
关
cure.4
Promotional poster for cancer prevention case collection
键
绩
Asoftheendof205,theHuaFoundationhadcompleted 23,432 publicwelfaresamplesfor
效 severethalassemia,
Reached 7,868familiesandhelped858childrenwiththalassemiaGndfullymatcheddonors;
TheWorldWithoutThalassemiaFundhasassistedover
successfullyundergoinghematopoieticstemcelltransplantation.
BGI Genomics Community ealth Public Welfare Tour cancer prevention campaign
Case Organizing specialized study tours for thalassemia families to promote social
study
InAugust,BGI
WorldWithoutThalassemiainitiative,andmultiplecompassionateenterprisestohosttheLeaping
Poverty5
! FirstParent-ChildStudyTourforThalassemiaFamilies.Designed
as an immersive science-themed educational tour, the program aimed to empower children living with thalassemia
by fostering their social inclusion. The nine young participants were selected from families previously supported by
BGI Genomics. Through a thoughtfully curated itinerary spanning three provinces, the initiative created meaningful
opportunitiesforthesechildrentoconnectwithsociety,experiencecareandencouragement,andbuildself-conGdence
and social engagement. This effort not only embodied BGI Genomics5 deep commitment to social responsibility but
also!throughsubsequentoutreach!signiGcantlyheightenedpublicawarenessandunderstandingofinheritedgenetic
Leaping Over the Thalassemia Poverty Line, Little Dreamers Building utures The irst Parent-Child Study Tour for
disorders,helpingcultivateamorecompassionateandinclusiveenvironmentforindividualsaFectedbysuchconditions. Thalassemia amilies Event
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Key performance
Indicator Unit 204 205 Indicator Unit 204 205
I.GovernancePerformance Signingrateofsupplierintegrityagreements % 10 10
NumberofShareholders5Meetingsheld Times 4 3 Numberofannualfaircompetitionviolations Cases 0 0
NumberofBoardmeetingsheld Times 7 4 Totalnumberofannualcompliancetrainingsessions Sessions / 27
TotalnumberofBoardSpecialCommitteemeetingsheld Times 13 6 Numberofdatasecurity/customerprivacybreachincidents Cases 0 0
AverageBoardattendancerate % 10 10 Financialimpactofdatasecurity/customerprivacybreaches RMB 0 0
ProportionofindependentdirectorsontheBoard % 3. 3. Numberofannualinformationsecurityandcustomerprivacytrainingsessions
Sessions 13 8
ProportionoffemaledirectorsontheBoard % 1. 1. Numberofparticipantsinannualinformationsecurityandcustomerprivacy
Person-
/ 542
training times
Numberofannualdirectortrainingsessions Times / 3
Numberofannualinformationsecurityemergencydrills Sessions / 2
Numberofincidentsinvolvingmajorpubliccontroversyorrevenuelosses
Times 0 0
exceeding0.5%duetoadministrativepenalties Informationsecurityincidentresponserate % / 10
Timelyresolutionrateofhighcompliancerisks % 10 10 II.InnovationandOperationalPerformance
Complianceincidentresponserate % 10 10 Productconformityrate % / 9.5
Legalproceedingresponserate % 10 10 RMB
R&Dinvestmentamount 67,94.5 50,82.
Numberofexternaldisclosuresissuedduringtheyear Copies 152 14
ProportionofR&Dinvestmenttooperatingrevenue % 17.5 13.7
Numberofregulatorypenaltiesfordisclosureviolations Cases 0 0
NumberoftimesachievingfullscoresindomesticandinternationalproGciency
Times Over80 Over80
testingannually
Numberofannualearningscallsheld Times 4 3
Timelyresponseratetoqualityissues % 10 10
NumberofannualoJineresearcheventsorganized/participatedin Sessions 23 20
Customerfeedbackresponserate % 10 10
Numberofannualonlineinstitutionalresearchsessions Times 5 3
Annualoverallcustomersatisfaction % 9 9
NumberofannualoJineroadshows(includinginstitutionalstrategy
Sessions 7 2
conferences)
Numberofcustomersatisfactionsurveyresponsescollectedannually
Copies 976 1,094
Numberofannualanti-briberyandanti-corruptiontrainingsessions Sessions 12 13
Customercomplaintresolutionrate % 10 10
Person-
Numberofparticipantsinanti-briberyandanti-corruptiontraining / 82
times Numberofannualcustomerservicetrainingsessions Sessions / 7
Signingrateofemployeecompliance/ integritypledges % 10 10 Trainingcoveragerateofcustomerservicepersonnel % / 10
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Indicator Unit 204 205 Indicator Unit 204 205
III.SocialandEmployeePerformance Numberofwork-relatedinjuriesandoccupationalillnessincidentsduringthe
Times 0 0
year
Totalnumberofemployeesatyear-end Persons 3,702 3,580
Cumulativenumberofseverethalassemiapublicwelfaresamplestestedbythe
Cases 21,965 23,4
HuaFoundation
Numberofnewhiresduringtheyear Persons 530 348
CumulativenumberofthalassemiachildrenhelpedbytheHuaFoundationto
Proportionoffemaleemployees % 57 57 Persons 805 85
Gndfullymatcheddonors
Numberofinternationalemployees Persons 79 5
Cumulativenumberofchildrenwithseverethalassemiaassisted Persons Nearly50 Over70
Numberofemployeeswithdisabilities Persons / 16
IV.EnvironmentalPerformance
Laborcontractsigningrateforfull-timeemployees % 10 10
RMB
Totalannualinvestmentinenvironmentalmanagement 152.7 12.95
Socialinsurancecoveragerate % 10 10
Numberofannualadministrativepenaltiesforenvironmentalincidents
Times 0 0
NumberofconGrmedincidentsofdiscrimination/childlabor/forcedlabor Cases 0 0
Numberofannualemergencydrillsforsuddenenvironmentalincidents
Sessions / 17
Totalnumberofannualemployeetrainingsessions Sessions / 47
Person-
Numberofparticipantscoveredbyemergencydrills / 1,59
RMB times
Totalannualexpenditureonemployeetraining 31 102
Tonnesof
Totalannualtraininghours Hours 48,659 6,827 Totalannualenergyconsumption standard / 2,439.7
coal
Averageannualtraininghoursperemployee Hours 13 16.28
Annualpurchasedelectricity kWh / 19,842
Employeetrainingcoveragerate % 10 10
Annualtotalwaterwithdrawal Tonnes / 6,140
Annualoverallemployeesatisfaction % 9.63 98.03
Totalannualwastewaterdischarge Tonnes / 6,72.5
Employeeengagement % 7.2 7.2
Cubic
Totalannualexhaustgasemissions / 1,86432.
meter
RMB
Annualinvestmentinemployeecommercialinsurancepremiums / Over13
Totalannualhazardouswastegenerated Tonnes / 136.5
Employeecommercialinsurancecoveragerate % 10 10
TotalhazardouswastegeneratedperRMB10millioninrevenue Tonnes / 3.69
RMB
Annualspecializedinvestmentinoccupationalhealthandsafety 29.7 3.97
Numberofemployeesinkeypositionsreceivingspecializedoccupational
Persons 31 213
diseasescreeningsannually
Occupationaldiseasescreeningcoveragerate % 10 10
Annualworksafetytrainingcoveragerate % 10 10
Numberofmajorworksafetyaccidentsduringtheyear Cases 0 0
BGI Genomics Co., Ltd. 2025 Environmental, Social and Governance Report
Benchmarking Index
Relevantprovisions Self-
of Regulatory Relevantprovisions Self-
of Regulatory
GuidelinesNo.17forListedCompanies GuidelinesNo.17forListedCompanies
GRIof
Relevantprovisions Standards GRIof
Relevantprovisions Standards
Reportsection onShenzhenStockExchange!? Reportsection onShenzhenStockExchange!?
SustainabilityReport(forTrial SustainabilityReport(forTrial
Implementation) Implementation)
Corporategovernance Article1,Article12 GRI2:GeneralDisclosures Employeetraininganddevelopment
Article50 GRI40:TrainingandEducation
Riskandcompliancemanagement Article18,Article52 GRI207:Compliance Occupationalhealthandsafety Article51 GRIOccupational
:304 HealthandSafety
Article53,Article54,Article5,Article GRI205:Anti-corruption,GRI206:Anti- Medicalaccessibilityandequitable
Businessethics Article39,Article46 GRI203:IndirectEconomicImpacts
Productsafetyandquality Article40,Article41 GRI416:CustomerHealthandSafety
Customerservice Article41 GRI416:CustomerHealthandSafety
Innovation-drivendevelopment Article38 GRI201:EconomicPerformance
Datasecurityandcustomerprivacy
Article42,Article43 GRI418:CustomerPrivacy
protection
GRI308:SupplierEnvironmental
Supplychainmanagement Article4,Article45 Assessment,GRI41:SupplierSocial
Assessment
Industrycollaboration Article54 GRI206:Anti-competitiveBehavior
Environmentalcompliance
Article29 GRI207:Compliance
management
PollutantandwastemanagementArticle30,Article31 GRI305:Emissions,GRI306:Waste
GRI305:Emissions,GRI201:Economic
Addressingclimatechange Article20toArticle28
Performance
Energymanagementandcircular GRI302:Energy,GRI30:Waterand
Article34,Article35,Article37
economy EJuents,GRI306:Waste
Ecosystemandbiodiversity
Article32 GRI304:Biodiversity
conservation
Employeeemployment GRI401:Employment,GRI405:Diversity
Article49 andEqualOpportunity,GRI406:Non-
Protectionofemployeerights discrimination
BGI Genomics Co., Ltd.
Reader Feedback
DearReaders,
Hello! Thank you very much for taking the time to read the 205 Environmental, Social, and Governance Report of
BGI Genomics Co., Ltd. To provide you and other stakeholders with more valuable information and continuously
enhanceourESGmanagementandreportingquality,wesincerelywelcomeyourfeedbackandsuggestions.
√ ) box
Multiple-choicequestions(Pleaseticktheappropriate
WhatisyouroverallevaluationofthisReport?
HowwelldoestheReportaddressanddiscloseissuesofconcerntostakeholders?
? Excellent ?
? Good ? ? Fair ? ? Poor ? ? Verypoor
HowwouldyourateBGIGenomics5performanceingovernanceresponsibility?
? Excellent ?
? Good ? ? Fair ? ? Poor ? ? Verypoor
HowwouldyourateBGIGenomics5performanceinindustrialdevelopmentandinnovationresponsibility?
? Excellent ?
? Good ? ? Fair ? ? Poor ? ? Verypoor
HowwouldyourateBGIGenomics5performanceinenvironmentalresponsibility?
? Excellent ?
? Good ? ? Fair ? ? Poor ? ? Verypoor
HowwouldyourateBGIGenomics5performanceinemployeeandsocialresponsibility? Address: BGI Center, No. 9 Yunhua Road, Yantian District, Shenzhen, China
Postal Code: 518083
? Excellent ?
? Good ? ? Fair ? ? Poor ? ? Verypoor
Tel: +86-755-36307265
Email: ir@bgi.com
Istheinformation,indicators,anddatadisclosedintheReportclear,accurate,andcomplete?
? Excellent ?
? Good ? ? Fair ? ? Poor ? ? Verypoor Website: www.bgi.com
DoyouGndthecontentarrangementandlayoutdesignofthisReporteasytoread?
?? Yes ? ? No
Open-endedquestions
DoyouhaveanycommentsorsuggestionsregardingBGIGenomics5ESGresponsibilitiesandthisReport? BGI Genomics Website BGI Genomics Official
WeChat Account
首页
微信公众号
证券之星APP
